Clinical Trials - LLY

NCT IDTitleStatusPhasesStart DateCompletion DatePrimary Completion Date
NCT07165028A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)NOT_YET_RECRUITINGPHASE32025-122032-082030-08
NCT07101328A Study of LY4152199 in Participants With Previously Treated B-cell Cancers and LeukemiaNOT_YET_RECRUITINGPHASE12025-122029-032027-04
NCT07186101LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:NOT_YET_RECRUITINGPHASE22025-112029-032027-05
NCT07213804A Two-Part Phase 3 Study of LY4170156 in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Part B) Ovarian CancerNOT_YET_RECRUITINGPHASE32025-112031-082028-04
NCT07202871A Study of How the Body Absorbs LY3537031NOT_YET_RECRUITINGPHASE12025-112026-092026-01
NCT07202884A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or OverweightNOT_YET_RECRUITINGPHASE32025-102028-032028-03
NCT07213791A Study of LY4337713 in Participants With FAP-Positive Solid TumorsNOT_YET_RECRUITINGPHASE12025-102033-032028-07
NCT07174336A Study of LY4064809 With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)NOT_YET_RECRUITINGPHASE32025-102033-052029-05
NCT07169851A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With CancerNOT_YET_RECRUITINGPHASE22025-102026-092026-09
NCT07165002A Study of the Pharmacokinetics and Safety of LY3537031 in Participants With Normal Liver Function and With Mild, Moderate, or Severe Liver ImpairmentNOT_YET_RECRUITINGPHASE12025-102026-082026-08
NCT07157774Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)RECRUITINGPHASE32025-09-022031-032031-03
NCT07153471A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the KneeNOT_YET_RECRUITINGPHASE32025-092028-052028-04
NCT07124013A Study of Olomorasib (LY3537982) in Healthy Japanese ParticipantsNOT_YET_RECRUITINGPHASE12025-092025-122025-12
NCT07165015A Study of Pharmacokinetics and Safety of LY3537031 in Participants With Normal Renal Function and Participants With Renal ImpairmentNOT_YET_RECRUITINGPHASE12025-092026-032026-03
NCT07142954Epidemiology and Biomarker Study in Alzheimer's DiseaseNOT_YET_RECRUITINGPHASE32025-092033-072033-07
NCT07100119A Study of LY4256984 in Participants With Sporadic Amyotrophic Lateral SclerosisNOT_YET_RECRUITINGPHASE12025-092027-092027-08
NCT07152002A Study of LY4064912 in Healthy Participants and With Overweight or ObesityRECRUITINGPHASE12025-08-282026-102026-10
NCT07030127A Study of LY3985863 in Healthy ParticipantsRECRUITINGPHASE12025-08-112026-042026-04
NCT07162181Long-Term Safety of Pirtobrutinib in Participants With Previously Treated Types of Blood CancersRECRUITINGPHASE22025-08-072030-052030-05
NCT07114601A Study of LY4257496 in Participants With Cancer (OMNIRAY)RECRUITINGPHASE12025-08-062035-042030-04
NCT07137689A Study of LY3537982 in Participants With Kidney Problems Compared With Participants With Normal Kidney FunctionNOT_YET_RECRUITINGPHASE12025-082026-032026-03
NCT07140744A Study Evaluating the Impact of P-tau217 Blood Biomarker Testing on Early Evaluation and Management of Patients Presenting With Cognitive ComplaintNOT_YET_RECRUITINGNA2025-082027-102027-10
NCT07073170A Study of LY3549492 in Chinese Participants With Type 2 Diabetes MellitusNOT_YET_RECRUITINGPHASE12025-082026-062026-06
NCT06721013A Study of Pirtobrutinib in Participants With Immune ThrombocytopeniaRECRUITINGPHASE1, PHASE22025-07-302027-022026-12
NCT07046923A Study of LY4175408 in Participants With Advanced CancerRECRUITINGPHASE12025-07-282030-072030-07
NCT07090785A Study of LY4088044 in Healthy ParticipantsRECRUITINGPHASE12025-07-242027-112027-11
NCT07085468A Study of LY3549492 in Healthy Weight Adult ParticipantsTERMINATEDPHASE22025-07-212025-08-142025-08-14
NCT07044271A Study of Multiple Olomorasib (LY3537982) Capsules in Healthy ParticipantsNOT_YET_RECRUITINGPHASE12025-072025-112025-09
NCT06937086Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b StudyRECRUITINGPHASE32025-06-262028-042028-04
NCT06937099Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or OverweightRECRUITINGPHASE32025-06-262028-052028-05
NCT07056309A Study of Remternetug (LY3372993) in Healthy ParticipantsACTIVE_NOT_RECRUITINGPHASE12025-06-242025-122025-12
NCT07039045A Study of [14C]-LY4065967 in Healthy ParticipantsCOMPLETEDPHASE12025-06-232025-08-162025-08-16
NCT07030868A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 DiabetesTERMINATEDPHASE22025-06-192025-07-292025-07-29
NCT07006792A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch BurdenRECRUITINGPHASE42025-06-162026-092026-04
NCT07005284A Study of LY3981314 in Healthy ParticipantsRECRUITINGPHASE12025-06-092027-022027-02
NCT06982846A Study to Investigate the Response of Participants With Type 2 Diabetes Mellitus on Once-Weekly Retatrutide to HypoglycemiaRECRUITINGPHASE12025-06-062026-052026-05
NCT06982859A Study to Evaluate the Effect of Retatrutide on Insulin Secretion and Insulin Sensitivity in Adult Participants With Type 2 Diabetes MellitusRECRUITINGPHASE12025-06-022026-112026-11
NCT07035093A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back PainRECRUITINGPHASE32025-05-292027-092027-09
NCT07021547A Study of LY3867070 in Healthy ParticipantsRECRUITINGPHASE12025-05-272026-082026-08
NCT06901349A Study of Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Participants With Obesity or Overweight With Type 2 DiabetesWITHDRAWNPHASE22025-05-232025-06-102025-06-10
NCT06991179A Study of Food Effect and Esomeprazole on LY4064809 in Healthy Adult ParticipantsCOMPLETEDPHASE12025-05-202025-09-022025-09-02
NCT06876649A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) PirtobrutinibRECRUITINGPHASE42025-05-202032-122030-05
NCT06876662A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin LymphomaRECRUITINGPHASE42025-05-202032-122030-05
NCT06972472A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 DiabetesRECRUITINGPHASE32025-05-192027-082027-01
NCT06945406A Study of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 DiabetesRECRUITINGPHASE12025-05-162026-122026-12
NCT06972459A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related ComorbidityRECRUITINGPHASE32025-05-152027-082027-01
NCT06993792A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 DiabetesRECRUITINGPHASE32025-05-152027-082027-01
NCT07046559A Single- and Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY4066708 in Healthy ParticipantsRECRUITINGPHASE12025-05-132027-092027-09
NCT06962280A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or OverweightRECRUITINGPHASE32025-05-122027-122027-04
NCT06869018A Study of LY3549492 in Japanese Participants With Type 2 Diabetes Mellitus (T2D) and Healthy Japanese ParticipantsRECRUITINGPHASE12025-05-072026-022026-02
NCT06964776A Study of LY4268989 (MORF-057) in Healthy ParticipantsRECRUITINGPHASE12025-05-012025-122025-12
NCT06948422A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening)RECRUITINGPHASE32025-04-302027-092027-09
NCT06948435A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1RECRUITINGPHASE32025-04-302027-092027-09
NCT06952530A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2RECRUITINGPHASE32025-04-302027-092027-09
NCT06914895A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or OverweightRECRUITINGPHASE32025-04-252027-052027-05
NCT06945419A Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 DiabetesRECRUITINGPHASE12025-04-232026-042026-04
NCT06916078A Study of Lepodisiran (LY3819469) in Participants With Normal, Mild, Moderate, or Severe Liver FunctionRECRUITINGPHASE12025-04-232026-012026-01
NCT06921759A Study to Investigate the Efficacy and Safety of Lebrikizumab in Participants With Moderate-to-Severe Atopic Hand and Foot DermatitisRECRUITINGPHASE32025-04-212026-092026-07
NCT06916091A Study of Eloralintide (LY3841136) in Chinese Participants With Obesity or OverweightACTIVE_NOT_RECRUITINGPHASE12025-04-212025-092025-08
NCT06916065A Study of Eloralintide (LY3841136) and Eloralintide With Tirzepatide in Participants With Overweight or ObesityRECRUITINGPHASE12025-04-092025-122025-12
NCT06916143Comparing the Extent to Which Three Different Formulations of LY4100511 (DC-853) Are Made Available in the Body, Alone and in the Presence of a Drug That Reduces Stomach AcidRECRUITINGPHASE12025-04-082026-012026-01
NCT06897475A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or TirzepatideRECRUITINGPHASE22025-03-282027-012026-12
NCT06890598Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung CancerRECRUITINGPHASE32025-03-272032-022029-05
NCT06890611A Study of Bimagrumab Alone (LY3985863) and Bimagrumab With Tirzepatide (LY900042) in Healthy ParticipantsCOMPLETEDPHASE12025-03-252025-09-262025-09-26
NCT06901336A Study of LY4064809 [14C]-STX-478 in Healthy Male ParticipantsCOMPLETEDPHASE12025-03-202025-05-062025-05-06
NCT06859294A Study of LY3541860 in Adult Participants With Moderately to Severely Active Rheumatoid ArthritisRECRUITINGPHASE22025-03-192026-092026-02
NCT06857942A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)RECRUITINGPHASE42025-03-192026-102026-10
NCT06864026A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)RECRUITINGPHASE42025-03-062027-022027-02
NCT06859268A Study of Retatrutide (LY3437943) in the Maintenance of Weight Reduction in Individuals With ObesityACTIVE_NOT_RECRUITINGPHASE32025-03-052028-042028-04
NCT06977880A Phase 1, First-in-human Study of MORF-440 (LY4292009) in Healthy ParticipantsRECRUITINGPHASE12025-02-192026-012026-01
NCT06809400A Study of LY4006896 in Healthy Participants and Participants With Parkinson's DiseaseRECRUITINGPHASE12025-02-182028-012028-01
NCT06824051A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or OverweightACTIVE_NOT_RECRUITINGPHASE12025-02-172025-122025-12
NCT06817356A Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use DisorderRECRUITINGPHASE22025-02-062026-082026-08
NCT06808802To Investigate the Effect of Retatrutide (LY3437943) on Metoprolol Pharmacokinetics in Healthy ParticipantsCOMPLETEDPHASE12025-02-032025-04-152025-04-15
NCT06739122A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)RECRUITINGPHASE32025-01-102026-072026-06
NCT06588478A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaRECRUITINGPHASE22025-01-032028-122028-06
NCT06692348A Study of Orforglipron (LY3502970) to Compare a Single Capsule and Multiple Capsules in Healthy ParticipantsCOMPLETEDPHASE12024-12-132025-06-092025-06-09
NCT06719128A Study of Olomorasib (LY3537982) in Participants With Hepatic Impairment and Healthy ParticipantsCOMPLETEDPHASE12024-12-062025-08-252025-08-25
NCT06704763A Drug-Drug Interaction Study of Orforglipron (LY3502970) With Quinidine in Healthy ParticipantsCOMPLETEDPHASE12024-12-062025-02-052025-02-05
NCT06709820A Study of LY4060874 in Healthy ParticipantsACTIVE_NOT_RECRUITINGPHASE12024-12-022025-122025-12
NCT06672939A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related ComorbiditiesRECRUITINGPHASE32024-11-182027-032027-02
NCT06672549A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)RECRUITINGPHASE32024-11-182027-032027-02
NCT06683508A Study to Investigate Weight Management With LY3549492 Compared With Placebo in Adult Participants With Obesity or OverweightACTIVE_NOT_RECRUITINGPHASE22024-11-132026-092026-04
NCT06690996A Study of LY4005130 in Healthy ParticipantsRECRUITINGPHASE12024-11-082026-012026-01
NCT06662383A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have ObesityACTIVE_NOT_RECRUITINGPHASE32024-11-012026-122026-12
NCT06657768A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)RECRUITINGPHASE12024-10-292027-072027-07
NCT06644378A Study of [14C]-LY3866288 in Healthy ParticipantsCOMPLETEDPHASE12024-10-282025-01-032025-01-03
NCT06413706A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children and Young Adults With High-grade Glioma Following RadiotherapyRECRUITINGPHASE22024-10-252028-022027-11
NCT06602219A Study of LY4100511 (DC-853) in Adult Participants With Moderate-to-Severe Plaque PsoriasisCOMPLETEDPHASE22024-10-252025-09-042025-07-24
NCT06653153A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)RECRUITINGPHASE32024-10-242030-102029-04
NCT06649045A Master Protocol for Orforglipron in Participants With Obstructive Sleep Apnea and Obesity or OverweightACTIVE_NOT_RECRUITINGPHASE32024-10-222027-012026-11
NCT06594159A Study of LY4065967 in Healthy Japanese ParticipantsCOMPLETEDPHASE12024-10-222025-03-112025-03-11
NCT06607185A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid TumorsRECRUITINGPHASE12024-10-212030-012030-01
NCT06643728A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or OverweightACTIVE_NOT_RECRUITINGPHASE22024-10-212027-012026-04
NCT06641037A Study of LY3866288 in Healthy ParticipantsCOMPLETEDPHASE12024-10-172024-12-022024-12-02
NCT06635057A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During RamadanRECRUITINGPHASE42024-10-112026-042026-04
NCT06362265A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes MellitusRECRUITINGPHASE12024-10-102026-112026-11
NCT06598943A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative ColitisRECRUITINGPHASE22024-10-102028-092027-12
NCT06598631Efficacy and Safety of Volenrelaxin in Adults With Chronic Kidney DiseaseWITHDRAWNPHASE22024-10-092024-12-302024-12-30
NCT06588283Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or OverweightACTIVE_NOT_RECRUITINGPHASE32024-09-302026-052025-12
NCT06588296Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or OverweightACTIVE_NOT_RECRUITINGPHASE32024-09-242026-082026-04
NCT06603571A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 DiabetesACTIVE_NOT_RECRUITINGPHASE22024-09-202026-082026-06
NCT06561685A Study of LY4050784 in Participants With Advanced or Metastatic Solid TumorsRECRUITINGPHASE12024-09-192027-102027-10
NCT06584916A Study of Orforglipron for the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-MAINTAIN)ACTIVE_NOT_RECRUITINGPHASE32024-09-132026-012026-01
NCT06586515MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid TumorsRECRUITINGPHASE12024-09-122029-032029-03
NCT06606106A Study of LY3537031 in Overweight, Obese, and Healthy ParticipantsRECRUITINGPHASE12024-09-052026-072026-07
NCT06538116A Study of Mevidalen (LY3154207) in Participants With Alzheimer's DiseaseRECRUITINGPHASE22024-08-262026-012025-12
NCT06627088A Study of LY4100511 (DC-853) Mass Balance and Absolute Bioavailability of LY4100511 in Healthy Male ParticipantsCOMPLETEDPHASE12024-08-232024-12-312024-12-31
NCT06568042Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory PolyneuropathyRECRUITINGPHASE22024-08-222026-092026-06
NCT06557356A Study of LY3532226 in Participants With ObesityACTIVE_NOT_RECRUITINGPHASE12024-08-162025-112025-11
NCT06297590A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's DiseaseRECRUITINGPHASE12024-08-152027-022027-02
NCT06516913A Study of Subcutaneous Injection in Healthy ParticipantsCOMPLETEDNA2024-07-222024-09-072024-09-07
NCT06226883A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's DiseaseRECRUITINGPHASE22024-07-182028-082026-11
NCT06503679A Drug-drug Interaction Study Evaluating the Perpetrator Potential of LY4100511 (DC-853) on Midazolam, Repaglinide, Digoxin, Rosuvastatin in Healthy ParticipantsCOMPLETEDPHASE12024-07-162024-12-312024-12-31
NCT06465069A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid TumorsRECRUITINGPHASE12024-07-012027-052027-05
NCT06440980A Study to Compare Tablets and Capsules of Orforglipron (LY3502970) in Healthy Participants Who Are Obese or OverweightCOMPLETEDPHASE12024-06-242025-06-022025-06-02
NCT06475729A Bioequivalence Study of Citrate Free Mirikizumab (LY3074828) in Healthy ParticipantsCOMPLETEDPHASE12024-06-242024-12-272024-12-27
NCT06395012A First-In-Human Study of LY3985297 in Healthy ParticipantsCOMPLETEDPHASE12024-06-072025-08-062025-08-06
NCT06444165Lebrikizumab Pen Ease of Use in Participants With Atopic DermatitisCOMPLETEDPHASE32024-06-042024-06-102024-06-10
NCT06439277A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)RECRUITINGPHASE32024-06-032030-122027-10
NCT06400472A Study of LY4170156 in Participants With Selected Advanced Solid TumorsRECRUITINGPHASE12024-05-202027-042027-02
NCT06280703A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)RECRUITINGPHASE12024-05-152025-102025-10
NCT06370728A Drug-Drug Interaction (DDI) Study of Orforglipron With Carbamazepine in Healthy ParticipantsCOMPLETEDPHASE12024-05-062024-07-232024-07-23
NCT06104683A Study of Pirtobrutinib (LY3527727 [LOXO-305]) Versus Placebo in Participants With Relapsing Multiple SclerosisWITHDRAWNPHASE22024-05-012026-02-132026-01-16
NCT06383390The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)RECRUITINGPHASE32024-04-302029-022029-02
NCT06338995A Study of Lebrikizumab (LY3650150) in Adult Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)RECRUITINGPHASE32024-04-292027-022026-10
NCT06339008A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1)RECRUITINGPHASE32024-04-262027-022025-10
NCT06373146A Study of Tirzepatide (LY3298176) Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With ObesityACTIVE_NOT_RECRUITINGPHASE22024-04-242026-042025-12
NCT06280716A Study of Lebrikizumab (LY3650150) With/Without Topical Corticosteroid Treatment in Participants With Moderate-to-Severe Atopic DermatitisACTIVE_NOT_RECRUITINGPHASE32024-04-242026-082025-09
NCT06370715A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in IndiaACTIVE_NOT_RECRUITINGPHASE42024-04-182025-102025-10
NCT06297616A Study of LY3841136 in Japanese Participants With Obesity or OverweightACTIVE_NOT_RECRUITINGPHASE12024-04-152025-112025-11
NCT06354660Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1)ACTIVE_NOT_RECRUITINGPHASE32024-04-102026-022026-01
NCT06229366[Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate CancerRECRUITINGPHASE12024-04-032032-122027-09
NCT06345794A Study to Assess LY4100511 (DC-853) in Healthy Adult ParticipantsCOMPLETEDPHASE12024-04-032024-06-182024-06-18
NCT06345066A Study of LY3841136 in Overweight and Obese ParticipantsACTIVE_NOT_RECRUITINGPHASE12024-04-032025-102025-10
NCT06243198A Study to Investigate the Safety and Pharmacokinetics of Lebrikizumab in Healthy Chinese ParticipantsCOMPLETEDPHASE12024-03-282024-09-032024-09-03
NCT06313528A Study to Measure Calorie Consumption and Usage in Participants With Obesity Using LY3437943COMPLETEDPHASE12024-03-202025-08-262025-08-26
NCT06220669A Study of LY3541860 in Adult Participants With Relapsing Multiple SclerosisRECRUITINGPHASE22024-03-192028-082027-08
NCT06311656A Study to Evaluate Safety, Tolerability of LY4100511 (DC-853) in Healthy Asian and Non-Asian ParticipantsCOMPLETEDPHASE12024-03-192024-10-042024-10-04
NCT06297603Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)RECRUITINGPHASE32024-03-152026-102026-09
NCT05509777A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's DiseaseRECRUITINGPHASE32024-03-132028-042027-12
NCT06292013A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)RECRUITINGPHASE32024-03-052029-032029-03
NCT06238479A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid TumorsRECRUITINGPHASE12024-03-052027-032027-03
NCT06342596A Study of Carbon-14-Labelled [14C] LY3473329 in Healthy Male ParticipantsCOMPLETEDPHASE12024-03-052024-05-012024-05-01
NCT06235983A Study of LY3537982 in Chinese Participants With Advanced Solid TumorsACTIVE_NOT_RECRUITINGPHASE12024-02-292027-042026-04
NCT06260722Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)ACTIVE_NOT_RECRUITINGPHASE32024-02-212027-012026-08
NCT06230523A Study of LY3841136 Compared With Placebo in Adult Participants With Obesity or OverweightCOMPLETEDPHASE22024-02-052025-08-142025-05-30
NCT05999968Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial TreatmentACTIVE_NOT_RECRUITINGPHASE12024-01-122026-072024-02-23
NCT06173895A Relative Bioavailability Study of LY3454738 in Healthy ParticipantsCOMPLETEDPHASE12024-01-122024-05-022024-05-02
NCT06192108A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With MetforminACTIVE_NOT_RECRUITINGPHASE32024-01-102025-092025-09
NCT06194500A Study of Carbon-14-Labeled [14C]-LY3549492 in Healthy ParticipantsCOMPLETEDPHASE12024-01-032024-02-152024-02-15
NCT06186622A Drug-Drug Interaction Study of Orforglipron (LY3502970) in Healthy Overweight and Obese ParticipantsCOMPLETEDPHASE12024-01-022024-07-102024-07-10
NCT06119581A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung CancerRECRUITINGPHASE32023-12-212029-102026-10
NCT06148272A Study of LY3971297 in Healthy ParticipantsRECRUITINGPHASE12023-12-072025-122025-12
NCT06169982A Multiple Dose Study of LY3209590 in Participants With Type 2 DiabetesCOMPLETEDPHASE12023-12-072024-07-182024-07-18
NCT06176768A Study of LY3972406 in Adult Participants With Moderate-to-Severe Plaque PsoriasisCOMPLETEDPHASE22023-12-062025-05-062025-04-01
NCT06153355A First-In-Human Study of LY3839840 in Healthy ParticipantsCOMPLETEDPHASE12023-12-042025-05-222025-05-22
NCT05784246A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to Severely or Active Ulcerative ColitisRECRUITINGPHASE32023-11-222026-082026-05
NCT06143956A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or OverweightRECRUITINGPHASE22023-11-172026-112026-09
NCT06124807A Study of LY3305677 Compared With Placebo in Adult Participants With Obesity or OverweightCOMPLETEDPHASE22023-11-172025-07-092025-01-22
NCT06132126A Study to Investigate the Safety and Tolerability of LY3938577 in Healthy Participants and Participants With Type 2 Diabetes MellitusCOMPLETEDPHASE12023-11-172024-06-282024-06-28
NCT06109311A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 InhibitorACTIVE_NOT_RECRUITINGPHASE32023-11-102025-092025-09
NCT06119529A Study of LY3872386 in Healthy Participants and Participants With Atopic DermatitisTERMINATEDPHASE12023-11-012024-04-082024-04-08
NCT06111521A Drug-Drug Interaction Study of LY3537982 on Midazolam, Digoxin, and Rosuvastatin in Healthy ParticipantsCOMPLETEDPHASE12023-10-272024-04-012024-04-01
NCT06046729A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis SuppurativaACTIVE_NOT_RECRUITINGPHASE22023-10-232026-082025-10
NCT06102512A Study of [14C]-LOXO-783 in Healthy Adult ParticipantsCOMPLETEDPHASE12023-10-232024-01-172023-12-23
NCT06085482A Phase I Study of LY3502970 in Healthy ParticipantsCOMPLETEDPHASE12023-10-192024-01-052024-01-05
NCT06075667A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related ComorbiditiesACTIVE_NOT_RECRUITINGPHASE32023-10-162029-072026-05
NCT06092931A Drug-Drug Interaction Study Evaluating the Perpetrator Potential of DC-806 on Cocktails of CYP450 Enzyme and Transporter Substrates in Healthy ParticipantsCOMPLETEDPHASE12023-10-162023-11-282023-11-28
NCT06074562A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic PainCOMPLETEDPHASE22023-10-052025-06-112025-06-11
NCT05893797A Study of LY8888AX in Participants Using a Connected Insulin Management PlatformCOMPLETEDNA2023-10-052024-09-162024-09-16
NCT06010004A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 DiabetesCOMPLETEDPHASE32023-09-282025-06-052025-06-05
NCT06045221A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With MetforminCOMPLETEDPHASE32023-09-222025-08-222025-08-22
NCT06037252A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and ObesityACTIVE_NOT_RECRUITINGPHASE22023-09-212026-102026-01
NCT06023095A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related ComorbiditiesCOMPLETEDPHASE12023-09-212024-07-292024-07-29
NCT06047548A Study of LY3298176 (Tirzepatide) For the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related ComorbiditiesACTIVE_NOT_RECRUITINGPHASE32023-09-202026-052026-05
NCT06052462A Study of Carbon-14-Labelled [14C] LY3556050 in Healthy Male ParticipantsCOMPLETEDPHASE12023-09-202023-11-042023-11-04
NCT06049108A Study of Carbon-14-Labelled [14C] LY3871801 in Healthy Male ParticipantsCOMPLETEDPHASE12023-09-152023-11-032023-11-03
NCT06045000Mass Balance and Pharmacokinetics (PK) of [14C]-DC-806 in Healthy Male ParticipantsCOMPLETEDPHASE12023-09-142023-10-022023-10-02
NCT06039826A Study of LY3437943 in Postmenopausal Female Participants Who Are Overweight or ObeseCOMPLETEDPHASE12023-09-122024-07-112024-07-11
NCT06028425A Study to Evaluate the Effect of Food on LOXO-783 in Healthy ParticipantsCOMPLETEDPHASE12023-09-012023-12-232023-12-23
NCT06003465A Research Study Looking at Similarity Between LY3437943 Versions for Different Injection DevicesCOMPLETEDPHASE12023-08-292024-02-082024-02-08
NCT06007638A Single and Multiple Ascending Dose Study of LY3876602 in Healthy ParticipantsCOMPLETEDPHASE12023-08-232025-09-202025-09-20
NCT05963022A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes (SURPASS-CN-MONO)COMPLETEDPHASE32023-08-212024-10-092024-10-09
NCT06007651A Study of LY3885125 in Participants With Dyslipidemia or Non-Alcoholic Fatty Liver Disease (NAFLD)TERMINATEDPHASE12023-08-102025-02-122025-02-12
NCT05971940A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise AloneCOMPLETEDPHASE32023-08-092025-04-032025-04-03
NCT05960851A Study of LY3871801 in Healthy Asian and Non-Asian ParticipantsCOMPLETEDPHASE12023-08-092023-10-252023-10-25
NCT05994807A Drug-Drug Interaction Study to Assess the Pharmacokinetics of DC-806 When Orally Administered Alone, When Coadministered With Itraconazole, and When Coadministered With Carbamazepine in Healthy Adult ParticipantsCOMPLETEDPHASE12023-08-082023-09-202023-09-20
NCT05931367A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the KneeACTIVE_NOT_RECRUITINGPHASE32023-08-012025-122025-12
NCT05931380A Study of Once-Daily Oral Orforglipron (LY3502970) in Japanese Adult Participants With Obesity DiseaseCOMPLETEDPHASE32023-07-312025-06-192025-06-19
NCT05978713A Study of Tirzepatide (LY3298176) in Healthy Lactating FemalesCOMPLETEDPHASE12023-07-312024-03-122024-03-12
NCT05906836A Drug Drug Interaction (DDI) Study of Selpercatinib (LY3527723) and Rosuvastatin in Healthy ParticipantsCOMPLETEDPHASE12023-07-272023-10-312023-10-31
NCT05959109A Relative Bioavailability Study of Peresolimab (LY3462817) Formulations in Healthy ParticipantsCOMPLETEDPHASE12023-07-212024-01-112024-01-11
NCT05936151A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 DiabetesACTIVE_NOT_RECRUITINGPHASE22023-07-202025-112025-11
NCT05959096A Study of LY3437943 in Healthy Participants With a High Body Mass IndexCOMPLETEDPHASE12023-07-182024-07-252024-07-25
NCT05916560A Study of LY3437943 in Participants With Impaired and Normal Liver FunctionCOMPLETEDPHASE12023-07-132025-03-022025-03-02
NCT05936138A Study of LY3502970 in Participants With Normal and Impaired Renal FunctionCOMPLETEDPHASE12023-07-132024-04-112024-04-11
NCT05929079A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or OverweightACTIVE_NOT_RECRUITINGPHASE32023-07-112026-052026-05
NCT05929066A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or OverweightACTIVE_NOT_RECRUITINGPHASE32023-07-102026-052026-04
NCT05932446A Study to Compare Two Formulations of LY3819469 in Healthy ParticipantsCOMPLETEDPHASE12023-06-302023-11-072023-11-07
NCT05855967A Study of Ixekizumab (LY2439821) in Participants Aged ≥18 Years With Moderate-to-Severe Plaque or Active Psoriatic Arthritis in IndiaCOMPLETEDPHASE42023-06-272024-09-232024-08-08
NCT05914688A Study to Compare Two Formulations of LY3209590 in Healthy ParticipantsCOMPLETEDPHASE12023-06-262024-01-182024-01-18
NCT05911841A Study of LY3454738 in the Treatment of Adult Participants With Moderate-to-Severe Atopic DermatitisTERMINATEDPHASE22023-06-212025-03-142024-10-10
NCT05882032A Study of LY3502970 in Participants With Impaired and Normal Liver FunctionCOMPLETEDPHASE12023-06-132024-11-182024-11-18
NCT05887999A Study of LY3532226 in Participants With Type 1 Diabetes MellitusCOMPLETEDPHASE12023-06-122024-02-212024-02-21
NCT05894928A Study to Evaluate the Effect of Cholestyramine on LOXO-783 in Healthy ParticipantsCOMPLETEDPHASE12023-06-072023-07-092023-07-09
NCT05872620A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 DiabetesCOMPLETEDPHASE32023-06-052025-08-082025-08-08
NCT05869903A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related ComorbiditiesACTIVE_NOT_RECRUITINGPHASE32023-06-052027-102025-07-25
NCT05901311A Study of [14C]-LY3537982 in Healthy ParticipantsCOMPLETEDPHASE12023-06-052023-08-102023-08-10
NCT05882045A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular DiseaseACTIVE_NOT_RECRUITINGPHASE32023-05-302026-052026-04
NCT05848258An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid ArthritisRECRUITINGPHASE22023-05-232026-072026-02
NCT05767021A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative ColitisACTIVE_NOT_RECRUITINGPHASE32023-05-172025-092024-08-09
NCT05860933A Study of the Effects of Itraconazole or Carbamazepine on LY3537982 in Healthy ParticipantsCOMPLETEDPHASE12023-05-082023-08-282023-08-28
NCT05896527A Study to Evaluate the Efficacy and Safety of DC-806 in Participants With Moderate to Severe Plaque PsoriasisCOMPLETEDPHASE22023-05-022024-03-252024-03-25
NCT05841238A Multiple Dose Study of LY3502970 in Healthy Overweight and Obese ParticipantsCOMPLETEDPHASE12023-04-262023-11-132023-09-14
NCT05841277A Study of LY3819469 in Participants With Impaired and Normal Renal FunctionCOMPLETEDPHASE12023-04-252024-01-092024-01-09
NCT05822830A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related ComorbiditiesCOMPLETEDPHASE32023-04-212024-11-132024-11-13
NCT05768139First-in-Human Study of STX-478 as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid TumorsRECRUITINGPHASE1, PHASE22023-04-172030-072030-07
NCT05824858A Study of the Effect of Food on LY3537982 in Healthy ParticipantsCOMPLETEDPHASE12023-04-122023-06-172023-06-17
NCT05803421A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular RiskACTIVE_NOT_RECRUITINGPHASE32023-04-032026-032026-03
NCT05810597A Research Study Looking at Similarity Between Tirzepatide Versions for Different Injection DevicesCOMPLETEDPHASE12023-04-032023-07-172023-07-17
NCT05794243A Multiple-Dose Study of LY3493269 in Healthy ParticipantsTERMINATEDPHASE12023-03-232023-06-202023-06-20
NCT05778864A Study of LY3473329 in Participants With Impaired and Normal Renal FunctionCOMPLETEDPHASE12023-03-172024-09-062024-09-06
NCT05757531A Study of Carbon-14-Labelled [14C] LY3437943 in Healthy Male ParticipantsCOMPLETEDPHASE12023-03-172023-06-232023-06-23
NCT05735483A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic DermatitisENROLLING_BY_INVITATIONPHASE32023-03-092029-042027-12
NCT05706506A Study of Tirzepatide (LY3298176) in Adults With Type 2 Diabetes Switching From a GLP-1 RA (SURPASS-SWITCH-2)COMPLETEDPHASE42023-03-082023-10-312023-10-31
NCT05738486A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6)ACTIVE_NOT_RECRUITINGPHASE32023-02-282025-052024-05-16
NCT05723198A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia AreataRECRUITINGPHASE32023-02-272029-082027-09
NCT05749848A Study of Carbon-14-Labelled [14C] LY3372689 in Healthy Male ParticipantsCOMPLETEDPHASE12023-02-242023-04-182023-04-18
NCT06937411A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of DC-853 in Healthy ParticipantsCOMPLETEDPHASE12023-02-132023-10-302023-10-30
NCT05727072A Study of LY3848575 in Healthy ParticipantsCOMPLETEDPHASE12023-02-102024-02-192024-02-19
NCT05536804A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 DiabetesACTIVE_NOT_RECRUITINGPHASE22023-02-082026-102026-09
NCT05696847A Study of Tirzepatide (LY3298176) in Pediatric Participants With ObesityCOMPLETEDPHASE12023-02-072025-01-162025-01-16
NCT05691712A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 DiabetesCOMPLETEDPHASE32023-02-052024-07-012024-07-01
NCT05592275A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)TERMINATEDPHASE22023-02-032025-01-222025-01-22
NCT05692869A Study of Continuous Blood Pressure Monitoring in Healthy ParticipantsCOMPLETEDNA2023-01-312023-04-042023-04-04
NCT05662332A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time (QWINT-1)COMPLETEDPHASE32023-01-142024-07-192024-07-19
NCT05614739FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3RECRUITINGPHASE12023-01-122027-062027-06
NCT05372419A Study of (LY3650150) Lebrikizumab to Assess the Safety and Efficacy of Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis and Skin of ColorCOMPLETEDPHASE32023-01-122025-02-172024-05-03
NCT05659537A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus in IndiaCOMPLETEDPHASE42022-12-292024-01-162024-01-16
NCT05369403A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With DupilumabCOMPLETEDPHASE32022-12-192025-02-052024-01-11
NCT05630196A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants With Chronic Low Back PainCOMPLETEDPHASE22022-12-082023-06-152023-06-09
NCT05644353A Bioequivalence Study of Mirikizumab (LY3074828) Solution in Healthy ParticipantsCOMPLETEDPHASE12022-12-052023-05-252023-05-25
NCT05564039A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH)COMPLETEDPHASE42022-11-302024-08-122024-07-15
NCT05596747A Study of LY3209590 in Chinese Participants With Type 2 Diabetes MellitusCOMPLETEDPHASE12022-11-302023-10-102023-10-10
NCT05563246A Study of LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular EventsCOMPLETEDPHASE22022-11-242024-03-142024-03-14
NCT05620563A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 In Participants With Osteoarthritis PainCOMPLETEDPHASE22022-11-222023-06-122023-06-05
NCT05580250A Study of LY3526318 in Healthy Male Japanese ParticipantsWITHDRAWNPHASE12022-11-222022-12-082022-12-08
NCT05611671A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UCACTIVE_NOT_RECRUITINGPHASE22022-11-212026-082024-11-28
NCT05616013Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or ObeseCOMPLETEDPHASE22022-11-162025-06-142024-05-16
NCT05611957A Study of LY3437943 in Healthy Participants and Participants With Impaired Renal FunctionCOMPLETEDPHASE12022-11-162023-09-052023-09-05
NCT05623839A Study of LY3305677 in Participants With Obesity Or OverweightCOMPLETEDPHASE12022-11-162023-06-272023-06-27
NCT05615467A Study of Effect of LY3556050 on Metformin in Healthy ParticipantsCOMPLETEDPHASE12022-11-152022-12-272022-12-27
NCT05609825A Study of LY3875383 in Healthy Participants and Participants With HypertriglyceridemiaTERMINATEDPHASE12022-11-142024-01-102024-01-10
NCT05620576A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants With Diabetic Peripheral Neuropathic Pain (NP05).COMPLETEDPHASE22022-11-142023-08-012023-07-19
NCT05615532A Relative Bioavailability Study of LY3209590 in Healthy ParticipantsCOMPLETEDPHASE12022-11-112023-06-282023-06-28
NCT05582096A Study of LY3457263 in Obese ParticipantsCOMPLETEDPHASE12022-11-112023-06-082023-06-08
NCT05602675A Drug Interaction Study of LY3871801 in Healthy ParticipantsCOMPLETEDPHASE12022-11-022023-03-292023-03-29
NCT05548231A Study of LY3437943 in Chinese Participants With Obesity Or OverweightCOMPLETEDPHASE12022-10-242023-07-272023-07-27
NCT05565742A Study of LY3819469 in Participants With Elevated Lipoprotein(a) [Lp(a)]COMPLETEDPHASE22022-10-202024-10-172023-10-23
NCT05559359A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic DermatitisRECRUITINGPHASE32022-10-182026-122025-12
NCT05573230A Drug Interaction Study of Cyclosporine and LY3502970 in Healthy ParticipantsCOMPLETEDPHASE12022-10-172023-01-172023-01-17
NCT05556512A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With ObesityACTIVE_NOT_RECRUITINGPHASE32022-10-112027-102027-10
NCT05508789A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)RECRUITINGPHASE32022-10-102028-072028-05
NCT05509790A Study of LY3484356 in Chinese Participants With Advanced Breast CancerACTIVE_NOT_RECRUITINGPHASE12022-10-092026-122024-02-18
NCT05514054A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast CancerRECRUITINGPHASE32022-10-042032-032027-10
NCT05567159A Study of Donanemab (LY3002813) in Healthy ParticipantsCOMPLETEDPHASE12022-10-042023-07-142023-07-14
NCT05440786CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's SarcomaACTIVE_NOT_RECRUITINGPHASE22022-09-202028-092025-01-15
NCT05533411A Study of Donanemab (LY3002813) in Healthy Chinese ParticipantsCOMPLETEDPHASE12022-09-142023-01-052023-01-05
NCT05509816A Study of Imlunestrant (LY3484356) in Healthy WomenCOMPLETEDPHASE12022-09-122022-11-302022-11-30
NCT05516758A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid ArthritisCOMPLETEDPHASE22022-08-312025-01-172023-11-20
NCT05515601A Bioequivalence Study of Mirikizumab (LY3074828) in Healthy ParticipantsCOMPLETEDPHASE12022-08-312023-02-202023-02-20
NCT05463744A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection TherapyCOMPLETEDPHASE32022-08-122024-05-072024-05-07
NCT05492201A Study of LY3873862 in Healthy ParticipantsCOMPLETEDPHASE12022-08-112025-04-292025-04-29
NCT05462756A Study of Insulin Efsitora Alfa (LY3209590) as a Weekly Basal Insulin Compared to Insulin Glargine in Adult Participants With Type 2 Diabetes on Multiple Daily InjectionsCOMPLETEDPHASE32022-08-112024-02-272024-02-27
NCT05486208A Study of LY3844583 in Healthy Participants and Participants With Atopic DermatitisTERMINATEDPHASE12022-08-112024-01-202024-01-20
NCT05444569A Study of LY3537021 in Healthy ParticipantsCOMPLETEDPHASE12022-08-082023-02-242023-02-24
NCT05463731A Study of Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1)ACTIVE_NOT_RECRUITINGPHASE32022-08-012026-032024-04-24
NCT05433584A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 DiabetesACTIVE_NOT_RECRUITINGPHASE42022-08-012027-112025-10
NCT05469126A Drug Interaction Study of Clarithromycin and LY3502970 in Healthy ParticipantsCOMPLETEDPHASE12022-08-012022-11-032022-11-03
NCT05254743A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)RECRUITINGPHASE32022-07-222028-012025-06-10
NCT05256654A Study of LY3561774 in Participants With Mixed DyslipidemiaCOMPLETEDPHASE22022-07-202024-05-232024-03-04
NCT05432193FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER)TERMINATEDPHASE12022-07-132024-10-022023-11-10
NCT05445232A Drug-Drug Interaction (DDI) Study of LY3437943 in Obese ParticipantsCOMPLETEDPHASE12022-07-082023-02-242023-02-24
NCT05444556A Study of Imlunestrant (LY3484356) in Female Healthy ParticipantsCOMPLETEDPHASE12022-07-072022-11-022022-11-02
NCT05440344A Study of Imlunestrant (LY3484356) in Female Participants With Impaired Liver FunctionCOMPLETEDPHASE12022-07-052024-02-282024-02-28
NCT05440136A Safety Study of LY3462817 in Healthy Japanese and Non-Japanese ParticipantsCOMPLETEDPHASE12022-06-282023-03-082023-03-08
NCT05412004Obstructive Sleep Apnea Master Protocol GPIF: A Study of Tirzepatide (LY3298176) in Participants With Obstructive Sleep ApneaCOMPLETEDPHASE32022-06-212024-03-292024-03-12
NCT05395481A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)RECRUITINGPHASE12022-06-082026-102026-10
NCT05407961A Study of LY3532226 in Participants With Type 2 Diabetes MellitusCOMPLETEDPHASE12022-06-072024-01-122024-01-12
NCT05362058A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First TimeCOMPLETEDPHASE32022-06-032024-04-102024-04-10
NCT05377333A Study of LY3457263 Alone and in Combination With Dulaglutide (LY2189265) in Participants With Type 2 DiabetesCOMPLETEDPHASE12022-06-022023-11-222023-11-22
NCT05313802A Study of LY3502970 in Healthy Overweight and Obese ParticipantsCOMPLETEDPHASE12022-05-262022-09-092022-09-09
NCT05291689A Phase 2a Open-Label Study to Evaluate the Efficacy and Safety of MORF-057 in Adults With UCCOMPLETEDPHASE22022-05-242025-02-192023-10-18
NCT05341089A Study of Two Different Formulations of LY3502970 in Healthy ParticipantsCOMPLETEDPHASE12022-05-172022-09-012022-09-01
NCT05307705A Study of LOXO-783 in Patients With Breast Cancer/Other Solid TumorsACTIVE_NOT_RECRUITINGPHASE12022-05-112025-122025-12
NCT05380323A Study of LY3541105 in Healthy and Overweight ParticipantsCOMPLETEDPHASE12022-05-102024-08-272024-08-27
NCT05327595A Study of LY3549492 in Participants With Type 2 Diabetes Mellitus (T2DM)COMPLETEDPHASE12022-05-092024-04-222024-04-22
NCT05324124A Study of the Effect of Food on Selpercatinib (LY3527723) in Healthy ParticipantsCOMPLETEDPHASE12022-04-192022-06-222022-06-22
NCT05288166A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)ACTIVE_NOT_RECRUITINGPHASE32022-04-142027-102024-02-15
NCT05260021A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or BothCOMPLETEDPHASE32022-04-132025-01-282024-07-30
NCT05295940A Study of LY3841136 in Healthy and Overweight ParticipantsCOMPLETEDPHASE12022-03-302024-01-252024-01-25
NCT04992312A Study of Nasal Glucagon (LY900018) in Pediatric Participants With Type 1 DiabetesCOMPLETEDPHASE12022-03-242023-11-052023-11-05
NCT05241834A Study of LOXO-260 in Cancer Patients With a Change in a Particular Gene (RET) That Has Not Responded to TreatmentACTIVE_NOT_RECRUITINGPHASE12022-03-232026-062024-09-17
NCT05292040A Study of LY3857210 in Healthy ParticipantsCOMPLETEDPHASE12022-03-172022-12-142022-12-14
NCT05169567Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast CancerACTIVE_NOT_RECRUITINGPHASE32022-03-112026-022024-02-08
NCT05275400A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal InsulinCOMPLETEDPHASE32022-03-082024-05-152024-05-15
NCT05123586A IMMA Master Protocol: A Study of LY3361237 in Participants With at Least Moderately Active Systemic Lupus ErythematosusTERMINATEDPHASE22022-03-072023-12-292023-12-29
NCT05262387A Study of LY900014 (Lyumjev) Versus Insulin Lispro (Humalog) in Participants With Type 1 DiabetesCOMPLETEDPHASE12022-02-142023-03-072023-03-07
NCT05222399A Study of LY3871801 in Healthy ParticipantsCOMPLETEDPHASE12022-02-042022-03-112022-03-11
NCT05177094Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Diabetic Peripheral Neuropathic PainCOMPLETEDPHASE22022-01-262022-10-132022-10-13
NCT05176314A Drug Drug Interaction (DDI) Study of Pirtobrutinib (LY3527727) and Rosuvastatin in Healthy ParticipantsCOMPLETEDPHASE12022-01-112022-04-202022-04-20
NCT05205447Study of the Effects of Itraconazole and Carbamazepine on LY3410738 in Healthy ParticipantsTERMINATEDPHASE12022-01-052022-04-122022-04-12
NCT05074420A Study of Baricitinib (LY3009104) in Children With COVID-19RECRUITINGPHASE32021-12-212026-052026-04
NCT04819100A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC)ACTIVE_NOT_RECRUITINGPHASE32021-12-202028-052026-05
NCT05127486A Study of Galcanezumab (LY2951742) in Adult Participants With Episodic MigraineCOMPLETEDPHASE42021-12-062023-05-232023-05-23
NCT05136404A Relative Bioavailability Study of Selpercatinib (LY3527723) in Healthy ParticipantsCOMPLETEDPHASE12021-12-032022-03-142022-03-14
NCT05154968A Study of Two Formulations (Both Refrigerated and Room Temperature) Using an Autoinjector Device in Healthy ParticipantsCOMPLETEDPHASE12021-11-242021-12-142021-12-14
NCT05108922A Study of Donanemab (LY3002813) Compared With Aducanumab in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 4)COMPLETEDPHASE32021-11-162023-09-192022-09-09
NCT05086445A Study of LY3502970 in Japanese Participants With Type 2 Diabetes MellitusCOMPLETEDPHASE12021-11-122022-09-052022-09-05
NCT05042310A Study of LY3541860 in Healthy Japanese and Non-Japanese ParticipantsCOMPLETEDPHASE12021-11-112023-12-272023-12-27
NCT05038787A Study of LY3473329 in Healthy Japanese ParticipantsCOMPLETEDPHASE12021-11-112022-04-072022-04-07
NCT05110794A Multiple-Dose Study of LY3502970 in Healthy ParticipantsCOMPLETEDPHASE12021-11-052022-02-102022-02-10
NCT05089019A Study Comparing Two Formulations of Selpercatinib (LY3527723) in Healthy ParticipantsCOMPLETEDPHASE12021-10-292022-07-192022-07-19
NCT05086289Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Chronic Low Back PainCOMPLETEDPHASE22021-10-252022-06-172022-06-17
NCT05067270A Study of Infusion Site Pain After Infusion of Excipients in Participants With Type 1 Diabetes MellitusCOMPLETEDPHASE12021-10-222021-12-062021-12-06
NCT05080660Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With OsteoarthritisCOMPLETEDPHASE22021-10-122022-06-062022-06-06
NCT06181084A Study Comparing Different Formulations of LY3410738 in Healthy Adult ParticipantsCOMPLETEDPHASE12021-10-112022-04-282022-04-28
NCT05069896A Study to Compare Two Formulations of Mirikizumab (LY3074828) in Healthy ParticipantsCOMPLETEDPHASE12021-10-052022-06-222022-06-22
NCT04975308A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast CancerACTIVE_NOT_RECRUITINGPHASE32021-10-042027-082024-06-24
NCT05024045Study of Oral LOXO-338 in Patients With Advanced Blood CancersACTIVE_NOT_RECRUITINGPHASE12021-09-302025-122023-06-14
NCT05051579A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related ComorbiditiesCOMPLETEDPHASE22021-09-292022-11-222022-08-25
NCT06258174A Study of Two Different Formulations of Pirtobrutinib (LOXO-305) In Healthy ParticipantsCOMPLETEDPHASE12021-09-282021-12-222021-12-22
NCT04848402A Device Study in Healthy ParticipantsCOMPLETEDPHASE12021-09-272022-07-222022-07-22
NCT05023980A Study of Pirtobrutinib (LOXO-305) Versus Bendamustine Plus Rituximab (BR) in Untreated Patients With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)ACTIVE_NOT_RECRUITINGPHASE32021-09-232026-082025-07-11
NCT06808815A Study to Assess S011806 (DC-806 or LY4100504) in Healthy Adult Participants and Participants With Chronic Plaque PsoriasisCOMPLETEDPHASE12021-09-222022-08-232022-08-23
NCT04965493A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)ACTIVE_NOT_RECRUITINGPHASE32021-09-202027-012026-04
NCT05063539A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's DiseaseCOMPLETEDPHASE22021-09-162025-05-222024-07-09
NCT05051566A Multiple Dose Study of LY3502970 in Healthy ParticipantsCOMPLETEDPHASE12021-09-162022-04-042022-04-04
NCT05048719A Study of LY3502970 in Participants With Type 2 Diabetes MellitusCOMPLETEDPHASE22021-09-152022-09-302022-09-30
NCT05024032A Study of Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Overweight (SURMOUNT-CN)COMPLETEDPHASE32021-09-012022-12-272022-12-27
NCT05026866A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)RECRUITINGPHASE32021-08-272027-112027-11
NCT04864977A Study of A Novel Approach to Titrate Basal Insulin (LY2963016) in Participants With Type 2 DiabetesWITHDRAWNPHASE42021-08-162022-06-062022-06-06
NCT04991766A Study of [¹⁴C]-LY3484356 in Healthy Female ParticipantsCOMPLETEDPHASE12021-08-132022-04-022022-04-02
NCT04975295A Study of LY3361237 in Participants With PsoriasisCOMPLETEDPHASE12021-07-272022-11-292022-11-29
NCT04956640Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)RECRUITINGPHASE1, PHASE22021-07-192027-042027-04
NCT04957914A Study of LY3209590 on Low Blood Sugar in Participants With Type 2 Diabetes MellitusCOMPLETEDPHASE12021-07-142022-10-172022-10-17
NCT04914546A Study of LY3819469 in Healthy ParticipantsCOMPLETEDPHASE12021-06-142022-11-092022-11-09
NCT04923269A Study of LY3532226 in Healthy ParticipantsCOMPLETEDPHASE12021-06-102021-10-282021-10-28
NCT04840901A Study of Lebrikizumab (LY3650150) Administered by Two Different Devices in Healthy ParticipantsCOMPLETEDPHASE12021-06-022022-02-112022-02-11
NCT04840914A Study of LY3461767 in Participants With Chronic Heart Failure With Reduced Ejection FractionCOMPLETEDPHASE12021-06-012024-05-092024-05-09
NCT04844606A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)RECRUITINGPHASE32021-05-262030-122030-12
NCT04823208A Study of LY3437943 in Japanese Participants With Type 2 Diabetes Mellitus (T2DM)COMPLETEDPHASE12021-05-242022-06-232022-06-23
NCT04874636Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Chronic Low Back PainCOMPLETEDPHASE22021-05-202022-02-092022-02-09
NCT04881760A Study of LY3437943 in Participants Who Have Obesity or Are OverweightCOMPLETEDPHASE22021-05-202022-11-222022-05-16
NCT04849416A Study of LOXO-305 in Chinese Participants With Blood Cancer (Including Lymphoma and Chronic Leukemia)ACTIVE_NOT_RECRUITINGPHASE22021-05-142025-122023-04-10
NCT04881747A Study to Compare Two Different Formulations of Lasmiditan in Healthy ParticipantsCOMPLETEDPHASE12021-05-142021-07-242021-07-24
NCT04867785A Study of LY3437943 in Participants With Type 2 DiabetesCOMPLETEDPHASE22021-05-132022-10-272022-07-08
NCT04752332A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast CancerTERMINATEDPHASE32021-05-102024-06-262024-06-26
NCT04844918A Study of Tirzepatide (LY3298176) in Participants With Obesity DiseaseCOMPLETEDPHASE32021-05-102023-06-242023-06-24
NCT04707157Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Diabetic Peripheral Neuropathic PainTERMINATEDPHASE22021-05-062022-06-132022-06-13
NCT04682106A Study of LY3493269 in Healthy ParticipantsCOMPLETEDPHASE12021-05-032021-11-112021-11-11
NCT04840888A Study of LY3484356 in Healthy Female ParticipantsCOMPLETEDPHASE12021-04-262022-04-122022-04-12
NCT04647487A Study of LY3484356 in Women With Breast Cancer Before Having SurgeryCOMPLETEDPHASE12021-04-212022-11-112022-11-11
NCT04847557A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT TrialCOMPLETEDPHASE32021-04-202024-07-022024-07-02
NCT04469062A Study of Mirikizumab (LY3074828) in Participants With Ulcerative ColitisWITHDRAWNPHASE32021-04-202024-06-052024-03-13
NCT04527380A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-related Arthritis (Including Juvenile Onset Ankylosing Spondylitis) and Juvenile Psoriatic ArthritisACTIVE_NOT_RECRUITINGPHASE32021-04-132028-042024-02-19
NCT04809220A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 DiabetesCOMPLETEDPHASE32021-04-132023-04-262022-10-01
NCT04662255Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL)ACTIVE_NOT_RECRUITINGPHASE32021-04-082028-042027-01
NCT04680767A Study of LY3502970 in Healthy Male ParticipantsCOMPLETEDPHASE12021-03-292021-07-032021-07-03
NCT04660643A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight LossCOMPLETEDPHASE32021-03-292023-05-182023-04-25
NCT04657016A Study of Tirzepatide (LY3298176) In Participants After A Lifestyle Weight Loss ProgramCOMPLETEDPHASE32021-03-292023-05-122023-04-20
NCT04657003A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are OverweightCOMPLETEDPHASE32021-03-292023-04-102023-03-16
NCT04768855A Study of LY3540378 in Healthy ParticipantsCOMPLETEDPHASE12021-03-172022-05-302022-05-30
NCT06194214A Drug Drug Interaction (DDI) Study of Pirtobrutinib (LOXO-305) and Digoxin (P-Glycoprotein Substrate) in Healthy ParticipantsCOMPLETEDPHASE12021-03-112021-06-092021-06-09
NCT04760314A Study of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids in Japanese Participants With Moderate-to-Severe Atopic DermatitisCOMPLETEDPHASE32021-03-102023-02-012022-07-31
NCT04666038Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)ACTIVE_NOT_RECRUITINGPHASE32021-03-092027-052023-08-29
NCT04782076A Drug Drug Interaction (DDI) Study of Selpercatinib and Dabigatran in Healthy ParticipantsCOMPLETEDPHASE12021-03-052021-05-172021-05-17
NCT04768842A Study of Two Different Formulations of LY3209590 in Healthy ParticipantsCOMPLETEDPHASE12021-03-032021-09-032021-09-03
NCT04647526Study Evaluating mCRPC Treatment Using PSMA [Lu-177]-PNT2002 Therapy After Second-line Hormonal TreatmentACTIVE_NOT_RECRUITINGPHASE32021-02-252028-032023-11-01
NCT06181045A Study of LY3410738 in Healthy Adult ParticipantsCOMPLETEDPHASE12021-02-242021-08-042021-08-04
NCT04557384A Study of Ramucirumab (LY3009806) Given by Injection Under the Skin in Participants With Advanced CancerTERMINATEDPHASE12021-02-232021-05-252021-05-25
NCT04707196A Study of Abemaciclib in Indian Women With Advanced Breast CancerCOMPLETEDPHASE42021-02-222023-01-092023-01-09
NCT04758234A Study of LY3549492 in Healthy ParticipantsCOMPLETEDPHASE12021-02-222022-01-102022-01-10
NCT04749914A Study of Lasmiditan in Healthy VolunteersCOMPLETEDPHASE12021-02-152021-07-062021-07-06
NCT06190678Study of Pirtobrutinib (LOXO-305) in Participants With Impaired Kidney Function and Healthy ParticipantsCOMPLETEDPHASE12021-02-012021-06-042021-06-04
NCT04701658A Real World Study of Bamlanivimab in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)COMPLETEDPHASE22021-02-012021-06-222021-06-22
NCT04682184A Study of Continuous Heart Rate Monitoring in Healthy ParticipantsCOMPLETEDNA2021-01-272021-03-252021-03-25
NCT04408924Abemaciclib (LY2835219) in Men With Heavily Treated Metastatic Castration-Resistant Prostate CancerCOMPLETEDPHASE22021-01-202023-06-022022-04-27
NCT04258826A Study to Evaluate LY3154207 on the Brain of Healthy ParticipantsCOMPLETEDPHASE12021-01-152022-01-282022-01-28
NCT06215430A Study of Effect of Multiple Doses of LOXO-305 on the Pharmacokinetics of Single Oral Doses of CYP1A2, CYP2C9, CYP2C19 Substrates in Healthy ParticipantsCOMPLETEDPHASE12021-01-112021-04-152021-04-15
NCT06180980A Study of the Effect of Food on Pirtobrutinib (LOXO-305) in Healthy ParticipantsCOMPLETEDPHASE12021-01-042021-03-082021-03-08
NCT04634253A Study of LY3462817 in Participants With Rheumatoid ArthritisCOMPLETEDPHASE22021-01-042022-06-292022-01-10
NCT04682119A Safety Study of LY3526318 in Healthy ParticipantsCOMPLETEDPHASE12020-12-292021-04-212021-04-21
NCT06190691Study of Pirtobrutinib (LOXO-305) in Participants With Impaired Liver Function and Healthy ParticipantsCOMPLETEDPHASE12020-12-182021-12-302021-12-30
NCT06215521A Study to Evaluate the Effect of Pirtobrutinib (LOXO-305) on QTc Interval in Healthy ParticipantsCOMPLETEDPHASE12020-12-152021-03-312021-03-31
NCT04648865A Study of LY3537031 in Healthy ParticipantsCOMPLETEDPHASE12020-12-092021-06-042021-06-04
NCT04591626A Study of Dulaglutide (LY2189265) in Chinese Participants With Type 2 DiabetesCOMPLETEDPHASE32020-12-072022-04-282022-04-28
NCT04653168A Study of LY3041658 in Healthy ParticipantsCOMPLETEDPHASE12020-12-072021-05-282021-05-28
NCT04644809A Study of LY3561774 in Participants With DyslipidemiaCOMPLETEDPHASE12020-11-302022-05-172022-05-17
NCT04616326A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic MigraineRECRUITINGPHASE32020-11-252026-032025-07
NCT04641312A Study of LY3457263 in Healthy Participants and Participants With Type 2 DiabetesCOMPLETEDPHASE12020-11-252021-12-212021-12-21
NCT04640077A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participants With Alzheimer's Disease (TRAILBLAZER-EXT)COMPLETEDPHASE22020-11-232024-02-272024-02-27
NCT04586907A Study of LY3537021 in Healthy Participants and Participants With Type 2 Diabetes MellitusCOMPLETEDPHASE12020-11-232021-11-302021-11-30
NCT04603001Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 MutationsACTIVE_NOT_RECRUITINGPHASE12020-11-192026-052023-07-03
NCT04626297A Study of Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic Dermatitis (ADopt-VA)COMPLETEDPHASE32020-11-172022-09-302022-08-03
NCT04498910A Study of LY3451838 in Participants With MigraineCOMPLETEDPHASE22020-11-162022-11-092022-11-09
NCT04627038Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With OsteoarthritisCOMPLETEDPHASE22020-11-122021-10-212021-10-21
NCT06165146A Study of the Effects of Pirtobrutinib (LOXO-305) on Repaglinide (CYP2C8 Substrate) in Healthy ParticipantsCOMPLETEDPHASE12020-11-102020-12-302020-12-30
NCT04238819A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including NeuroblastomaCOMPLETEDPHASE1, PHASE22020-11-092025-08-192024-03-15
NCT04605991A Study of Mealtime Insulin LY900014 in Participants With Type 2 Diabetes Using Continuous Glucose Monitoring (PRONTO-Time in Range)COMPLETEDPHASE32020-11-042022-02-042022-02-04
NCT04607733A Study of Mirikizumab in Healthy ParticipantsCOMPLETEDPHASE12020-11-022021-05-172021-05-17
NCT04611789A Study of LY3832479 (LY-CoV016) in Healthy Participants 1COMPLETEDPHASE12020-11-022021-02-102021-02-10
NCT04585776A Study of LY900014 and Insulin Degludec in Participants With Type 1 DiabetesCOMPLETEDPHASE22020-10-302021-05-272021-05-27
NCT04634409A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 IllnessCOMPLETEDPHASE22020-10-292021-10-182021-07-27
NCT04517253A Study of Baricitinib (LY3009104) in Adult and Pediatric Japanese Participants With NNS/CANDLE, SAVI, and AGSTERMINATEDPHASE2, PHASE32020-10-272024-11-282023-04-04
NCT04235959A Study of Tirzepatide in Chinese Participants With Type 2 Diabetes MellitusCOMPLETEDPHASE12020-10-212021-08-172021-08-17
NCT04586920A Study of LY3509754 in Healthy Non-Japanese and Japanese ParticipantsTERMINATEDPHASE12020-10-202022-10-142022-10-14
NCT04537923A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without MetforminCOMPLETEDPHASE32020-10-192022-11-012022-10-11
NCT04559568A Study of LY3522348 in Healthy ParticipantsCOMPLETEDPHASE12020-10-152021-08-172021-08-17
NCT04426474A Study of LY3502970 in Participants With Type 2 DiabetesCOMPLETEDPHASE12020-10-082021-07-122021-07-12
NCT04294147A Study of Gastrointestinal Emptying Time in Adult Participants With Migraine Before and After Start of a mAb CGRP AntagonistCOMPLETEDPHASE42020-10-062021-03-052021-03-05
NCT04521686Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 MutationsACTIVE_NOT_RECRUITINGPHASE12020-10-012026-052023-07-17
NCT04541628Safety & Efficacy of Encapsulated Allogeneic FVIII Cell Therapy in Haemophilia ATERMINATEDPHASE1, PHASE22020-09-282023-01-092022-10-28
NCT04580745Study of MORF 057 to Evaluate Single and Multi Ascending Doses in Healthy VolunteersCOMPLETEDPHASE12020-09-232021-04-122021-03-31
NCT06180954A Study of Carbon-14-Labelled [14C] LOXO-305 (Pirtobrutinib) in Healthy Male ParticipantsCOMPLETEDPHASE12020-09-232020-11-062020-11-06
NCT04407234A Study to Measure Stomach Emptying in Overweight Non-diabetic and Diabetic Participants Using TirzepatideCOMPLETEDPHASE12020-09-152021-01-072021-01-07
NCT04548219A Study to Compare Two Different Formulations of Mirikizumab in Healthy ParticipantsCOMPLETEDPHASE12020-09-112021-01-112021-01-11
NCT06180967A Drug Drug Interaction (DDI) Study of Pirtobrutinib (LOXO-305) and Different Formulations of Midazolam in Healthy ParticipantsCOMPLETEDPHASE12020-09-032020-10-202020-10-20
NCT04498390A Safety Study of LY3493269 in Healthy ParticipantsCOMPLETEDPHASE12020-09-032020-12-282020-12-28
NCT04537910A Study of LY3819253 (LY-CoV555) in Healthy ParticipantsCOMPLETEDPHASE12020-09-022020-12-282020-12-28
NCT04493502A Study of LY3041658 in Adults With Hidradenitis SuppurativaCOMPLETEDPHASE22020-08-262022-10-132022-03-15
NCT04515576A Study of LY3493269 in Participants With Type 2 DiabetesCOMPLETEDPHASE12020-08-252021-03-092021-03-09
NCT04529096Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Chronic Low Back PainCOMPLETEDPHASE22020-08-252021-10-042021-06-04
NCT04311411A Study of Tirzepatide in Overweight and Very Overweight ParticipantsCOMPLETEDPHASE12020-08-242022-12-162022-12-16
NCT04472676A Study of LY3473329 in Healthy ParticipantsCOMPLETEDPHASE12020-08-182021-11-092021-11-09
NCT06181006A Study to Evaluate Pirtobrutinib (LOXO-305) in Healthy Adult ParticipantsCOMPLETEDPHASE12020-08-142020-12-012020-12-01
NCT04392271A Study of the Effects of Multiple Doses of LY3372689 on the Brain in Healthy ParticipantsCOMPLETEDPHASE12020-08-062020-10-142020-10-14
NCT04497987A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Preventing SARS-CoV-2 Infection and COVID-19 in Nursing Home Residents and StaffCOMPLETEDPHASE32020-08-022021-05-202021-01-16
NCT04495478A Study of Ramucirumab (LY3009806) in Healthy ParticipantsCOMPLETEDPHASE12020-07-302021-05-092021-05-09
NCT04311424Study of Tirzepatide in Healthy ParticipantsCOMPLETEDPHASE12020-07-282020-10-022020-10-02
NCT04476108Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Diabetic Peripheral Neuropathic PainCOMPLETEDPHASE22020-07-152021-11-112021-07-08
NCT04484779A Study of an Insulin Management System in Participants With Type 1 or Type 2 DiabetesCOMPLETEDNA2020-07-142020-12-222020-12-22
NCT04081337A Study to Measure Energy Expenditure and Food Intake in Participants With Obesity Using TirzepatideCOMPLETEDPHASE12020-07-092022-05-262022-05-26
NCT04451408A Study of LY3372993 in Participants With Alzheimer's Disease (AD) and Healthy ParticipantsCOMPLETEDPHASE12020-07-072024-11-182024-11-18
NCT04450407A Study of LY3209590 in Participants With Type 1 DiabetesCOMPLETEDPHASE22020-07-062021-10-012021-10-01
NCT04456686Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With OsteoarthritisCOMPLETEDPHASE22020-07-012021-08-262021-04-22
NCT04450394A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes MellitusCOMPLETEDPHASE22020-07-012021-10-082021-10-08
NCT04396574A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With MigraineRECRUITINGPHASE32020-06-302028-012028-01
NCT04232553A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's DiseaseACTIVE_NOT_RECRUITINGPHASE32020-06-222026-122024-11-28
NCT04437511A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)ACTIVE_NOT_RECRUITINGPHASE32020-06-192028-112023-04-14
NCT04441931A Study of LY3832479 (LY-CoV016) in Healthy ParticipantsCOMPLETEDPHASE12020-06-192020-10-022020-10-02
NCT04427501A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 IllnessCOMPLETEDPHASE2, PHASE32020-06-172023-02-212023-02-21
NCT04396236A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With MigraineRECRUITINGPHASE32020-06-152026-112026-11
NCT04392154Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)COMPLETEDPHASE32020-06-152025-04-222024-07-19
NCT04352114A Study of LY3461767 in Healthy ParticipantsCOMPLETEDPHASE12020-06-152021-01-132021-01-13
NCT04421027A Study of Baricitinib (LY3009104) in Participants With COVID-19COMPLETEDPHASE32020-06-122021-06-102021-02-12
NCT04106219A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory NeuroblastomaACTIVE_NOT_RECRUITINGPHASE12020-06-112026-082022-04-13
NCT04255433A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 DiabetesCOMPLETEDPHASE32020-05-292025-06-122025-06-12
NCT04411628A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19COMPLETEDPHASE12020-05-282020-08-262020-08-26
NCT04004611A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC)COMPLETEDPHASE22020-05-182023-03-152023-03-15
NCT04342897A Study of LY3127804 in Participants With COVID-19TERMINATEDPHASE22020-04-202020-10-122020-10-12
NCT04285229A Study of Ixekizumab (LY2439821) in Chinese Participants With Radiographic Axial SpondyloarthritisCOMPLETEDPHASE32020-04-102022-03-172021-03-31
NCT04280081A Study of Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET ActivationACTIVE_NOT_RECRUITINGPHASE22020-03-162027-112021-03-25
NCT04270370A Study of LY3478045 in Healthy ParticipantsCOMPLETEDPHASE12020-03-162021-06-232021-06-23
NCT04145700CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Synovial SarcomaTERMINATEDPHASE1, PHASE22020-03-042023-02-232023-02-23
NCT04276428A Study of LY3209590 in Japanese Participants With Type 2 Diabetes MellitusCOMPLETEDPHASE12020-02-282020-11-282020-11-28
NCT04172987A Study of the Effect of Tirzepatide on How the Body Handles Birth Control Pills in Healthy Female ParticipantsCOMPLETEDPHASE12020-02-262021-02-092021-02-09
NCT04276207A Study of LY900014 Versus Insulin Lispro (Humalog) on High Blood Sugar in Participants With Type 1 Diabetes Who Use Insulin PumpsCOMPLETEDPHASE12020-02-252020-08-102020-08-10
NCT04050553A Study of Tirzepatide in Participants With Type 2 Diabetes MellitusCOMPLETEDPHASE12020-02-242022-01-252022-01-25
NCT04194944A Study of Selpercatinib (LY3527723) in Participants With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung CancerACTIVE_NOT_RECRUITINGPHASE32020-02-172026-062023-05-01
NCT04230122A Study of LY3478006 in Healthy ParticipantsTERMINATEDPHASE12020-02-172020-06-042020-06-04
NCT04086745A Study of Baricitinib in Participants With Rheumatoid ArthritisCOMPLETEDPHASE42020-02-142025-05-192025-05-19
NCT04088396A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With Systemic Juvenile Idiopathic Arthritis (sJIA)RECRUITINGPHASE32020-02-122026-052026-04
NCT05134337Study of the Effects of Itraconazole and Rifampin on LOXO-305 in Healthy ParticipantsCOMPLETEDPHASE12020-02-122020-10-302020-10-30
NCT04211337A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid CancerACTIVE_NOT_RECRUITINGPHASE32020-02-112026-022023-05-22
NCT04250350Study to Assess the Safety and Efficacy of Lebrikizumab (LY3650150) in Adolescent Participants With Moderate-to-Severe Atopic DermatitisCOMPLETEDPHASE32020-02-112022-06-222022-04-20
NCT05134350Study of the Effect of Food and a Proton Pump Inhibitor (PPI; Omeprazole) on LOXO-305 in Healthy ParticipantsCOMPLETEDPHASE12020-02-062020-03-232020-03-23
NCT04259346A Study of Two Formulations of Ixekizumab in Healthy ParticipantsCOMPLETEDPHASE12020-02-052021-02-192021-02-19
NCT04250337Safety and Efficacy of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroid in Moderate-to-Severe Atopic Dermatitis.COMPLETEDPHASE32020-02-032021-09-162021-08-11
NCT05986292A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic PainRECRUITINGPHASE22020-01-302027-042027-04
NCT05999994A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With CancerRECRUITINGPHASE22020-01-222027-052027-05
NCT04145349CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell TumorACTIVE_NOT_RECRUITINGPHASE1, PHASE22020-01-222025-102024-06-14
NCT04148937A Study of the CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced CancerCOMPLETEDPHASE12020-01-162022-06-202021-05-12
NCT04178733A Safety Study of LY3493269 Given as a Single Injection in Healthy ParticipantsCOMPLETEDPHASE12020-01-102020-05-112020-05-11
NCT04161976A Study of LY900027 Given by Insulin Pump to Participants With Type 1 Diabetes MellitusCOMPLETEDPHASE12019-12-272020-07-142020-07-14
NCT04071262A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Therapies in Japanese Participants With Advanced CancerCOMPLETEDPHASE12019-12-202021-08-302021-02-12
NCT04143802A Study of LY3437943 in Participants With Type 2 Diabetes Mellitus (T2DM)COMPLETEDPHASE12019-12-182020-12-282020-12-28
NCT04153981A Study of Insulin Glargine (LY2963016) in Adult Participants With Type 2 Diabetes in IndiaCOMPLETEDPHASE42019-12-162021-07-302021-07-30
NCT04183283A Study of LY3526318 in Healthy WomenCOMPLETEDPHASE12019-12-122020-03-062020-02-28
NCT04188548A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial CancerACTIVE_NOT_RECRUITINGPHASE12019-12-102027-122020-06-29
NCT04093752A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes on Metformin With or Without Sulfonylurea (SURPASS-AP-Combo)COMPLETEDPHASE32019-12-092021-11-242021-11-01
NCT04158700A Study of LY3200882 and Pembrolizumab in Participants With Advanced CancerWITHDRAWNPHASE1, PHASE22019-12-052023-05-112023-05-11
NCT04184622A Study of Tirzepatide (LY3298176) in Participants With Obesity or OverweightCOMPLETEDPHASE32019-12-042024-07-062022-04-01
NCT04137380A Study of Mirikizumab in Healthy Chinese ParticipantsCOMPLETEDPHASE12019-12-042020-12-112020-12-11
NCT04047940A Study of LY900020 in Healthy Chinese ParticipantsCOMPLETEDPHASE12019-11-292020-02-182020-02-18
NCT04165031A Study of LY3499446 in Participants With Advanced Solid Tumors With KRAS G12C MutationTERMINATEDPHASE1, PHASE22019-11-282020-10-302020-10-30
NCT04152382A Safety Study of LY3462817 and LY3509754 in Participants With PsoriasisTERMINATEDPHASE12019-11-202022-02-092022-02-09
NCT04085289A Study of Galcanezumab (LY2951742) in Healthy Chinese ParticipantsCOMPLETEDPHASE12019-11-202020-05-212020-05-21
NCT04156750A Study of LY3556050 in Healthy ParticipantsCOMPLETEDPHASE12019-11-202020-08-032020-08-03
NCT04166773A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)COMPLETEDPHASE22019-11-192024-01-102023-12-11
NCT04049123A Study of LY900014 in Healthy Chinese ParticipantsCOMPLETEDPHASE12019-11-182020-10-232020-10-23
NCT04159701A Study of LY3454738 in Adults With Chronic Spontaneous UrticariaTERMINATEDPHASE22019-11-152021-02-242021-02-24
NCT04081324A Study of Lasmiditan in Healthy Chinese ParticipantsCOMPLETEDPHASE12019-11-132020-06-152020-06-15
NCT04178967Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic DermatitisCOMPLETEDPHASE32019-10-292022-04-282021-07-12
NCT04099277A Study of LY3435151 in Participants With Solid TumorsTERMINATEDPHASE12019-10-282020-03-052020-03-05
NCT03928379A Study of LY3305677 in Participants With Type 2 DiabetesCOMPLETEDPHASE12019-10-272021-07-082021-07-08
NCT04106206A Safety Study of LY3372689 in Healthy ParticipantsCOMPLETEDPHASE12019-10-232020-02-122020-02-12
NCT04088409A Study of Baricitinib (LY3009104) in Participants From 2 Years to Less Than 18 Years Old With Active JIA-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive UveitisACTIVE_NOT_RECRUITINGPHASE32019-10-162028-072023-07-17
NCT04146363Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate1)COMPLETEDPHASE32019-09-242022-05-032021-06-21
NCT03988114A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast CancerWITHDRAWNPHASE42019-09-162023-03-232022-03-23
NCT04050670A Study of Tirzepatide at Different Injection Sites in Participants With Different Body SizesCOMPLETEDPHASE12019-09-132020-04-032020-04-03
NCT03843125A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE)TERMINATEDPHASE32019-09-092022-04-012022-04-01
NCT04052594A Study of LY3475766 in Healthy ParticipantsCOMPLETEDPHASE12019-09-032021-03-312021-03-31
NCT04039503A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without MetforminCOMPLETEDPHASE32019-08-302021-01-132020-12-22
NCT04004988A Study of Tirzepatide Administered by Two Different Devices in Healthy ParticipantsCOMPLETEDPHASE12019-08-192019-12-162019-12-16
NCT04031885A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast CancerTERMINATEDPHASE42019-08-142020-08-112020-08-11
NCT04014361A Study of LY3154885 in Healthy ParticipantsTERMINATEDPHASE12019-08-092020-02-092020-02-09
NCT03955939A Study of LY3295668 Erbumine in Participants With Breast Cancer That Has Spread to Other Parts of the BodyCOMPLETEDPHASE12019-08-022020-05-142020-05-14
NCT04033341A Study of LY3214996 in Healthy ParticipantsCOMPLETEDPHASE12019-08-012019-09-092019-09-09
NCT03963232A Study of Galcanezumab (LY2951742) in Participants With Episodic MigraineCOMPLETEDPHASE32019-07-302022-03-112021-07-27
NCT03987919A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 DiabetesCOMPLETEDPHASE32019-07-302021-02-152021-01-28
NCT03926130A Study of Mirikizumab (LY3074828) in Participants With Crohn's DiseaseCOMPLETEDPHASE32019-07-232023-10-022023-08-23
NCT03940742A Study of Tirzepatide in Participants With Impaired Liver FunctionCOMPLETEDPHASE12019-07-222020-09-222020-09-22
NCT03988088A Study of Lasmiditan (LY573144) in Children Aged 6 to 17 With MigraineCOMPLETEDPHASE12019-07-222020-02-242020-01-19
NCT03898791A Study of LY3295668 Erbumine in Participants With Extensive-stage Small-Cell Lung CancerCOMPLETEDPHASE12019-07-162021-03-302020-06-02
NCT03899259A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia AreataCOMPLETEDPHASE32019-07-082024-11-192021-01-24
NCT05338502Study of H2 Antagonist and a Proton Pump Inhibitor of Selpercatinib in Healthy ParticipantsCOMPLETEDPHASE12019-07-082019-09-032019-09-03
NCT03942042A Study of Ixekizumab (LY2439821) in Participants in Japan With Generalized Pustular Psoriasis and Erythrodermic PsoriasisCOMPLETEDPHASE42019-07-052020-07-222020-07-22
NCT03951753A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus (T2DM)COMPLETEDPHASE12019-06-282021-04-082021-04-08
NCT03670810A Study of Lasmiditan (LY573144) Over Four Migraine AttacksCOMPLETEDPHASE32019-06-242021-07-082020-06-12
NCT03977974A Study of LY3526318 in Healthy ParticipantsTERMINATEDPHASE12019-06-212020-03-052020-03-05
NCT03942029A Drug Interaction Study of LY3154207 in Healthy ParticipantsCOMPLETEDPHASE12019-06-212019-12-282019-12-28
NCT03899792A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) TumorsACTIVE_NOT_RECRUITINGPHASE1, PHASE22019-06-132029-052024-11-08
NCT03929744A Study of LY3502970 in Healthy ParticipantsCOMPLETEDPHASE12019-06-122020-11-022020-11-02
NCT03954834A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise AloneCOMPLETEDPHASE32019-06-032020-10-282020-10-05
NCT03962738A Study Lasmiditan (LY573144) in a Single Migraine Attack in Japanese Participants With MigraineCOMPLETEDPHASE22019-05-312020-06-082020-06-08
NCT03952130A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 1 DiabetesCOMPLETEDPHASE32019-05-292022-01-102022-01-10
NCT03952143A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 DiabetesCOMPLETEDPHASE32019-05-272021-01-202021-01-20
NCT03952559A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic DermatitisACTIVE_NOT_RECRUITINGPHASE32019-05-242026-052022-04-24
NCT03936959A Study of LY3434172, a PD-1 and PD-L1 Bispecific Antibody, in Advanced CancerTERMINATEDPHASE12019-05-242021-04-292020-03-30
NCT03933943A Study of LY3361237 in Participants With Systemic Lupus ErythematosusCOMPLETEDPHASE12019-05-212021-02-152021-02-15
NCT03944031A Study of the Effects of LY3372689 on the Brain in Healthy ParticipantsCOMPLETEDPHASE12019-05-082020-02-192020-02-19
NCT03861052A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 DiabetesCOMPLETEDPHASE32019-05-072021-03-312021-03-10
NCT03913260A Study of Different Injectable Formulations of LY3375880 in Healthy ParticipantsCOMPLETEDPHASE12019-05-012019-09-192019-09-19
NCT03915964A Study of Baricitinib (LY3009104) in Participants With Rheumatoid ArthritisCOMPLETEDPHASE42019-04-252025-05-282025-05-28
NCT05630274A Study of Effect of Selpercatinib (LY3527723) on Corrected QT (QTc) Interval in Healthy ParticipantsCOMPLETEDPHASE12019-04-162019-06-212019-06-21
NCT03740919A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 DiabetesCOMPLETEDPHASE32019-04-072021-07-022021-07-02
NCT03773965A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic ArthritisRECRUITINGPHASE32019-04-052031-072031-07
NCT03882970A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 DiabetesCOMPLETEDPHASE32019-04-012021-01-042020-12-11
NCT03861039A Long-term Safety Study of Tirzepatide (LY3298176) in Participants With Type 2 DiabetesCOMPLETEDPHASE32019-03-302021-02-162021-01-26
NCT03742973A Study of Baricitinib (LY3009104) in Participants With Primary Biliary Cholangitis Who do Not Respond or Cannot Take UDCATERMINATEDPHASE22019-03-282019-09-262019-09-26
NCT03890003A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 DiabetesCOMPLETEDNA2019-03-282019-05-062019-05-06
NCT03886948A Study of Injections of LY3074828 in Healthy ParticipantsCOMPLETEDPHASE12019-03-272019-10-042019-10-04
NCT03740529A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHLACTIVE_NOT_RECRUITINGPHASE1, PHASE22019-03-152027-092027-09
NCT03841630A Safety Study of LY3437943 Given as a Single Injection in Healthy ParticipantsCOMPLETEDPHASE12019-03-132019-07-252019-07-25
NCT03849612A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes MellitusCOMPLETEDNA2019-02-212019-03-272019-03-27
NCT03848767A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus During Meal ChallengesCOMPLETEDNA2019-02-202019-04-012019-04-01
NCT03760640A Study of LY900014 in a Medtronic PumpCOMPLETEDPHASE22019-02-182019-10-072019-10-07
NCT03830281A Study Comparing LY900014 to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes Using Insulin Pump TherapyCOMPLETEDPHASE32019-02-142020-01-062020-01-06
NCT05338515A Study of Selpercatinib (LY3527723) in Healthy ParticipantsCOMPLETEDPHASE12019-02-122019-03-262019-03-12
NCT03831191A Study of LY3375880 in Adults With Moderate-to-Severe Atopic DermatitisTERMINATEDPHASE22019-02-122020-02-272020-02-27
NCT03819270A Safety Study of LY3372689 Given By Mouth to Healthy ParticipantsCOMPLETEDPHASE12019-02-052019-06-242019-06-23
NCT03770494A Study of LY3405105 in Participants With Advanced CancerTERMINATEDPHASE12019-01-312021-02-042021-02-04
NCT03848403Study of Ixekizumab in Healthy ParticipantsTERMINATEDPHASE12019-01-292019-07-182019-07-18
NCT05469113A Study of Effects of Selpercatinib (LY3527723) on Repaglinide in Healthy ParticipantsCOMPLETEDPHASE12019-01-292019-03-052019-03-05
NCT03848416A Study of Ixekizumab in Healthy ParticipantsCOMPLETEDPHASE12019-01-292019-06-072019-06-07
NCT03792139An Interaction Study of LY3200882 in Healthy ParticipantsCOMPLETEDPHASE12019-01-082019-02-232019-02-23
NCT05469100A Study of Effect of Selpercatinib (LY3527723) in Participants With Normal and Impaired Renal FunctionCOMPLETEDPHASE12018-12-192019-08-072019-08-07
NCT03773978A Study of Baricitinib in Participants From 2 Years to Less Than 18 Years Old With Juvenile Idiopathic ArthritisCOMPLETEDPHASE32018-12-172022-01-262022-01-26
NCT03715192A Safety Study of LY3462817 in Healthy ParticipantsCOMPLETEDPHASE12018-12-132019-12-112019-12-11
NCT03692949A Study of LY3451838 in Healthy ParticipantsCOMPLETEDPHASE12018-12-112020-02-262020-02-26
NCT05436912A Study of Effects of Selpercatinib in Hepatically Impaired Participants and Healthy ParticipantsCOMPLETEDPHASE12018-12-102019-10-302019-10-04
NCT03764774A Study of LY3463251 in Healthy ParticipantsTERMINATEDPHASE12018-12-062020-12-072020-12-07
NCT03750643A Study of LY3454738 in Healthy Participants and Participants With Atopic DermatitisCOMPLETEDPHASE12018-11-292021-09-072021-09-07
NCT03703466A Study of Abemaciclib (LY2835219) With and Without Food in Participants With Metastatic Breast CancerCOMPLETEDPHASE22018-11-282023-03-092019-07-29
NCT03706365A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate CancerACTIVE_NOT_RECRUITINGPHASE2, PHASE32018-11-262026-062024-01-02
NCT03752177A Study of LY3415244 in Participants With Advanced Solid TumorsTERMINATEDPHASE12018-11-222019-10-092019-10-09
NCT03730662A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular RiskCOMPLETEDPHASE32018-11-202021-04-222021-01-22
NCT03726125A Study of LY3374849 in Healthy ParticipantsCOMPLETEDPHASE12018-11-202019-09-272019-09-27
NCT03765502A Study Comparing User Experience of Different Delivery Devices for GlucagonCOMPLETEDPHASE12018-11-192019-01-032019-01-03
NCT03736772A Study of LY3090106 in Japanese and Caucasian Healthy ParticipantsCOMPLETEDPHASE12018-11-192019-03-132019-03-13
NCT03733301A Study of Baricitinib (LY3009104) in Combination With Topical Corticosteroids in Adults With Moderate to Severe Atopic DermatitisCOMPLETEDPHASE32018-11-162019-08-222019-07-29
NCT03736785A Study of LY3209590 in Participants With Type 2 Diabetes MellitusCOMPLETEDPHASE22018-11-152020-02-182020-02-18
NCT03743285A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus (T1D)COMPLETEDNA2018-11-142019-01-282019-01-28
NCT03573323A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque PsoriasisCOMPLETEDPHASE42018-11-092020-01-082019-07-15
NCT03720548A Study of LY3372993 in Healthy Participants and Participants With Alzheimer's Disease (AD)COMPLETEDPHASE12018-11-052019-05-142019-05-14
NCT03695198A Study of LY3361237 in Healthy ParticipantsCOMPLETEDPHASE12018-10-262019-08-292019-08-29
NCT03718884A Study of Mirikizumab in Participants With Plaque PsoriasisCOMPLETEDPHASE12018-10-232019-10-282019-10-28
NCT03524092A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative ColitisCOMPLETEDPHASE32018-10-192024-12-132021-11-03
NCT03724981A Study Comparing the Dulaglutide Pen and the Semaglutide PenCOMPLETEDPHASE42018-10-182019-04-122019-04-12
NCT03748940Study of LY3074828 in Healthy ParticipantsCOMPLETEDPHASE12018-10-102019-06-182019-06-18
NCT03555305A Study of Insulin Glargine (LY2963016) in Healthy Chinese ParticipantsCOMPLETEDPHASE12018-09-262019-11-042019-11-04
NCT03570749A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia AreataCOMPLETEDPHASE2, PHASE32018-09-242025-01-292021-02-02
NCT03662100A Study of Two Formulations of LY3074828 in Healthy ParticipantsCOMPLETEDPHASE12018-09-062019-01-252019-01-25
NCT03556202A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)TERMINATEDPHASE32018-09-032022-02-072022-02-07
NCT03611608A Study of LY3316531 in Healthy ParticipantsCOMPLETEDPHASE12018-08-302019-03-152019-03-15
NCT03603704A Study of LY3209590 in Japanese Participants With Type 2 DiabetesCOMPLETEDPHASE12018-08-172019-05-272019-05-27
NCT03616795Study of LY3154207 in Healthy ParticipantsCOMPLETEDPHASE12018-08-092018-11-052018-11-05
NCT03616977Study to Compare 2 Formulations of LY900014 in Healthy ParticipantsCOMPLETEDPHASE12018-08-032018-10-192018-10-19
NCT03616912A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus ErythematosusTERMINATEDPHASE32018-08-022022-03-092021-11-01
NCT03616964A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE-BRAVE II)COMPLETEDPHASE32018-08-022021-10-202021-09-24
NCT05630287A Study of Absorption, Metabolism, Excretion, and Absolute Bioavailability of Carbon-14-Labelled [14C] Selpercatinib (LY3527723) in Healthy Male ParticipantsCOMPLETEDPHASE12018-08-012018-09-242018-09-24
NCT03559257A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant MigraineCOMPLETEDPHASE32018-07-312019-09-192019-06-19
NCT03519945A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)RECRUITINGPHASE32018-07-182027-122026-07
NCT03590860A Study of LY3322207 in Healthy Participants and in Participants With Hypertension (High Blood Pressure)TERMINATEDPHASE12018-07-132019-01-172019-01-17
NCT05338476A Study of Effects of Selpercatinib (LY3527723) on Midazolam in Healthy ParticipantsCOMPLETEDPHASE12018-07-122018-09-182018-08-01
NCT03559270A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic DermatitisTERMINATEDPHASE32018-06-272022-06-132021-10-14
NCT03579940A Study of Lasmiditan in Healthy Japanese and Caucasian ParticipantsCOMPLETEDPHASE12018-06-272018-08-092018-08-09
NCT03535194A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)COMPLETEDPHASE32018-06-262020-06-032020-03-05
NCT03518086An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)COMPLETEDPHASE32018-06-182024-05-152021-01-21
NCT03559088A Study of the Effect of a Disease-Specific Migraine Smart Phone Application (App) on Participant CareCOMPLETEDNA2018-06-112019-04-262019-04-26
NCT03545087A Study of Lanabecestat in Participants With Severe Kidney Impairment Compared to Healthy ParticipantsWITHDRAWNPHASE12018-062019-012019-01
NCT03506399A Study of Lanabecestat in Healthy Female Participants Taking Oral ContraceptiveWITHDRAWNPHASE12018-062018-102018-10
NCT03499041A Study of LY3314814 in Participants With Liver ImpairmentWITHDRAWNPHASE12018-062018-122018-12
NCT05468164A Study of Effect of Food and a Proton Pump Inhibitor on Selpercatinib (LY3527723) in Healthy ParticipantsCOMPLETEDPHASE12018-05-312018-09-132018-09-13
NCT03428100A Long-term Study of Baricitinib (LY3009104) With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis That Are Not Controlled With Cyclosporine or for Those Who Cannot Take Oral Cyclosporine Because it is Not Medically AdvisableCOMPLETEDPHASE32018-05-152023-04-202019-11-25
NCT05338489A Study of Effects of Itraconazole and Rifampin on Selpercatinib (LY3527723) in Healthy ParticipantsCOMPLETEDPHASE12018-05-112018-08-222018-07-28
NCT03518073A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's DiseaseCOMPLETEDPHASE22018-04-302021-10-252021-08-23
NCT03364309A Study of Ixekizumab (LY2439821) in Chinese Participants With Moderate-to-Severe Plaque PsoriasisCOMPLETEDPHASE32018-04-262020-06-042020-06-04
NCT03482011A Study to Evaluate the Efficacy and Safety of Mirikizumab (LY3074828) in Participants With Moderate-to-Severe Plaque PsoriasisCOMPLETEDPHASE32018-04-242020-01-162019-03-21
NCT03414047A Study of Prexasertib (LY2606368) in Platinum-Resistant or Refractory Recurrent Ovarian CancerCOMPLETEDPHASE22018-04-102020-10-032019-06-03
NCT03495102A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 DiabetesCOMPLETEDPHASE32018-04-052019-10-102019-05-28
NCT03482024A Study of Tirzepatide (LY3298176) in Participants With Impaired Kidney FunctionCOMPLETEDPHASE12018-03-302019-08-192019-08-19
NCT03334435A Study of Long-term Baricitinib (LY3009104) Therapy in Atopic DermatitisCOMPLETEDPHASE32018-03-282023-07-122020-09-21
NCT03459612A Study of Lasmiditan on Simulated Driving Performance in Healthy ParticipantsCOMPLETEDPHASE12018-03-262018-06-232018-06-23
NCT03465878A Study of LY900014 in Participants With Type 1 Diabetes MellitusCOMPLETEDPHASE12018-03-262019-11-142019-11-14
NCT03338023A Study of LY2963016 Compared to Lantus® in Adult Chinese Participants With Type 1 Diabetes MellitusCOMPLETEDPHASE32018-03-232020-03-052020-03-05
NCT03338010A Study of LY2963016 Compared to Lantus® in Adult Chinese Participants With Type 2 Diabetes MellitusCOMPLETEDPHASE32018-03-222020-03-182020-03-18
NCT03382912Study of Pegilodecakin (LY3500518) With Nivolumab Compared to Nivolumab Alone Second-line Tx in Participants With Metastatic Non-Small Cell Lung CancerTERMINATEDPHASE22018-03-222020-03-032019-08-28
NCT03382899Study of Pegilodecakin (LY3500518) With Pembrolizumab Compared to Pembrolizumab Alone First-line Tx in Participants With Metastatic Non-Small Cell Lung CancerTERMINATEDPHASE22018-03-192020-03-052019-12-06
NCT03449433A Meal Test Study of LY900014 in Participants With Type 1 Diabetes MellitusCOMPLETEDPHASE12018-03-152018-08-142018-08-14
NCT03432286A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic MigraineRECRUITINGPHASE32018-03-142026-112025-11
NCT03456713A Study of LY3074828 in Healthy ParticipantsCOMPLETEDPHASE12018-03-062018-08-132018-08-13
NCT03433677A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 DiabetesCOMPLETEDPHASE32018-02-212018-09-042018-09-04
NCT03421379A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes MellitusCOMPLETEDPHASE32018-02-212018-08-202018-08-20
NCT03435081A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic DermatitisCOMPLETEDPHASE32018-02-202021-08-162019-12-09
NCT03407118A Study of LY900014 in Japanese Participants With Type 1 Diabetes MellitusCOMPLETEDPHASE12018-02-172018-07-122018-06-23
NCT03418493A Study of LY3316531 in Healthy Participants and in Participants With PsoriasisCOMPLETEDPHASE12018-01-302019-07-292018-12-24
NCT03443024A Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic DermatitisCOMPLETEDPHASE22018-01-302019-05-232019-02-07
NCT03406260A Study of Lasmiditan in Healthy Elderly ParticipantsCOMPLETEDPHASE12018-01-252018-04-132018-04-13
NCT04194892A Crossover Study to Evaluate Pegilodecakin (LY3500518) in Healthy ParticipantsCOMPLETEDPHASE12018-01-192018-03-142018-03-14
NCT03367377A Study of LY3209590 in Participants With Type 2 DiabetesCOMPLETEDPHASE12018-01-032018-10-032018-10-03
NCT02623478A Study of a Novel Insulin Lispro Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin PumpsWITHDRAWNPHASE12018-012018-042018-04
NCT02623452A Study of a New Type of Insulin in Participants With Type 1 Diabetes on Insulin Injection TherapyWITHDRAWNPHASE12018-012018-042018-04
NCT02623465A Study of a New Type of Insulin in Participants With Type 2 Diabetes on Insulin Injection TherapyWITHDRAWNPHASE12018-012018-042018-04
NCT03375463A Study of Tirzepatide (LY3298176) in Healthy ParticipantsCOMPLETEDPHASE12017-12-192018-12-272018-12-27
NCT03367403A Study of LY3002813 in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ)COMPLETEDPHASE22017-12-182021-09-212020-12-04
NCT03381547A 3-Way Crossover Study to Evaluate the Pharmacokinetics in Participants After Dosing With Pegilodecakin (LY3500518)COMPLETEDPHASE12017-12-182018-02-112018-02-11
NCT03363906A Study of Dulaglutide in Healthy ParticipantsCOMPLETEDPHASE12017-12-072018-06-062018-06-06
NCT03334448A Study to Compare 2 Formulations of LY900014 in Healthy ParticipantsCOMPLETEDPHASE12017-12-042018-03-152018-03-15
NCT03334422Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic DermatitisCOMPLETEDPHASE32017-11-272018-12-122018-12-12
NCT03334396A Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic DermatitisCOMPLETEDPHASE32017-11-232019-08-162018-12-06
NCT03343613A Study of LY3381916 Alone or in Combination With LY3300054 in Participants With Solid TumorsTERMINATEDPHASE12017-11-172020-05-042020-02-07
NCT03343587A Study of LY3375880 in Healthy ParticipantsCOMPLETEDPHASE12017-11-172018-11-162018-11-16
NCT03322631A Study of Tirzepatide (LY3298176) in Japanese Participants With Type 2 DiabetesCOMPLETEDPHASE12017-11-152018-11-282018-05-29
NCT03341299A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants With Type 1 Diabetes MellitusCOMPLETEDPHASE12017-11-132018-04-032018-04-03
NCT03341312A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants With Type 2 Diabetes Mellitus (T2DM)COMPLETEDPHASE12017-11-132018-03-312018-03-31
NCT03339453A Study of Nasal Glucagon in Participants With Type 1 Diabetes MellitusCOMPLETEDPHASE12017-11-102018-01-132017-12-17
NCT03305809A Study of LY3154207 in Participants With Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB)COMPLETEDPHASE22017-11-092020-07-102020-07-10
NCT03367390A Study of an Automated Insulin Delivery System in Participants With Type 1 Diabetes Mellitus (T1DM)COMPLETEDPHASE12017-11-082018-02-092018-02-09
NCT03315780A Study of the Glucodynamic Effects of Dulaglutide (LY2189265) in Japanese Participants With Type 2 DiabetesCOMPLETEDPHASE42017-10-282018-02-282018-02-28
NCT03325387A Study of Multiple Doses of LY3305677 in Healthy ParticipantsCOMPLETEDPHASE12017-10-272018-08-032018-08-03
NCT03311724A Study of Tirzepatide (LY3298176) in Participants With Type 2 DiabetesCOMPLETEDPHASE22017-10-192018-04-242018-04-24
NCT03283696A Study of Olaratumab (LY3012207), Doxorubicin, and Ifosfamide in Participants With Advanced or Metastatic Soft Tissue SarcomaCOMPLETEDPHASE12017-10-182019-08-252019-04-29
NCT03310411A Study of Lasmiditan When Given With Sumatriptan in Healthy ParticipantsCOMPLETEDPHASE12017-10-172017-12-232017-12-23
NCT03308669A Study of Lasmiditan in Healthy Participants When Co-administered With TopiramateCOMPLETEDPHASE12017-10-162017-12-022017-12-02
NCT03286751A Comparative Study of LY900014 to Insulin Lispro (Humalog) in Healthy ParticipantsCOMPLETEDPHASE12017-10-132018-02-062018-02-06
NCT03305822A Study of LY900014 in Participants With Type 2 Diabetes MellitusCOMPLETEDPHASE12017-10-112017-12-142017-12-14
NCT03286218A Study of the Abuse Potential of Lasmiditan in Participants Who Are Recreational Drug UsersCOMPLETEDPHASE12017-09-152017-11-202017-11-20
NCT03267732A Study to Evaluate the Pharmacokinetics in Participants After Dosing With Pegilodecakin (LY3500518)COMPLETEDPHASE12017-09-052017-10-302017-10-30
NCT03270644A Study of Lasmiditan and Propranolol in Healthy ParticipantsCOMPLETEDPHASE12017-08-312017-11-222017-11-22
NCT03151551A Study of Ixekizumab (LY2439821) Versus Adalimumab in Participants With Psoriatic ArthritisCOMPLETEDPHASE42017-08-242019-09-042018-11-15
NCT03247790A Study of Lasmiditan in Participants With MigraineCOMPLETEDPHASE12017-08-162018-01-152018-01-15
NCT03252015A Study of Multiple Doses of Lasmiditan in Healthy ParticipantsCOMPLETEDPHASE12017-08-152018-01-022018-01-02
NCT03232983A Study of LY900014 Formulation at Different Injection Sites in Healthy ParticipantsCOMPLETEDPHASE12017-08-142017-11-092017-11-09
NCT02919696A Study of Abemaciclib (LY2835219) in Native Chinese Participants With Advanced and/or Metastatic CancersCOMPLETEDPHASE12017-08-072019-09-032018-11-23
NCT03214367A Study of LY900014 in Participants With Type 1 DiabetesCOMPLETEDPHASE32017-07-172019-08-222018-09-06
NCT03220126A Study to Assess the Amount of LY3074828 That Gets Into the Body When Given With LY9999QS, in Healthy ParticipantsCOMPLETEDPHASE12017-07-172018-02-232018-02-23
NCT03214380A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 DiabetesCOMPLETEDPHASE32017-07-142019-03-132018-08-14
NCT03155997Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast CancerACTIVE_NOT_RECRUITINGPHASE32017-07-122029-052020-03-16
NCT03126591A Study of Olaratumab (LY3012207) Plus Pembrolizumab in Participants With Advanced or Metastatic Soft Tissue SarcomaCOMPLETEDPHASE12017-07-032023-02-212021-05-06
NCT03188510A Study of Two Different Formulations of LY3074828 in Healthy ParticipantsCOMPLETEDPHASE12017-06-302017-11-272017-11-27
NCT03212638A Study of Baricitinib in Healthy ParticipantsCOMPLETEDPHASE12017-06-272017-11-012017-07-31
NCT03086369A Study of Nab-Paclitaxel and Gemcitabine With or Without Olaratumab (LY3012207) in Participants With Metastatic Pancreatic CancerCOMPLETEDPHASE1, PHASE22017-06-222021-06-172021-01-05
NCT03182920A Study of Lasmiditan in Healthy ParticipantsCOMPLETEDPHASE12017-06-162017-08-142017-08-14
NCT03115099A Study of LY3325656 in Healthy Participants and Participants With Type 2 DiabetesCOMPLETEDPHASE12017-05-312018-04-052018-04-05
NCT03092934A Study of AK-01 (LY3295668) in Solid TumorsCOMPLETEDPHASE1, PHASE22017-05-292020-04-202020-04-20
NCT03131687A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes MellitusCOMPLETEDPHASE22017-05-242018-08-012018-08-01
NCT03148431A Study of LY3002815 in Healthy ParticipantsTERMINATEDPHASE12017-05-242018-09-262017-12-15
NCT03166124A Study of LY900014 in Elderly and Younger Adult Participants With Type 1 Diabetes MellitusCOMPLETEDPHASE12017-05-242017-11-182017-11-18
NCT03129100A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial SpondyloarthritisCOMPLETEDPHASE32017-05-092021-05-272020-05-26
NCT03157128A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)ACTIVE_NOT_RECRUITINGPHASE1, PHASE22017-05-022026-022025-02-14
NCT03053622A Study of Mirikizumab (LY3074828) Injection in Healthy ParticipantsCOMPLETEDPHASE12017-04-242018-04-032018-04-03
NCT03040362Absorption, Metabolism and Excretion of [14C]-Lasmiditan - Single Oral Dose AdministrationCOMPLETEDPHASE12017-04-202017-05-062017-05-06
NCT03073213A Study of Ixekizumab in Chinese Participants With Psoriasis VulgarisCOMPLETEDPHASE12017-04-132019-05-142019-05-14
NCT03099109A Study of LY3321367 Alone or With LY3300054 in Participants With Advanced Relapsed/Refractory Solid TumorsCOMPLETEDPHASE12017-04-122023-08-302019-12-10
NCT03099148A Study of LY3337641 in Healthy ParticipantsCOMPLETEDPHASE12017-04-042017-05-312017-05-31
NCT03009162Study of Oral Lasmiditan in Participants With Normal and Impaired Renal FunctionCOMPLETEDPHASE12017-04-012017-06-022017-06-02
NCT03073200Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque PsoriasisCOMPLETEDPHASE32017-03-282021-03-232019-02-07
NCT03127956A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne VulgarisCOMPLETEDPHASE32017-03-212018-04-272018-04-27
NCT03076970Effect of Single Oral Doses of Lasmiditan When Coadministered With Single Oral Doses of Sumatriptan in Healthy ParticipantsCOMPLETEDPHASE12017-03-212017-04-132017-04-13
NCT03083561A Study of LY3337641 in Japanese and Caucasian Healthy ParticipantsCOMPLETEDPHASE12017-03-152017-05-252017-05-25
NCT03040479Pharmacokinetic Single Dose Study of Oral Lasmiditan in Participants With Normal and Impaired Hepatic FunctionCOMPLETEDPHASE12017-03-142017-07-172017-07-17
NCT03025009A Study of LY3192767 in Healthy ParticipantsCOMPLETEDPHASE12017-03-062018-04-112018-04-11
NCT02898077A Study of Paclitaxel With or Without Ramucirumab (LY3009806) in Participants With Gastric or Gastroesophageal CancerCOMPLETEDPHASE32017-03-022021-04-122020-06-30
NCT02923921Study of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic CancerCOMPLETEDPHASE32017-03-012020-03-052019-09-09
NCT03056456A Study of LY900014 Administered in Participants With Type 1 Diabetes Using an Insulin PumpCOMPLETEDPHASE12017-02-232017-06-192017-06-19
NCT02959190A Study of LY2951742 (Galcanezumab) in Japanese Participants With MigraineCOMPLETEDPHASE32017-02-072019-08-102019-08-10
NCT03073486A Study of Olumacostat Glasaretil Gel in Subjects With Acne VulgarisCOMPLETEDPHASE32017-02-062017-12-212017-12-21
NCT03018938A Study of Basal Insulin Analog and Insulin Analog Mid Mixture in Chinese Participants With Type 2 Diabetes MellitusCOMPLETEDPHASE42017-02-062019-07-122019-02-19
NCT03027284A Study of Merestinib (LY2801653) in Japanese Participants With Advanced or Metastatic CancerCOMPLETEDPHASE12017-02-032020-03-172019-06-20
NCT03019536A Study of LY3303560 in Participants With Mild Cognitive Impairment or Alzheimer's DiseaseCOMPLETEDPHASE12017-01-312019-06-052019-06-05
NCT03012334The Effects of Lasmiditan on Simulated Driving Performance - Healthy ParticipantsCOMPLETEDPHASE12017-01-162017-06-082017-06-08
NCT03023826A Study of LY3202626 in Healthy ParticipantsCOMPLETEDPHASE12017-01-152017-04-042017-04-04
NCT02981342A Study of Abemaciclib (LY2835219) Alone or in Combination With Other Agents in Participants With Previously Treated Pancreatic Ductal AdenocarcinomaCOMPLETEDPHASE22017-01-122018-11-092018-04-20
NCT02963766A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 DiabetesCOMPLETEDPHASE32016-12-292022-01-122021-06-12
NCT03028363A Study of Olumacostat Glasaretil Gel in Subjects With Acne VulgarisCOMPLETEDPHASE32016-12-272017-11-282017-11-28
NCT02993471A Study of Ixekizumab in Participants With Plaque PsoriasisCOMPLETEDPHASE12016-12-222017-11-212017-11-21
NCT02942914A Study of LY3209590 in Healthy Participants and Participants With Type 2 DiabetesCOMPLETEDPHASE12016-12-202017-10-182017-10-18
NCT02891226A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's DiseaseCOMPLETEDPHASE22016-12-142021-02-052018-12-11
NCT02989389A Study of LY3323795 in Healthy ParticipantsCOMPLETEDPHASE12016-12-122017-07-212017-07-21
NCT02763566A Study of Abemaciclib (LY2835219) in Participants With Breast CancerACTIVE_NOT_RECRUITINGPHASE32016-12-052027-012019-03-29
NCT02972645A Study of LY3305677 in Healthy ParticipantsCOMPLETEDPHASE12016-12-052017-07-142017-07-14
NCT02973100A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin MonotherapyCOMPLETEDPHASE22016-122017-08-142017-07-15
NCT02963779A Study of LY2775240 in Healthy ParticipantsCOMPLETEDPHASE12016-122017-10-052017-10-05
NCT02937272A Study of LY3200882 in Participants With Solid TumorsACTIVE_NOT_RECRUITINGPHASE12016-11-212025-082020-02-27
NCT02779751A Study of Abemaciclib (LY2835219) in Participants With Non-Small Cell Lung Cancer or Breast CancerACTIVE_NOT_RECRUITINGPHASE12016-11-142025-122020-02-03
NCT02955953A Study Comparing Two Formulations of Insulin Glargine in Healthy ParticipantsCOMPLETEDPHASE12016-11-142017-01-042017-01-04
NCT02959177A Study of LY2951742 (Galcanezumab) in Japanese Participants With Episodic MigraineCOMPLETEDPHASE22016-11-092019-01-182019-01-18
NCT02896868A Study of LY3041658 in Participants With Skin DiseasesCOMPLETEDPHASE12016-11-082019-03-192019-03-19
NCT02784795A Study of LY3039478 in Participants With Advanced or Metastatic Solid TumorsTERMINATEDPHASE12016-11-042020-02-132018-08-09
NCT02831491A Study of Ramucirumab (LY3009806) in Combination With Weekly Docetaxel in Participants With Stage IV Non-Small Cell Lung CancerWITHDRAWNPHASE22016-112018-012017-07
NCT02951780A Study of LY3185643 and rGlucagon in Healthy ParticipantsCOMPLETEDPHASE12016-11-012017-03-012017-01-24
NCT02941601A Study of Gemcitabine-Carboplatin Plus Necitumumab (LY3012211) in Chemotherapy-Naïve Participants With Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)WITHDRAWNPHASE22016-112019-022017-12
NCT02942654A Study of LY900014 Formulation in Healthy ParticipantsCOMPLETEDPHASE12016-112016-122016-12
NCT02789345A Study of Ramucirumab (LY3009806) or Necitumumab (LY3012211) Plus Osimertinib in Participants With Lung CancerCOMPLETEDPHASE12016-10-242022-05-092017-10-19
NCT02745769A Study in Advanced Cancers Using Ramucirumab (LY3009806) and Other Targeted AgentsCOMPLETEDPHASE12016-10-212019-01-222018-11-05
NCT02783599A Study of Olaratumab (LY3012207) in Participants With Soft Tissue SarcomaCOMPLETEDPHASE12016-10-112018-07-052018-07-05
NCT02906618Study of LY3039478 in Healthy ParticipantsCOMPLETEDPHASE12016-10-042016-11-112016-11-11
NCT02857270A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic CancerCOMPLETEDPHASE12016-09-292022-10-242021-02-10
NCT02766517Biomarker Study in Participants With MigraineCOMPLETEDEARLY_PHASE12016-09-282017-01-012017-01-01
NCT02778126A Study of Prexasertib (LY2606368) in Participants With Advanced CancerCOMPLETEDPHASE12016-09-222017-07-272017-04-29
NCT02747004A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast CancerACTIVE_NOT_RECRUITINGPHASE22016-09-142025-122018-06-15
NCT05341102A Study of Single and Repeated Doses of LY3556050 in Healthy ParticipantsCOMPLETEDPHASE12016-09-142017-06-022017-06-02
NCT02899988A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Plaque PsoriasisCOMPLETEDPHASE22016-09-142019-05-082017-06-19
NCT02836600A Study of LY3039478 in Japanese Participants With Advanced Solid TumorsCOMPLETEDPHASE12016-09-092023-05-302019-07-05
NCT02917733A Study of the Absorption, Distribution, Metabolism and Excretion of LY3039478 in Healthy ParticipantsCOMPLETEDPHASE12016-092016-112016-11
NCT02914379A Study of LY3337641 in Healthy Male ParticipantsCOMPLETEDPHASE12016-092016-112016-11
NCT02737072A Study of LY2510924 and Durvalumab in Participants With Solid TumorsTERMINATEDPHASE12016-092017-09-252017-09-25
NCT02677116A Study of Olaratumab Alone and in Combination With Standard Chemotherapies in Children With CancerCOMPLETEDPHASE12016-08-292019-04-032018-10-10
NCT02628028A Study of LY3337641 in Rheumatoid ArthritisTERMINATEDPHASE22016-08-222018-08-152018-04-25
NCT02860780A Study of Prexasertib (LY2606368) in Combination With Ralimetinib in Participants With Advanced or Metastatic CancerCOMPLETEDPHASE12016-08-102017-05-152017-05-15
NCT02757352A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial SpondyloarthritisCOMPLETEDPHASE32016-08-022019-05-072019-03-01
NCT02750410A Study of Dulaglutide in Japanese Participants With Type 2 DiabetesCOMPLETEDPHASE42016-082018-06-182018-06-18
NCT02884089A Study of the Effect of Abemaciclib on Metformin and Iohexol in Healthy ParticipantsCOMPLETEDPHASE12016-082016-122016-12
NCT02797951A Study of LY2951742 (Galcanezumab) in Participants With Cluster HeadacheCOMPLETEDPHASE32016-07-132021-01-212021-01-21
NCT02836613A Study of Galcanezumab in Healthy Participants.COMPLETEDPHASE12016-072017-11-092017-02-27
NCT02818335A Study of LY3023414 Formulations and the Effect of FoodCOMPLETEDPHASE12016-072016-102016-10
NCT02791334A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid TumorsCOMPLETEDPHASE12016-06-292024-06-272020-05-22
NCT02718911A Study of LY3022855 in Combination With Durvalumab or Tremelimumab in Participants With Advanced Solid TumorsCOMPLETEDPHASE12016-06-162018-12-142018-12-14
NCT02791191A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease DementiaTERMINATEDPHASE22016-06-162018-07-022018-07-02
NCT02734160A Study of Galunisertib (LY2157299) and Durvalumab (MEDI4736) in Participants With Metastatic Pancreatic CancerCOMPLETEDPHASE12016-06-152019-04-172018-08-02
NCT02760602A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's DiseaseTERMINATEDPHASE32016-062017-052017-05
NCT02675231A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast CancerCOMPLETEDPHASE22016-05-232023-11-092019-04-08
NCT02711553A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract CancerACTIVE_NOT_RECRUITINGPHASE22016-05-192026-122018-02-16
NCT02759107A Study of Tirzepatide (LY3298176) in Healthy Participants and Participants With Type 2 Diabetes (T2DM)COMPLETEDPHASE12016-05-112017-06-262017-06-26
NCT02735980A Study of Prexasertib (LY2606368) in Participants With Extensive Stage Disease Small Cell Lung CancerCOMPLETEDPHASE22016-05-112019-02-122017-07-31
NCT02696785A Study of Ixekizumab (LY2439821) in bDMARD-Naive Participants With Radiographic Axial SpondyloarthritisCOMPLETEDPHASE32016-05-022018-10-172017-12-08
NCT02605174Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute Treatment of MigraineCOMPLETEDPHASE32016-052017-06-302017-06-30
NCT02758613A Study of Baricitinib (LY3009104) in Healthy Chinese ParticipantsCOMPLETEDPHASE12016-052016-072016-07
NCT02779738A Study of Merestinib (LY2801653) in Healthy ParticipantsCOMPLETEDPHASE12016-052016-082016-08
NCT02770521A Study of Treprostinil and a New Formulation of LY900014 in Healthy Japanese ParticipantsCOMPLETEDPHASE12016-052016-072016-07
NCT02754830A Study of LY3303560 in Healthy Participants and Participants With Alzheimer's Disease (AD)COMPLETEDPHASE12016-04-252018-07-102018-07-10
NCT02696798A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial SpondyloarthritisCOMPLETEDPHASE32016-04-122019-05-032018-05-18
NCT02718898A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Genital PsoriasisCOMPLETEDPHASE32016-042018-02-212017-02-22
NCT02752919Study of Galunisertib in Healthy ParticipantsCOMPLETEDPHASE12016-042016-062016-06
NCT02752087A Study to Compare the Effects of a Test and Reference Formulation of LY900014 in Healthy ParticipantsCOMPLETEDPHASE12016-042016-052016-05
NCT02708095A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (SLE)COMPLETEDPHASE22016-03-242017-11-092017-10-12
NCT02688088A Study of Abemaciclib in Participants With Cancer That is Advanced or Has Spread to Another Part(s) of the BodyCOMPLETEDPHASE12016-03-082021-01-062018-02-04
NCT02659020A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue SarcomaCOMPLETEDPHASE1, PHASE22016-03-012021-04-272020-07-28
NCT02714569A Study to Evaluate LY3202328 in Overweight Healthy Participants and DyslipidemiaCOMPLETEDPHASE12016-032017-02-152017-02-15
NCT02703324A Study of LY900014 Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin PumpsCOMPLETEDPHASE12016-032016-082016-08
NCT02703350A Study of LY900014 in Participants With Type 1 Diabetes on Insulin Injection TherapyCOMPLETEDPHASE12016-032016-072016-07
NCT02703337A Study of LY900014 in Participants With Type 2 Diabetes on Insulin Injection TherapyCOMPLETEDPHASE12016-032016-082016-08
NCT02555644A Study of Prexasertib (LY2606368) With Chemotherapy and Radiation in Participants With Head and Neck CancerCOMPLETEDPHASE12016-02-242019-01-142019-01-14
NCT02572687A Study of Ramucirumab (LY3009806) Plus MEDI4736 in Participants With Advanced Gastrointestinal or Thoracic MalignanciesCOMPLETEDPHASE12016-02-192021-01-132018-03-27
NCT02576938A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic DermatitisCOMPLETEDPHASE22016-022017-032017-02
NCT02677844A Study of Abemaciclib in Healthy ParticipantsCOMPLETEDPHASE12016-022016-072016-07
NCT02672423A Study of Abemaciclib in Healthy ParticipantsCOMPLETEDPHASE12016-022016-102016-10
NCT02634801A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis Naive to Systemic TreatmentCOMPLETEDPHASE32016-01-202017-11-142016-11-29
NCT02588950A Study of U-500 Insulin (LY041001) in Participants With Type 2 DiabetesTERMINATEDPHASE12016-01-122017-05-252017-05-25
NCT02659865A Study of LY3039478 in Healthy ParticipantsCOMPLETEDPHASE12016-012016-062016-06
NCT02624778A Study of LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or ADCOMPLETEDPHASE12015-12-222019-08-282019-08-28
NCT02564198A Study of Ramucirumab (LY3009806) in Children With Refractory Solid TumorsCOMPLETEDPHASE12015-12-112019-07-162019-07-16
NCT02614716A Study of LY3090106 in Participants With Sjögren's Syndrome (SS)COMPLETEDPHASE12015-12-102018-09-052018-09-05
NCT02589665A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Ulcerative ColitisCOMPLETEDPHASE22015-12-092019-05-072017-12-19
NCT02614196Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 StudyCOMPLETEDPHASE32015-12-042018-10-052017-03-29
NCT02568423A Study of Mirikizumab (LY3074828) in Healthy ParticipantsCOMPLETEDPHASE12015-12-022018-10-242018-07-16
NCT02614131A Study of LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)TERMINATEDPHASE12015-122016-122016-12
NCT02636361A Study of Various Formulations of LY900014 in Healthy ParticipantsCOMPLETEDPHASE12015-122016-022016-02
NCT02614261Evaluation of Galcanezumab in the Prevention of Chronic MigraineCOMPLETEDPHASE32015-11-302021-07-142017-03-16
NCT02614183Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 StudyCOMPLETEDPHASE32015-11-302018-08-092017-03-22
NCT02614287A Safety Study of Galcanezumab in Participants With Migraine, With or Without AuraCOMPLETEDPHASE32015-11-302018-08-142017-05-12
NCT02604160A Study of LY3113593 in Participants With Chronic Kidney DiseaseCOMPLETEDPHASE12015-11-172016-06-222016-06-22
NCT02597036A Study of LY3127804 With Ramucirumab in Participants With Advanced Solid TumorsCOMPLETEDPHASE12015-11-062020-05-242017-11-23
NCT02597049A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes MellitusCOMPLETEDPHASE32015-112017-022017-02
NCT02595736A Study of LY3200327 in Healthy ParticipantsCOMPLETEDPHASE12015-112016-082016-08
NCT02603861A Study of LY3154207 on Sleep in Healthy Male ParticipantsCOMPLETEDPHASE12015-112016-032016-03
NCT02561078An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Participants With Type 2 Diabetes MellitusCOMPLETEDPHASE32015-10-202017-05-092017-05-09
NCT02576951A Study of Galcanezumab in Healthy ParticipantsCOMPLETEDPHASE12015-10-192018-01-082016-09-03
NCT02514551A Study of Ramucirumab (LY3009806) in Combination With Paclitaxel in Participants With Gastric CancerCOMPLETEDPHASE22015-10-122018-12-282017-10-27
NCT02392507A Study of Nab-Paclitaxel and Carboplatin Plus Necitumumab (LY3012211) in Participants With Stage IV Squamous NSCLCCOMPLETEDPHASE22015-10-122019-11-062018-01-29
NCT02565186An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of MigraineCOMPLETEDPHASE32015-10-072019-08-202019-08-20
NCT02539225A Study of Ramucirumab in Participants With Gastric or Gastroesophageal Junction AdenocarcinomaCOMPLETEDPHASE22015-10-052021-03-102017-10-25
NCT02561806A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsoriasisCOMPLETEDPHASE32015-102017-102016-05
NCT02518113A Study of LY3039478 in Combination With Dexamethasone in Participants With T-ALL/T-LBLCOMPLETEDPHASE1, PHASE22015-10-012018-01-152018-01-15
NCT02514603A Study of Prexasertib (LY2606368) in Japanese Participants With Advanced CancersCOMPLETEDPHASE12015-102017-04-102017-04-10
NCT02575703A Study of [¹⁴C]-LY3023414 in Healthy ParticipantsCOMPLETEDPHASE12015-102015-112015-11
NCT02562768A Study of LY3154207 in Healthy Participants and Participants With Parkinson's DiseaseCOMPLETEDPHASE12015-09-302017-03-032017-03-03
NCT02451943A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue SarcomaCOMPLETEDPHASE32015-09-142024-06-272018-12-05
NCT02584855A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic ArthritisCOMPLETEDPHASE32015-09-142018-10-302018-10-30
NCT02451930A Study of the Combination of Necitumumab (LY3012211) and Pembrolizumab (MK3475) in Participants With NSCLCCOMPLETEDPHASE12015-09-042019-09-172017-01-26
NCT02555449A Study of [¹⁴C]-LY3202626 in Healthy Male ParticipantsCOMPLETEDPHASE12015-092015-112015-11
NCT02529553A Study of LY3076226 in Participants With Advanced or Metastatic CancerCOMPLETEDPHASE12015-092018-03-282018-03-28
NCT02536586A Study of LY3023414 in Japanese Participants With Advanced CancerCOMPLETEDPHASE12015-092017-02-092017-02-09
NCT02543918A Study of the Immune Response to Vaccines and Ixekizumab (LY2439821) in Healthy ParticipantsCOMPLETEDPHASE12015-092015-122015-11
NCT02450539A Study of Abemaciclib (LY2835219) in Participants With Stage IV Squamous Non-small Cell Lung CancerCOMPLETEDPHASE22015-08-062020-07-292017-03-31
NCT02441946A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast CancerCOMPLETEDPHASE22015-082018-02-122016-08-16
NCT02513550A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque PsoriasisCOMPLETEDPHASE32015-082017-08-032016-11
NCT02525744A Study of a New LY900014 Formulation in Healthy ParticipantsCOMPLETEDPHASE12015-082015-102015-10
NCT02443324A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract CancerCOMPLETEDPHASE12015-07-292022-04-122018-08-31
NCT02435433A Study of Ramucirumab (LY3009806) Versus Placebo in Participants With Hepatocellular Carcinoma and Elevated Baseline Alpha-FetoproteinCOMPLETEDPHASE32015-07-202021-11-192018-03-15
NCT02426125A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial CancerCOMPLETEDPHASE32015-07-132022-07-262017-04-21
NCT02443883A Phase 2 Study of Ramucirumab (LY3009806) in Participants With Gastric or Gastroesophageal Junction (GEJ) CancerCOMPLETEDPHASE22015-07-072019-06-052016-11-18
NCT02497391A Study of Different Particle Sizes of Evacetrapib in Healthy ParticipantsCOMPLETEDPHASE12015-072015-112015-11
NCT02443337A Study of LY3023414 and Necitumumab in Squamous Lung CancerTERMINATEDPHASE22015-072017-092017-09
NCT02490670A Study of Cephalexin Liquid in Healthy ParticipantsCOMPLETEDPHASE12015-072015-072015-07
NCT02438826A Study of Galcanezumab in Participants With Chronic Cluster HeadacheCOMPLETEDPHASE32015-06-182019-08-142018-03-27
NCT02411591A Study of Necitumumab and Abemaciclib in Participants With Non-Small Cell Lung Cancer (NSCLC)COMPLETEDPHASE12015-06-042019-05-282017-06-23
NCT02482935A Study of Abemaciclib (LY2835219) in Healthy Participants With and Without FoodCOMPLETEDPHASE12015-062015-092015-09
NCT02397473A Study Of Galcanezumab In Participants With Episodic Cluster HeadacheCOMPLETEDPHASE32015-05-222018-06-042018-02-12
NCT02411448A Study of Ramucirumab (LY3009806) in Combination With Erlotinib in Previously Untreated Participants With EGFR Mutation-Positive Metastatic NSCLC (RELAY)ACTIVE_NOT_RECRUITINGPHASE32015-05-062025-122019-01-23
NCT02265536A Study of LY3022855 In Participants With Breast or Prostate CancerCOMPLETEDPHASE12015-05-012017-11-032017-11-03
NCT02304419A Study of Galunisertib on the Immune System in Participants With CancerCOMPLETEDPHASE12015-052016-082016-08
NCT02407054A Study of Enzalutamide and LY3023414 in Men With Prostate CancerCOMPLETEDPHASE22015-04-292020-04-162018-09-26
NCT02308020A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the BrainCOMPLETEDPHASE22015-04-202019-11-082018-11-08
NCT02431052A Dose-ranging Study of DRM01 in Subjects With Acne VulgarisCOMPLETEDPHASE22015-042016-042016-04
NCT02439320Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:COMPLETEDPHASE32015-042016-082016-07
NCT02417935A Study of Duloxetine (LY248686) in Participants With Diabetic Peripheral Neuropathic Pain (DPNP)COMPLETEDPHASE42015-042017-05-132017-05-13
NCT02387801A Study of the Early Activity of Ixekizumab (LY2439821) in Moderate-to-Severe PsoriasisCOMPLETEDPHASE32015-042016-082015-09
NCT02431754A Study of Tadalafil (LY450190) in Participants With Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia LUTS (BPH-LUTS).COMPLETEDPHASE42015-042016-022016-02
NCT02377752A Study of Olaratumab in Japanese Participants With Advanced CancerCOMPLETEDPHASE12015-03-232020-01-142018-08-27
NCT02402933Clinical Usability of Nasal Glucagon in Treatment of Hypoglycemia in Children and AdolescentsCOMPLETEDPHASE32015-032015-082015-08
NCT02387814A Study of Abemaciclib in Participants With Varying Degrees of Liver ImpairmentCOMPLETEDPHASE12015-032015-082015-08
NCT02385084A Study of LY2409021 Formulations in Healthy ParticipantsTERMINATEDPHASE12015-032015-052015-05
NCT02359058A Study of Ramucirumab Combination Therapy in Japanese Participants Who Have Advanced Stomach CancerCOMPLETEDPHASE12015-022016-112016-07
NCT02106364A Study of Insulin Peglispro (LY2605541) in Participants With Type 2 Diabetes MellitusWITHDRAWNPHASE32015-022016-062015-11
NCT02370485A Study of LY2801653 in Healthy Participants Who Are Not Able to Have ChildrenCOMPLETEDPHASE12015-022015-052015-05
NCT02365571A Study of LY3154207 in Healthy ParticipantsCOMPLETEDPHASE12015-022015-052015-05
NCT02326025A Study of Olaratumab and Doxorubicin in Participants With Advanced Soft Tissue SarcomaCOMPLETEDPHASE12015-01-222018-11-022015-05-20
NCT02314117A Study of Ramucirumab (LY3009806) in Combination With Capecitabine and Cisplatin in Participants With Stomach CancerCOMPLETEDPHASE32015-01-202020-08-142017-01-17
NCT02423343A Study of Galunisertib (LY2157299) in Combination With Nivolumab in Advanced Refractory Solid Tumors and in Recurrent or Refractory NSCLC, or Hepatocellular CarcinomaCOMPLETEDPHASE1, PHASE22015-01-012020-07-082018-12-13
NCT02335346An Extension Study of Duloxetine in Osteoarthritis and Knee Pain (Extension of F1J-JE-HMGX, NCT02248480)COMPLETEDPHASE32015-012016-032016-03
NCT02342314A Study of LY3143753 and LY3185643 in Healthy ParticipantsCOMPLETEDPHASE12015-012016-092016-09
NCT02337387A Study of 2 Different Formulations of Blosozumab (LY2541546) in Post Menopausal WomenTERMINATEDPHASE12015-012015-032015-03
NCT02233296Food-Effect Study in Healthy ParticipantsCOMPLETEDPHASE12015-012015-032015-02
NCT02365558A Study to Evaluate the Effect of Increased Stomach pH on Evacetrapib in Healthy ParticipantsCOMPLETEDPHASE12015-012015-042015-04
NCT02260648A Study of Evacetrapib (LY2484595) in Combination With Atorvastatin in Japanese Participants With Primary HypercholesterolemiaTERMINATEDPHASE32015-012015-112015-11
NCT02327143A Study of LY2835219 in Healthy ParticipantsCOMPLETEDPHASE12015-012015-022015-02
NCT02340104A Study to Measure Baricitinib (LY3009104) Absorption in Healthy ParticipantsCOMPLETEDPHASE12015-012015-022015-02
NCT02806973A Study of Single or Repeated Doses of Glucagon in Participants With DiabetesCOMPLETEDPHASE12015-012015-042015-04
NCT02317575A Study of LY900014 Formulations in Healthy ParticipantsCOMPLETEDPHASE12015-012015-092015-04
NCT02349295A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic ArthritisCOMPLETEDPHASE32014-12-312019-06-262016-09-09
NCT02293551A Study of Lispro Formulations in Healthy ParticipantsCOMPLETEDPHASE12014-122015-092015-09
NCT02323334A Study of LY3202626 in Healthy Participants and Participants With Alzheimer's DiseaseCOMPLETEDPHASE12014-122016-022016-02
NCT02302716A Study of LY2963016 Compared to LANTUS® in Adult Participants With Type 2 Diabetes MellitusCOMPLETEDPHASE32014-122016-072016-07
NCT02240433A Study of LY2157299 in Participants With Unresectable Hepatocellular Cancer (HCC)COMPLETEDPHASE12014-11-122019-12-252017-07-19
NCT02246621A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast CancerACTIVE_NOT_RECRUITINGPHASE32014-11-062025-122017-01-31
NCT02300259A Study of LY2623091 in Healthy ParticipantsCOMPLETEDPHASE12014-112015-042015-04
NCT02260635A Study of Evacetrapib (LY2484595) in Japanese Participants With Primary HypercholesterolemiaTERMINATEDPHASE32014-112015-122015-07
NCT02263911A Study of Baricitinib in Healthy Japanese ParticipantsCOMPLETEDPHASE12014-112014-122014-12
NCT02152631A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung CancerACTIVE_NOT_RECRUITINGPHASE32014-10-032025-122017-09-15
NCT02248480A Study of Duloxetine (LY248686) in Participants With Chronic Osteoarthritis and Knee Pain in JapanCOMPLETEDPHASE32014-102015-062015-06
NCT02224846A Study of Tadalafil (LY450190) in Chinese Men With Erectile DysfunctionCOMPLETEDPHASE42014-102017-052016-05
NCT02227784A Study of Evacetrapib (LY2484595) in Participants With High CholesterolTERMINATEDPHASE32014-102015-122015-12
NCT02265705A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis (RA)COMPLETEDPHASE32014-102017-052017-05
NCT02256267A Study of LY2835219 in Healthy ParticipantsCOMPLETEDPHASE12014-102014-112014-11
NCT02271425A Study to Measure the Amount of Evacetrapib That Enters the Blood Stream in Healthy ParticipantsCOMPLETEDPHASE12014-102014-112014-11
NCT02242903A Study of LY3079514 in Healthy ParticipantsCOMPLETEDPHASE12014-102015-062015-06
NCT02242981A Study of How the Body Breaks Down and Eliminates LY2623091COMPLETEDPHASE12014-092014-112014-11
NCT02226653A Study of Evacetrapib in Healthy Japanese ParticipantsCOMPLETEDPHASE12014-092015-042015-04
NCT02178358A Study of LY2157299 in Participants With Advanced Hepatocellular CarcinomaCOMPLETEDPHASE22014-08-082021-02-182017-06-30
NCT02194465A Study of LY2623091 in Participants With High Blood PressureCOMPLETEDPHASE22014-082015-032015-03
NCT02221882A Study of LY3164530 in Participants With CancerCOMPLETEDPHASE12014-082017-03-072017-03-07
NCT02217618A Study of LY2409021 in Healthy ParticipantsCOMPLETEDPHASE12014-082014-092014-09
NCT02107703A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast CancerACTIVE_NOT_RECRUITINGPHASE32014-07-222025-122017-02-14
NCT02163993A Study of Galcanezumab (LY2951742) in Participants With Migraine HeadacheCOMPLETEDPHASE22014-07-072018-02-122015-08-19
NCT02192190A Study of LY2951742 in Participants With Mild to Moderate Osteoarthritis Knee PainTERMINATEDPHASE22014-072015-062015-04
NCT02197520A Study To Compare the Effects of Insulin Peglispro and Glargine on Insulin Sensitivity and Meal Time Insulin Requirements in Type 2 DiabeticsCOMPLETEDPHASE12014-072015-062015-06
NCT01870284Study of Ixekizumab in Participants With Active Ankylosing Spondylitis (AS)WITHDRAWNPHASE32014-072018-042016-04
NCT02124148A Study of Prexasertib (LY2606368) With Chemotherapy or Targeted Agents in Participants With Advanced CancerCOMPLETEDPHASE12014-06-182020-02-132020-02-13
NCT02148627Safety Study of LY3041658 in Healthy ParticipantsCOMPLETEDPHASE12014-06-162017-02-112017-02-11
NCT02102490A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has SpreadCOMPLETEDPHASE22014-06-102018-10-222016-04-30
NCT02806960A Study of Single and Repeated Doses of Glucagon Administered to Participants With DiabetesTERMINATEDPHASE12014-062014-082014-06
NCT02104765A Study of LY2951742 in Healthy Japanese and Caucasian ParticipantsCOMPLETEDPHASE12014-062015-012015-01
NCT02152384A Study to Compare and Measure the Effects of Insulin Peglispro (LY2605541) and Glargine on Meal Time Insulin RequirementsCOMPLETEDPHASE12014-062014-122014-12
NCT02144285A Study of LY3113593 in Healthy Participants and Participants With Chronic Kidney Disease Treated With HemodialysisCOMPLETEDPHASE12014-062015-082015-08
NCT02121834A Study of LY3050258 in Healthy ParticipantsCOMPLETEDPHASE12014-062014-122014-12
NCT02161731Study of Evacetrapib (LY2484595) and Warfarin in Healthy ParticipantsCOMPLETEDPHASE12014-062014-092014-09
NCT02156492A Study of Evacetrapib With Selected Statins in Healthy Chinese ParticipantsCOMPLETEDPHASE12014-062014-122014-12
NCT02144272Safety Study to Evaluate LY3114062 in Participants With Inflammatory ArthritisCOMPLETEDPHASE12014-062015-062015-05
NCT02132637A Study to Compare the Effect of a Double Dose of Two Long-acting Insulin Therapies in Participants With Type 2 DiabetesCOMPLETEDPHASE32014-052015-072015-07
NCT02152371A Study of Dulaglutide (LY2189265) in Participants With Type II DiabetesCOMPLETEDPHASE32014-052015-102015-10
NCT02168803A Study of Evacetrapib in Participants With Abnormal CholesterolCOMPLETEDPHASE12014-052015-122015-12
NCT02171130Clinical Usability of Intranasal Glucagon in Treatment of HypoglycemiaCOMPLETEDPHASE32014-052015-082015-08
NCT02154646A Study of LY2157299 in Participants With Pancreatic Cancer That is Advanced or Has Spread to Another Part of the BodyCOMPLETEDPHASE12014-052015-072014-09
NCT02123472A Study of Cephalexin Liquid for Pediatrics in Healthy Adults ParticipantsCOMPLETEDPHASE12014-052014-052014-05
NCT02123459A Study of Cephalexin Suspension in Healthy ParticipantsCOMPLETEDPHASE12014-052014-052014-05
NCT02111083A Study of 2 Different Formulations of Insulin Lispro in Healthy ParticipantsCOMPLETEDPHASE12014-052014-082014-08
NCT02111096A Study of LY2409021 in Participants With Type 2 Diabetes MellitusTERMINATEDPHASE22014-042015-092015-09
NCT02117648A Study of LY2835219 in Participants With CancerCOMPLETEDPHASE12014-042015-082015-02
NCT02109029A Study of LY2605541 (Insulin Peglispro) and Human Insulin Concentrations in Fat TissueCOMPLETEDPHASE12014-042015-032015-03
NCT02109042A Study of Blosozumab (LY2541546) in Postmenopausal Female ParticipantsCOMPLETEDPHASE12014-042014-072014-07
NCT02069041A Study of Ramucirumab (LY3009806) in Participants With Advanced Liver CancerCOMPLETEDPHASE12014-042016-092016-09
NCT02123446A Study of Cephalexin Capsules in Healthy ParticipantsCOMPLETEDPHASE12014-042014-052014-05
NCT02100826A Study of Cephalexin in Healthy ParticipantsCOMPLETEDPHASE12014-042014-052014-05
NCT02079636A Study of Abemaciclib (LY2835219) in Combination With Another Anti-cancer Drug in Participants With Lung Cancer (NSCLC)COMPLETEDPHASE12014-03-282019-08-292018-05-02
NCT02057133A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has SpreadACTIVE_NOT_RECRUITINGPHASE12014-03-102025-122021-03-15
NCT02082210A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced CancerCOMPLETEDPHASE1, PHASE22014-03-072018-01-242017-12-05
NCT02008318A Study of Galunisertib in Participants With Myelodysplastic SyndromesCOMPLETEDPHASE2, PHASE32014-032017-092016-03
NCT02091362A Study of LY2409021 on Blood Pressure and Pulse Rate in Participants With Type 2 Diabetes MellitusCOMPLETEDPHASE22014-032015-012015-01
NCT02008357Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory LossCOMPLETEDPHASE32014-02-282023-06-082022-12-27
NCT01824290A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)COMPLETEDPHASE32014-02-052021-03-102019-03-18
NCT02072096A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)TERMINATEDPHASE42014-022015-102015-10
NCT02059148A Study of LY2835219 in Healthy ParticipantsCOMPLETEDPHASE12014-022014-082014-08
NCT02041091A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With LupusTERMINATEDPHASE32014-012015-112014-10
NCT02014129A Study of LY2835219 in Japanese Participants With Advanced CancerCOMPLETEDPHASE12013-12-182019-08-212015-04-01
NCT02020616A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 DiabetesTERMINATEDPHASE1, PHASE22013-122015-022015-02
NCT01983878A Study of Ramucirumab in Treating Japanese Participants With Metastatic Gastric or Gastroesophageal Junction CancerCOMPLETEDPHASE22013-122016-022015-01
NCT01991483A Study of LY2928057 in Hemodialysis ParticipantsCOMPLETEDPHASE12013-122015-102015-10
NCT02018887A Study of LY2969822 in Healthy ParticipantsCOMPLETEDPHASE12013-122015-022015-02
NCT01995526A Study of Insulin Peglispro in Healthy Male Japanese ParticipantsCOMPLETEDPHASE12013-122014-012014-01
NCT01995656A Study of LY3108743 in Healthy Participants and Participants With Type 2 DiabetesCOMPLETEDPHASE12013-122014-042014-04
NCT02004132A Study of Axiron® in Healthy ParticipantsCOMPLETEDPHASE12013-122013-122013-12
NCT02014116A Study of LY3009120 in Participants With Advanced Cancer or Cancer That Has Spread to Other Parts of Their BodyTERMINATEDPHASE12013-11-262018-10-052017-04-07
NCT02009449A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid TumorsCOMPLETEDPHASE12013-11-152023-07-222019-02-19
NCT01994746Efficacy and Safety of Nasal Glucagon for Treatment of Hypoglycemia in AdultsCOMPLETEDPHASE32013-112015-012015-01
NCT01925989A Study of How Insulin Peglispro (LY2605541) and Insulin Glargine Affect the Breakdown of Fat and Sugar in Type 1 DiabeticsCOMPLETEDPHASE12013-112015-102015-10
NCT01997411Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 DiabetesCOMPLETEDPHASE2, PHASE32013-112015-012015-01
NCT01981408A Study of LY2801653 in Healthy ParticipantsCOMPLETEDPHASE12013-112013-122013-12
NCT01947933A Safety Study of Mirikizumab (LY3074828)COMPLETEDPHASE12013-102015-022015-02
NCT01993420A Safety and Efficacy of DRM02 in Subjects With Atopic DermatitisCOMPLETEDPHASE22013-102014-032014-02
NCT01993433A Safety and Efficacy Study of DRM02 in Subjects With Plaque PsoriasisCOMPLETEDPHASE22013-102014-032014-02
NCT01993446A Safety and Efficacy Study of DRM02 in Subjects With RosaceaCOMPLETEDPHASE22013-102014-032014-02
NCT01968070A Study of LY3127760 in Healthy ParticipantsCOMPLETEDPHASE12013-102014-042014-04
NCT01771250A Study of Insulin Peglispro and Glargine on Fats in Participants With Type 1 DiabetesCOMPLETEDPHASE12013-102014-122014-12
NCT01965782A Study of [14C]-LY3023703 in Healthy ParticipantsTERMINATEDPHASE12013-102013-102013-10
NCT01958489A Study of Evacetrapib in Japanese and Non-Japanese ParticipantsCOMPLETEDPHASE12013-102014-012014-01
NCT01960140A Study of Baricitinib and Simvastatin in Healthy ParticipantsCOMPLETEDPHASE12013-102013-122013-12
NCT01925144A Study of Baricitinib and Omeprazole in Healthy ParticipantsCOMPLETEDPHASE12013-102013-112013-11
NCT01968057A Study of Baricitinib and Ciclosporin in Healthy ParticipantsCOMPLETEDPHASE12013-102013-122013-12
NCT01965808A Study of LY2157299 in Healthy ParticipantsCOMPLETEDPHASE12013-102013-122013-11
NCT01865084A Study of Tadalafil for Duchenne Muscular DystrophyTERMINATEDPHASE32013-092016-032015-12
NCT01937026A Study of Baricitinib and Probenecid in Healthy ParticipantsCOMPLETEDPHASE12013-092013-112013-11
NCT01937871A Study of Tadalafil in Men With Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED)COMPLETEDPHASE32013-092015-122015-12
NCT01931475A Study of Duloxetine in Participants With Chronic Pain Due to Osteoarthritis in ChinaCOMPLETEDPHASE32013-092015-062015-03
NCT01959334Evaluate the Immunogenicity of a Novel Glucagon FormulationCOMPLETEDPHASE32013-092013-122013-12
NCT01914666An Open Label Extension Study of Duloxetine (LY248686) in Participants With Chronic Low Back PainCOMPLETEDPHASE32013-092014-122014-12
NCT01897480A Study of LY2875358 in Participants With Non-Small Cell Lung Cancer With Activating Epidermal Growth Factor Receptor MutationsACTIVE_NOT_RECRUITINGPHASE22013-08-282025-122016-03-14
NCT01936324A Safety, Tolerability and Preliminary Efficacy Study of DRM01B Topical GelCOMPLETEDPHASE1, PHASE22013-082014-062014-06
NCT01900652A Study of Emibetuzumab in Non Small Cell Lung Cancer (NSCLC) ParticipantsCOMPLETEDPHASE22013-082016-032015-02
NCT01919398A Study of LY2940680 in Japanese Participants With Advanced CancersCOMPLETEDPHASE12013-082017-06-282016-05
NCT01913314A Study of Carbon-14-Labeled LY2835219 ([^14C]-LY2835219) in Healthy ParticipantsCOMPLETEDPHASE12013-082013-102013-10
NCT01929707A Study of LY3050258 in Healthy ParticipantsCOMPLETEDPHASE12013-082013-122013-12
NCT01929109A Study of LY2409021 in Participants With Different Levels of Kidney FunctionCOMPLETEDPHASE12013-082014-082014-08
NCT01924299A Study of Baricitinib When Administered With Ketoconazole or Fluconazole in Healthy ParticipantsCOMPLETEDPHASE12013-082013-112013-11
NCT01910311A Study of Baricitinib and Rifampicin in Healthy ParticipantsCOMPLETEDPHASE12013-082013-102013-10
NCT01925157A Study of LY3090106 in Healthy Participants and Participants With Rheumatoid Arthritis (RA)COMPLETEDPHASE12013-082015-092015-01
NCT01874938A Study of LY2875358 in Participants With MET Positive, Advanced Gastric CancerCOMPLETEDPHASE22013-082014-122014-08
NCT01900665Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus PlaceboTERMINATEDPHASE32013-072017-022016-10
NCT01894568A Study Comparing Insulin Peglispro With Insulin Glargine as Basal Insulin TreatmentCOMPLETEDPHASE32013-072015-042015-04
NCT01897493A Study of Evacetrapib and Digoxin in Healthy ParticipantsCOMPLETEDPHASE12013-072013-092013-09
NCT01908582A Study of Evacetrapib and Rifampin in Healthy ParticipantsCOMPLETEDPHASE12013-072013-092013-09
NCT01903434A Study of Evacetrapib (LY2484595) in Healthy ParticipantsCOMPLETEDPHASE12013-072013-112013-11
NCT01896726A Study of Baricitinib and Birth Control Pills in Healthy FemalesCOMPLETEDPHASE12013-072013-102013-10
NCT01893281The Effect of Testosterone Topical Solution (LY900011) in Hypogonadal Men With Suboptimal Response to a Topical Testosterone GelCOMPLETEDPHASE42013-072014-012014-01
NCT01697514A Study of LY2940680 in Pediatric Medulloblastoma or RhabdomyosarcomaWITHDRAWNPHASE12013-072016-072016-07
NCT01885078An Extension Study in Participants With Moderate to Severe Rheumatoid ArthritisCOMPLETEDPHASE32013-06-272020-11-122020-11-12
NCT01872910A Study of LY3023703 Testing Pain Relief After Wisdom Teeth RemovalCOMPLETEDPHASE22013-062013-102013-10
NCT01890967A Study of LY3015014 in Participants With High CholesterolCOMPLETEDPHASE22013-062014-062014-04
NCT01870297A Study of LY3025876 in Participants With DiabetesCOMPLETEDPHASE12013-062014-122014-12
NCT01867216A Study of Multiple Doses of LY2922470 in Participants With DiabetesCOMPLETEDPHASE12013-062014-012014-01
NCT01877265A Study of LY2605541 in Healthy ParticipantsCOMPLETEDPHASE12013-062013-092013-09
NCT01870388A Pharmacokinetic Study of Baricitinib in Participants With Liver DiseaseCOMPLETEDPHASE12013-062013-072013-07
NCT01871493A Study of LY2605541 and Insulin Lispro Mixture in Healthy ParticipantsCOMPLETEDPHASE12013-062013-092013-09
NCT01763788A Study of Necitumumab in the First-Line Treatment of Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC)COMPLETEDPHASE1, PHASE22013-05-072018-10-172017-06-28
NCT01837641A Study of LY3002813 in Participants With Alzheimer's DiseaseCOMPLETEDPHASE12013-05-032016-08-242016-08-24
NCT01836198The Effect of Gemfibrozil, Ketoconazole and Clarithromycin on the Amount of LY2409021 in the BloodstreamCOMPLETEDPHASE12013-052013-112013-11
NCT01849055A Multiple Dose Study of LY3023703 in Healthy ParticipantsCOMPLETEDPHASE12013-052013-122013-12
NCT01846702A Study of LY3084077 in Healthy ParticipantsCOMPLETEDPHASE12013-052013-122013-12
NCT01859078A Drug Drug Interaction (DDI) Study of Baricitinib (LY3009104) and Digoxin in Healthy ParticipantsCOMPLETEDPHASE12013-052013-082013-08
NCT01816295A Study in Men With Low Testosterone to Measure the Effects of Testosterone Solution on Testosterone Levels, Sex Drive and EnergyCOMPLETEDPHASE32013-052015-042014-10
NCT01808651A Study of Fluoxetine in Major Depressive Disorder (MDD) Long-Term DosingCOMPLETEDPHASE32013-052015-032015-03
NCT01855919A Study of Duloxetine (LY248686) in Participants With Chronic Low Back PainCOMPLETEDPHASE32013-052014-072014-07
NCT01821703A Study of LY3045697 After Multiple Oral Dosing in Healthy ParticipantsCOMPLETEDPHASE12013-052013-092013-09
NCT01830764Open-label Safety and Tolerability Study of LTS-PDT in Healthy VolunteersCOMPLETEDPHASE12013-042013-062013-06
NCT01794000A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease (SCD)TERMINATEDPHASE32013-042015-122015-07
NCT01836185A Study of Evacetrapib (LY2484595) in Participants With Hepatic (Liver) ImpairmentCOMPLETEDPHASE12013-042013-102013-10
NCT01825876A Study of Evacetrapib (LY2484595) and Warfarin in Healthy ParticipantsCOMPLETEDPHASE12013-042013-062013-06
NCT01825889A Study of Evacetrapib (LY2484595) in Participants With Severe Renal Impairment and in Healthy ParticipantsCOMPLETEDPHASE12013-042013-102013-10
NCT01739309Study of LY2835219 for Mantle Cell LymphomaCOMPLETEDPHASE22013-03-202022-09-052015-09-28
NCT01777191Evaluation of Ixekizumab Using Auto-Injector or Prefilled Syringe in Participants With Moderate to Severe Plaque PsoriasisCOMPLETEDPHASE32013-032015-052014-05
NCT01774981Study of LY3016859 in Participants With Diabetic NephropathyCOMPLETEDPHASE1, PHASE22013-032015-082015-08
NCT01807026A Study of LY2886721 in Healthy Participants and Participants Diagnosed With Alzheimer's DiseaseCOMPLETEDPHASE12013-032013-052013-05
NCT01632306A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreatic CancerTERMINATEDPHASE1, PHASE22013-032015-062015-06
NCT01810432Study of Food on Evacetrapib (LY2484595) in Healthy ParticipantsCOMPLETEDPHASE12013-032013-062013-06
NCT01790438A Study to Compare a New Long-Acting Insulin (LY2605541) and Human Insulin NPH in Participants With Type 2 DiabetesCOMPLETEDPHASE32013-032014-052014-05
NCT01818245A Study of LY2605541 in Healthy Participants and in the ElderlyCOMPLETEDPHASE12013-032013-072013-07
NCT02778100A Study of Nasal Glucagon in Participants With a Common ColdCOMPLETEDPHASE12013-032013-042013-04
NCT01788566A Study of Gemcitabine-Cisplatin Chemotherapy Plus Necitumumab in the First-Line Treatment of Participants With Squamous Lung CancerCOMPLETEDPHASE22013-032015-122014-08
NCT01808612A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term DosingCOMPLETEDPHASE32013-032014-072014-07
NCT01775904A Study of Two Dosage Forms of LY2886721 in Healthy ParticipantsCOMPLETEDPHASE12013-022013-052013-05
NCT01769404A Study of LY2605541 and Glargine in Participants With Type 1 DiabetesCOMPLETEDPHASE12013-022013-122013-12
NCT01784211A Study of LY2605541 and Glargine and Exercise in Participants With Type 1 DiabetesCOMPLETEDPHASE12013-022013-112013-11
NCT01792284A Study of LY2605541 in Participants With Type 1 Diabetes MellitusCOMPLETEDPHASE32013-022014-042014-04
NCT01774968Study of Human Regular U-500 Insulin in Adult Participants With Type 2 DiabetesCOMPLETEDPHASE42013-022014-052014-05
NCT01769391A Study of Necitumumab and Chemotherapy in Participants With Stage IV Squamous Non-Small Cell Lung CancerCOMPLETEDPHASE22013-012017-072015-04
NCT01721044A Moderate to Severe Rheumatoid Arthritis StudyCOMPLETEDPHASE32013-012014-092014-06
NCT01746745A Study of LY2940680 in Healthy ParticipantsCOMPLETEDPHASE12013-012013-032013-03
NCT01769378Study of How Dulaglutide Compares to Placebo in Participants With Type 2 Diabetes Who Are Also on Sulfonylurea Therapy (AWARD-8)COMPLETEDPHASE32013-012014-122014-12
NCT01753856Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With OsteoporosisCOMPLETEDPHASE42013-012014-062014-06
NCT01722292A Study of LY2940680 in Small Cell Lung CancerTERMINATEDPHASE1, PHASE22013-012015-022015-02
NCT01773473Comparison of Insulin Mix25 Versus Mix50COMPLETEDPHASE42013-012014-082014-08
NCT01750853A Study of LY3045697 in Healthy ParticipantsCOMPLETEDPHASE12013-012013-072013-07
NCT01746004A Study of LY2157299 Monohydrate in Healthy VolunteersCOMPLETEDPHASE12013-012013-022013-02
NCT01721057A Study in Moderate to Severe Rheumatoid Arthritis ParticipantsCOMPLETEDPHASE32012-122014-122014-09
NCT01703091A Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non-Small Cell Lung CancerCOMPLETEDPHASE22012-122016-072014-12
NCT01748552A Study of LY2922083 in Healthy Participants and Participants With DiabetesCOMPLETEDPHASE12012-122013-082013-08
NCT01746017A Study of LY2922470 in Healthy Participants and Participants With DiabetesCOMPLETEDPHASE12012-122013-032013-03
NCT01695239A Study of Ixekizumab in Participants With Active Psoriatic ArthritisCOMPLETEDPHASE32012-122017-092014-12
NCT01751399A Single Dose Study of LY2605541 in Participants With Liver ImpairmentCOMPLETEDPHASE12012-122013-092013-09
NCT01736254A Study of Evacetrapib in Healthy ParticipantsCOMPLETEDPHASE12012-122013-022013-02
NCT01746732A Study of Evacetrapib in Healthy Female ParticipantsCOMPLETEDPHASE12012-122013-052013-05
NCT01736241A Study of LY3053102 in Healthy ParticipantsCOMPLETEDPHASE12012-122013-072013-07
NCT01711359A Study in Participants With Moderate to Severe Rheumatoid ArthritisCOMPLETEDPHASE32012-112015-082015-02
NCT01682135A Study in Participants With Advanced Solid TumorsCOMPLETEDPHASE12012-112015-032015-03
NCT01725451A Study of Effect of Deodorant and Axillary Hair on Testosterone Absorption in Healthy ParticipantsCOMPLETEDPHASE12012-112013-012013-01
NCT01722825Study of LY2157299 in Japanese Participants With CancerCOMPLETEDPHASE12012-112014-062014-06
NCT01687998A Study of Evacetrapib in High-Risk Vascular DiseaseTERMINATEDPHASE32012-102016-072016-03
NCT01709110VERtebral Fracture Treatment Comparisons in Osteoporotic WomenCOMPLETEDPHASE42012-102016-072016-07
NCT01710358A Study in Moderate to Severe Rheumatoid ArthritisCOMPLETEDPHASE32012-102015-092015-03
NCT01695005A Study of LY3039478 in Participants With Advanced CancerCOMPLETEDPHASE12012-102018-06-262018-06-26
NCT01634555A Study to Assess the Pharmacokinetics of Ramucirumab (IMC-1121B) in Combination With FOLFIRICOMPLETEDPHASE22012-102018-022013-08
NCT01687478A Study of Olanzapine and Fluoxetine for Treatment-resistant DepressionTERMINATEDPHASE32012-092015-112015-11
NCT01681186A Study of LY2940680 in Healthy ParticipantsCOMPLETEDPHASE12012-092012-122012-12
NCT01676701Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)TERMINATEDPHASE32012-092013-082013-08
NCT01688635A Study to Compare LY2963016 and US-approved Lantus® After Single Dose Administration to Healthy ParticipantsCOMPLETEDPHASE12012-092013-022013-02
NCT01606748A Drug-Interaction Study of Necitumumab (IMC-11F8) in Combination With Gemcitabine-CisplatinCOMPLETEDPHASE22012-082016-062013-06
NCT01683409A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney DiseaseCOMPLETEDPHASE22012-082014-112014-09
NCT01671085A Study of LY3015014 in Healthy Participants With High CholesterolCOMPLETEDPHASE12012-082013-032013-03
NCT01624467A Study of Necitumumab Monotherapy and the QT/QTc Interval in Patient With Advanced Solid TumorsCOMPLETEDPHASE22012-082015-062014-05
NCT01667900A Study of Dulaglutide in Chinese ParticipantsCOMPLETEDPHASE12012-082014-062014-06
NCT01655225A Study of LY3023414 in Participants With Advanced CancerCOMPLETEDPHASE12012-07-312022-02-022019-04-04
NCT01646177A Study in Participants With Moderate to Severe Psoriasis (UNCOVER-3)COMPLETEDPHASE32012-07-282019-07-222014-05-22
NCT01640249A Study of LY3006072 in Healthy ParticipantsTERMINATEDPHASE12012-07-242012-11-262012-11-26
NCT01515306A Study of Ramucirumab (IMC-1121B) and Paclitaxel in Participants With Solid TumorsCOMPLETEDPHASE22012-07-192021-02-222013-03-20
NCT01484431A Pharmacokinetics Study for Pediatric Participants With Pulmonary Arterial HypertensionCOMPLETEDPHASE1, PHASE22012-07-172019-04-032017-04-21
NCT01602224A Study of Tabalumab (LY2127399) in Participants With Previously Treated Multiple Myeloma (MM)COMPLETEDPHASE22012-072014-072014-07
NCT01621178A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)COMPLETEDPHASE32012-072016-122016-06
NCT01644500A Study Comparing the Effects and Safety of Dulaglutide With Glimepiride in Type 2 Diabetes MellitusCOMPLETEDPHASE32012-072014-082014-08
NCT01648582A Study Comparing the Effects and Safety of Dulaglutide With Insulin Glargine in Type 2 Diabetes MellitusCOMPLETEDPHASE32012-072014-122014-08
NCT01663857A Study LY2228820 for Recurrent Ovarian CancerCOMPLETEDPHASE1, PHASE22012-072018-05-112017-05-25
NCT01556438Study of Tabalumab (LY2127399) in Japanese Participants With Relapsed or Refactory Multiple MyelomaCOMPLETEDPHASE12012-072015-082015-02
NCT01654380A Study of LY2605541 Versus Insulin Glargine on Blood SugarCOMPLETEDPHASE12012-072013-102013-10
NCT01646203A Study of IMC-TR1 in Participants With Advanced Solid TumorsCOMPLETEDPHASE12012-072014-102014-10
NCT01640834Study of LY2409021 in Participants With Type 1 DiabetesCOMPLETEDPHASE12012-072012-092012-09
NCT01567163A Study of Ramucirumab and Docetaxel in Participants With Solid TumorsCOMPLETEDPHASE22012-072014-032012-12
NCT01634165A Study of LY2963016 in Healthy ParticipantsCOMPLETEDPHASE12012-072012-092012-09
NCT01648790A Study of Prasugrel in Healthy ParticipantsCOMPLETEDPHASE12012-072012-082012-08
NCT01625988A Study of LY2951742 in Participants With MigraineCOMPLETEDPHASE22012-06-282013-09-182013-07
NCT01520220Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative NeoplasmsCOMPLETEDPHASE12012-06-112017-02-242015-06-26
NCT01624233A Study in Japanese Participants With Moderate-to-Severe PsoriasisCOMPLETEDPHASE32012-062017-092013-09
NCT01632566A Multiple-dose Study of LY3031207 in Healthy ParticipantsTERMINATEDPHASE12012-062013-042013-04
NCT01618916A Study of LY3015014 in Otherwise Healthy Participants With High Low-density Lipoprotein (LDL) CholesterolCOMPLETEDPHASE12012-062013-022013-02
NCT01632579A Single Dose Study of LY3023703 in Healthy ParticipantsCOMPLETEDPHASE12012-062012-092012-09
NCT01602289A Study of LY2875358 in Japanese Participants With Advanced CancerCOMPLETEDPHASE12012-062014-082014-08
NCT01621191An Extension Study of Duloxetine in Fibromyalgia (Extension of F1J-JE-HMGZ, NCT01552057)COMPLETEDPHASE32012-062014-022014-02
NCT01624259A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 DiabetesCOMPLETEDPHASE32012-062013-112013-11
NCT01594723A Study of LY2784544 in Participants With Myeloproliferative NeoplasmsACTIVE_NOT_RECRUITINGPHASE22012-05-222026-122015-03-20
NCT01597245A Phase 3 Study in Participants With Moderate to Severe Psoriasis (UNCOVER-2)COMPLETEDPHASE32012-05-182019-06-182014-03-25
NCT01576549A Study of LY2127399 in Rheumatoid ArthritisTERMINATEDPHASE22012-052013-052013-05
NCT01604408A Study in Older Participants Who Have Fallen and Have Muscle WeaknessCOMPLETEDPHASE22012-052013-122013-09
NCT01582451A Study of LY2605541 in Participants With Type 2 Diabetes MellitusCOMPLETEDPHASE32012-052013-122013-05
NCT01600950A Study to Compare LY2963016 to Lantus After a Single Dose to Participants With Type 1 Diabetes MellitusCOMPLETEDPHASE12012-052012-072012-07
NCT01582269A Study in Recurrent Glioblastoma (GB)COMPLETEDPHASE22012-04-262024-10-102014-07-26
NCT01588366The Effects of LY2409021 on the LiverCOMPLETEDPHASE12012-042013-092013-09
NCT01545583A Study of LY3016859 in Healthy VolunteersCOMPLETEDPHASE12012-042012-092012-09
NCT01584232A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes MellitusCOMPLETEDPHASE32012-042013-072013-07
NCT01569126A Study of LY110140 in Healthy Japanese Male ParticipantsCOMPLETEDPHASE12012-042012-092012-09
NCT01524237A Study of LY2979165 and LY2140023 in Healthy VolunteersCOMPLETEDPHASE12012-042013-072013-07
NCT01577355A Study of LY2784544 in Healthy Male SubjectsCOMPLETEDPHASE12012-042012-062012-06
NCT01556594Safety and Efficacy of a Novel Glucagon Formulation in Type 1 Diabetic Patients Following Insulin-induced HypoglycemiaCOMPLETEDPHASE22012-032012-072012-07
NCT01561430Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's DiseaseTERMINATEDPHASE1, PHASE22012-032013-082013-08
NCT01558271A Study of LY2189265 in Japanese Participants With Type 2 Diabetes MellitusCOMPLETEDPHASE32012-032014-052013-10
NCT01552057A Study of Duloxetine in FibromyalgiaCOMPLETEDPHASE32012-032013-122013-12
NCT01524770A Study to Compare the Effect of Giving Dulaglutide Using an Auto-injector Versus a Manual SyringeCOMPLETEDPHASE12012-032012-062012-06
NCT01469000A Study of Pemetrexed and Gefitinib Versus Gefitinib in Non-Small Cell Lung Cancer (NSCLC)COMPLETEDPHASE22012-022017-112015-04
NCT01534273A Study of LY2886721 in Healthy ParticipantsCOMPLETEDPHASE12012-022012-072012-07
NCT01537887A Study of LY2484595 on the Electrical Activity of the HeartCOMPLETEDPHASE12012-022012-062012-06
NCT01528124A Study of LY3025876 in Healthy VolunteersCOMPLETEDPHASE12012-022012-052012-05
NCT01536951A Study of LY3009104 in Healthy ParticipantsCOMPLETEDPHASE12012-022013-052013-05
NCT01473589Effect of Teriparatide on Hip Fracture HealingCOMPLETEDPHASE32012-022013-122013-12
NCT01515358A Study to Evaluate the Safety and Tolerability of LY3000328 in Healthy ParticipantsCOMPLETEDPHASE12012-022012-052012-05
NCT01488708On Open-Label Study in Participants With Systemic Lupus ErythematosusTERMINATEDPHASE32012-012015-102015-10
NCT01481779A Study in Participants With Type 1 Diabetes MellitusCOMPLETEDPHASE32012-012014-062013-05
NCT01454284A Study in Participants With Type I Diabetes MellitusCOMPLETEDPHASE32012-012014-022014-02
NCT01473602Second Study of the Effect of Teriparatide on Hip Fracture HealingCOMPLETEDPHASE32012-012013-112013-11
NCT01490736Phase 1/2 Sequentially Staged Safety Study in Healthy Subjects and Subjects With Mild AcneCOMPLETEDPHASE1, PHASE22011-122013-062013-03
NCT01490632A Phase 2b Study of Baricitinib in Participants With Moderate to Severe PsoriasisCOMPLETEDPHASE22011-122014-082012-12
NCT01505530A Phase 2 Study of LY2495655 in Participants With Pancreatic CancerCOMPLETEDPHASE22011-122016-012014-10
NCT01463631A Study of LY3007113 in Participants With Advanced CancerCOMPLETEDPHASE12011-122013-122013-12
NCT01459016A Non-drug Methods Study in Participants With Alzheimer's DiseaseCOMPLETEDPHASE12011-122014-122014-12
NCT01468987A Study in Participants With Type 2 Diabetes MellitusCOMPLETEDPHASE32011-122013-082013-08
NCT01473563A Study of Home Administration of Pemetrexed as Maintenance Treatment for Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC)COMPLETEDPHASE22011-122013-092013-09
NCT01474538Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump TherapyCOMPLETEDPHASE32011-122013-022013-02
NCT01460342Phase 3 Study of Tadalafil Once-Daily in Asian Men With Benign Prostatic Hyperplasia (BPH)COMPLETEDPHASE32011-122012-102012-10
NCT01487083A Long-Term Study in SchizophreniaTERMINATEDPHASE32011-122012-102012-10
NCT01474512A Phase 3 Study in Participants With Moderate to Severe PsoriasisCOMPLETEDPHASE32011-11-162018-09-202014-06-24
NCT01432951A Study of Enzastaurin in Chinese Patients With Advanced and/or Metastatic Solid Tumors or LymphomaCOMPLETEDPHASE12011-112018-01-052013-01-11
NCT01469013Oral Baricitinib (LY3009104)Treatment in Japanese Participants With Active Rheumatoid Arthritis on Background Methotrexate TherapyCOMPLETEDPHASE22011-112013-122012-11
NCT01435616A Study in Patients With Type 2 Diabetes MellitusCOMPLETEDPHASE32011-112014-012014-01
NCT01427933A Study of Ramucirumab (IMC-1121B) in Combination With Eribulin Versus Eribulin Alone in Participants With Breast CancerCOMPLETEDPHASE22011-112014-062013-09
NCT01468181A Study of LY2189265 in Japanese Participants With Type 2 Diabetes MellitusCOMPLETEDPHASE32011-112013-122013-12
NCT01476345A Study to Compare the Pharmacokinetics and Pharmacodynamics of LY2963016 to Lantus in Healthy ParticipantsCOMPLETEDPHASE12011-112012-072012-07
NCT01477567A First-in-Human Study of LY3009385 in Healthy ParticipantsCOMPLETEDPHASE12011-112012-032012-03
NCT01476696A Study of Prasugrel in Pediatric Participants With Sickle Cell DiseaseCOMPLETEDPHASE22011-112012-112012-11
NCT01449630A Study of LY3031207 in Healthy SubjectsCOMPLETEDPHASE12011-10-242012-04-022012-04-02
NCT01448824A Study of LY2484595 on Pharmacokinetics in Healthy ParticipantsCOMPLETEDPHASE12011-102012-022012-02
NCT01460368A Study on the Effects of LY2409021 on the Electrical Impulses of the HeartCOMPLETEDPHASE12011-102012-032012-03
NCT01460407A Study to Evaluate the Effect of Clarithromycin on LY2216684COMPLETEDPHASE12011-102011-122011-12
NCT01460381A Study to Evaluate the Effect of Genotype on LY2216684COMPLETEDPHASE12011-102012-082012-08
NCT01450098A Study of LY2484595 in Healthy SubjectsCOMPLETEDPHASE12011-102011-122011-12
NCT02778113A Study of Glucagon Administered in Different Forms and Routes to Healthy AdultsCOMPLETEDPHASE12011-102011-112011-10
NCT01458210A Study of the Effect of Dulaglutide on How the Body Handles Oral Contraceptive in Healthy Female ParticipantsCOMPLETEDPHASE12011-102012-022012-02
NCT03465436A Study of Lasmiditan on the Heart in Healthy ParticipantsCOMPLETEDPHASE12011-09-162011-12-202011-12-20
NCT01427972A Study of LY2623091 in Male and Females With Chronic Kidney DiseaseCOMPLETEDPHASE22011-092013-032013-03
NCT01439568A Study of LY2510924 in Participants With Extensive-Stage Small Cell Lung CarcinomaCOMPLETEDPHASE22011-092016-082014-01
NCT01426412A Study of LY3015014 in Healthy Participants With Elevated Low Density Lipoprotein CholesterolCOMPLETEDPHASE12011-092013-062013-06
NCT01421459A Study in Adults With Type 2 DiabetesCOMPLETEDPHASE32011-092012-092012-09
NCT01432938A Study of the Effect of Dulaglutide on the Action of Warfarin in Healthy ParticipantsCOMPLETEDPHASE12011-092011-122011-12
NCT01436201A Study of the Effect of Dulaglutide on How Body Handles Digoxin in Healthy ParticipantsCOMPLETEDPHASE12011-092011-112011-11
NCT01430091A Relative Bioavailability Study of a Prasugrel Orally Disintegrating TabletCOMPLETEDPHASE12011-092011-102011-10
NCT01440478The Effects of Urinary pH Changes on an Investigational Compound in Healthy SubjectsCOMPLETEDPHASE12011-092011-102011-10
NCT01408095A Study in Patients With Type 2 DiabetesWITHDRAWNPHASE22011-092012-092012-09
NCT01388335A Drug Interaction Study to Assess the Effect of LY317615 on the Metabolic Pathway of WarfarinCOMPLETEDPHASE12011-082012-122012-10
NCT01416389A Study of LY2523355 in Participants With Breast CancerCOMPLETEDPHASE22011-082013-092012-08
NCT01391130A Study of LY2510924 and Sunitinib in Patients With Metastatic Renal Cell CarcinomaTERMINATEDPHASE22011-082017-022014-09
NCT01370499A Study of LY2216684 in Participants With Major Depression DisorderCOMPLETEDPHASE32011-082014-012014-01
NCT01316263A Study of Olaratumab (IMC-3G3) in Previously Treated Participants With Unresectable and/or Metastatic Gastrointestinal Stromal TumorsTERMINATEDPHASE22011-082012-112012-05
NCT01419236A Study of Ejaculatory Dysfunction in Men With Low Testosterone LevelsCOMPLETEDPHASE22011-082013-122013-12
NCT01408888A Study of LY2189265 and Sitagliptin in Participants With Type 2 DiabetesCOMPLETEDPHASE12011-082012-042012-04
NCT01421147A Study in Adults With Type 1 DiabetesCOMPLETEDPHASE32011-082013-042012-08
NCT01430104A Study of Teriparatide in Japanese Osteoporosis PatientsCOMPLETEDPHASE42011-082011-122011-12
NCT01394952Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)COMPLETEDPHASE32011-07-222018-08-212018-08-21
NCT01401543A Bioavailability Study of LY2452473 and TadalafilCOMPLETEDPHASE12011-072011-092011-09
NCT01389752A Study to Evaluate the Effect of Activated Charcoal on the Absorption of LY2216684 in Healthy SubjectsCOMPLETEDPHASE12011-072011-092011-09
NCT01389765A Study to Evaluate the Effect of Food on LY2216684COMPLETEDPHASE12011-072011-082011-08
NCT01369511A Study of LY2495655 in Older Participants Undergoing Elective Total Hip ReplacementCOMPLETEDPHASE22011-072014-022014-02
NCT01398475A Relative Bioavailability and Food Effect Study of New FormulationsCOMPLETEDPHASE12011-072011-092011-09
NCT01383967A Study of LY2979165 in Healthy SubjectsCOMPLETEDPHASE12011-072012-062012-06
NCT01346358A Study of IMC-CS4 in Subjects With Advanced Solid TumorsCOMPLETEDPHASE12011-06-152018-05-312018-05-31
NCT01367262Disposition of Carbon-14-Labeled LY2886721 ([^14C]-LY2886721) Following Oral Administration in Healthy Human ParticipantsCOMPLETEDPHASE12011-062011-072011-07
NCT01380691A Study of LY2216684 in Healthy ParticipantsCOMPLETEDPHASE12011-062011-092011-09
NCT01372085Single Dose Study in Healthy Participants to Investigate the Safety and Absorption of LY2584702COMPLETEDPHASE12011-062011-092011-09
NCT01215942An Open Label Study for Participants With Rheumatoid ArthritisTERMINATEDPHASE32011-062014-022014-02
NCT01373931A Study of LY2216684 in Healthy FemalesCOMPLETEDPHASE12011-062011-122011-12
NCT01375075A Study of LY2484595 in Japanese SubjectsCOMPLETEDPHASE22011-062012-032012-03
NCT01358968A Drug Interaction Study to Assess the Effect of LY2603618 on the Metabolic Pathway of DesipramineCOMPLETEDPHASE12011-062012-122012-04
NCT01373164A Study in Metastatic Cancer and Advanced or Metastatic Unresectable Pancreatic CancerCOMPLETEDPHASE1, PHASE22011-062016-122015-11
NCT01374178A Comparison of LY2963016 to a Basal Insulin After a Single Dose in Healthy SubjectsCOMPLETEDPHASE12011-062011-072011-07
NCT01226511A Study in Pediatric Participants With Generalized Anxiety DisorderCOMPLETEDPHASE32011-062013-062013-02
NCT01352507A Study of Tadalafil and Sildenafil in Men With Erectile Dysfunction in ChinaCOMPLETEDPHASE42011-062012-072012-06
NCT01358981A Study of LY2881835 in Healthy People and People With DiabetesCOMPLETEDPHASE12011-05-242011-08-172011-08-17
NCT01341470A Study of LY2495655 in Healthy SubjectsCOMPLETEDPHASE12011-052012-052012-05
NCT01341457A Study of LY2603618 in Combination With Gemcitabine in Participants With Solid TumorsCOMPLETEDPHASE12011-052016-072013-06
NCT01299272A Study in Prevention of Re-emergence of Depression SymptomsCOMPLETEDPHASE32011-052013-112013-11
NCT01059643A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and NeckCOMPLETEDPHASE22011-042012-122012-12
NCT01232452A Study in Non-Small Cell Lung CancerCOMPLETEDPHASE22011-042016-062013-01
NCT01282463Study of Ramucirumab or Icrucumab (IMC-18F1) With Docetaxel or Docetaxel Alone as Second-Line Therapy in Participants With Bladder,Urethra, Ureter, or Renal Pelvis CarcinomaCOMPLETEDPHASE22011-042015-032015-02
NCT01354496A Study of LY2409021 Formulations and the Effect of FoodCOMPLETEDPHASE12011-042011-102011-10
NCT01200290A Study in Participants With End-Stage Renal DiseaseCOMPLETEDPHASE22011-042014-032014-03
NCT01220271A Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant GliomaCOMPLETEDPHASE1, PHASE22011-042016-112015-08
NCT01246960A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal CancerCOMPLETEDPHASE22011-042014-052013-09
NCT01179672A Study in Participants With Diabetic Peripheral Neuropathic Pain in ChinaCOMPLETEDPHASE32011-042013-082013-08
NCT01175824Comparison of the Efficacy and Safety of Two Insulin Intensification StrategiesCOMPLETEDPHASE42011-042012-112012-11
NCT01337596A Study of LY2951742 in Healthy VolunteersCOMPLETEDPHASE12011-042012-042012-04
NCT01246986A Study of LY2157299 in Participants With Hepatocellular CarcinomaCOMPLETEDPHASE22011-03-302019-12-242019-06-06
NCT01319929A Study of LY2828360 in Patients With Osteoarthritic Knee PainCOMPLETEDPHASE22011-032011-092011-09
NCT01237587A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia SyndromeCOMPLETEDPHASE32011-032017-11-282017-05-31
NCT01234402Study of Icrucumab (IMC-18F1) or Ramucirumab Drug Product (DP) in Combination With Capecitabine or Capecitabine on Previously Treated Breast Cancer PatientsCOMPLETEDPHASE22011-032017-072013-10
NCT01288989A Study of Anti-VEGFR-3 Monoclonal Antibody IMC-3C5 in Subjects With Advanced Solid TumorsCOMPLETEDPHASE12011-032014-072014-07
NCT01313286A Study to Compare Two Forms of LY2608204 in Healthy PeopleCOMPLETEDPHASE12011-032011-042011-04
NCT01185340A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake InhibitorCOMPLETEDPHASE32011-032013-042013-04
NCT01187407A Study of Flexible or Fixed Dose LY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) TreatmentCOMPLETEDPHASE32011-032013-082013-08
NCT01330953A First Human Study of a Ferroportin AntibodyCOMPLETEDPHASE12011-032011-092011-09
NCT01324388A Study of the Effect of LY2189265 on Two Blood Pressure DrugsCOMPLETEDPHASE12011-032011-082011-08
NCT01136746Hospital Management of Hyperglycemia Study of Insulin Glargine Plus Insulin Lispro Versus Human Regular InsulinTERMINATEDPHASE32011-032011-112011-11
NCT01296568C14 Study in Oncology Patients With Advanced and/or Metastatic Solid TumorsCOMPLETEDPHASE12011-022012-022011-12
NCT01139775A Study in Non Small Cell Lung CancerCOMPLETEDPHASE1, PHASE22011-022014-082013-05
NCT01299285Disposition of 14C-LY3009104 Following Oral Administration in Healthy Human SubjectsCOMPLETEDPHASE12011-022011-032011-03
NCT01286818A Study of Irinotecan, Levofolinate, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab (IMC-1121B)COMPLETEDPHASE12011-022012-032012-02
NCT01301092A Study to Compare the Concentrations of LY2189265 After Different Methods of Administration to Healthy Volunteers.COMPLETEDPHASE12011-022011-082011-08
NCT01300260Effect of LY2189265 on Insulin Secretion in Response to Intravenous GlucoseCOMPLETEDPHASE12011-022011-082011-08
NCT01175811A Study Comparing Insulin Intensification Therapies in Patients With Type 2 Diabetes MellitusCOMPLETEDPHASE42011-022012-112012-11
NCT01184508A Study in Migraine PreventionTERMINATEDPHASE22011-012012-042012-04
NCT01205438A Study of LY2127399 in Participants With Systemic Lupus ErythematosusCOMPLETEDPHASE32011-012015-032014-08
NCT01202773A Study in Participants With Rheumatoid ArthritisTERMINATEDPHASE32011-012014-012013-03
NCT01202760A Rheumatoid Arthritis Study in ParticipantsCOMPLETEDPHASE32011-012013-072012-12
NCT01241448A Study of LY2409021 in Patients With Type 2 DiabetesCOMPLETEDPHASE22011-012012-032012-02
NCT01275157Disposition of 14C-LY2452473 Following Oral Administration in Healthy Human SubjectsCOMPLETEDPHASE12011-012011-022011-02
NCT01183780A Study in Second Line Metastatic Colorectal CancerCOMPLETEDPHASE32010-12-022016-06-202014-07-17
NCT01127633Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's DiseaseTERMINATEDPHASE32010-122017-022014-07
NCT01170663A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric AdenocarcinomaCOMPLETEDPHASE32010-122017-022013-07
NCT01168973A Study of Chemotherapy and Ramucirumab Versus Chemotherapy Alone in Second Line Non-Small Cell Lung Cancer (NSCLC) Participants Who Received Prior First Line Platinum-based ChemotherapyCOMPLETEDPHASE32010-122016-082013-12
NCT01212107A Phase 1 Study of LY2874455 in Participants With Advanced CancerCOMPLETEDPHASE12010-122015-022014-08
NCT01227252A Safety Study of LY2886721 Multiple Doses in Healthy SubjectsCOMPLETEDPHASE12010-122011-042011-04
NCT01263106A Study of LY2216684 and Theophylline in Healthy SubjectsCOMPLETEDPHASE12010-122011-012011-01
NCT01263197A Study of LY2216684 in Healthy Participants Receiving Albuterol or PropanololCOMPLETEDPHASE12010-122011-032011-03
NCT01263119A Study of LY2216684 and Warfarin in Healthy SubjectsCOMPLETEDPHASE12010-122011-022011-02
NCT01275144A Study of the Effect of LY2216684 on LorazepamCOMPLETEDPHASE12010-122011-022011-02
NCT01196091A Study of LY2127399 in Participants With Systemic Lupus ErythematosusCOMPLETEDPHASE32010-122015-062014-07
NCT01198002A Rheumatoid Arthritis Study in Participants on a Background Treatment of MethotrexateTERMINATEDPHASE32010-122014-012012-12
NCT01266590A Study of LY2216684 and Digoxin in Healthy SubjectsCOMPLETEDPHASE12010-122011-022011-02
NCT01263223A Study of LY2216684 in Major Depressive Disorder in Patients Taking Selective Serotonin Reuptake InhibitorsCOMPLETEDPHASE12010-122011-032011-03
NCT01263093A Pharmacokinetic Study on the Effect of LY2216684 on the Active Metabolite of ClopidogrelCOMPLETEDPHASE12010-122011-032011-03
NCT01236118A Study of LY2439821 in Rheumatoid ArthritisCOMPLETEDPHASE12010-122013-012013-01
NCT01250834LY2189265 and Atorvastatin Interaction StudyCOMPLETEDPHASE12010-122011-032011-03
NCT01256567A Study of Ramucirumab (IMC-1121B) in Participants With Breast CancerCOMPLETEDPHASE12010-122013-022012-11
NCT01215955Study of Insulin Lispro in Participants With Inadequately Controlled Type 2 DiabetesCOMPLETEDPHASE42010-122013-012013-01
NCT01232439A Study of Brain Receptor Occupancy in Healthy SubjectsCOMPLETEDPHASE12010-122011-042011-04
NCT01165021A Study of Pemetrexed/Cisplatin as Pre-operative Treatment of Early Stage Nonsquamous Non-Small Cell Lung CancerCOMPLETEDPHASE22010-112016-042013-07
NCT01250873A Pharmacokinetic Study of the Coadministration of LY2216684 With SertralineCOMPLETEDPHASE12010-112011-012011-01
NCT01247363A Study of LY2608204 in Patients With Type 2 DiabetesCOMPLETEDPHASE12010-112011-032011-03
NCT01214603A Study in Participants With Acute LeukemiaCOMPLETEDPHASE22010-112012-122012-12
NCT01241461A Study of LY2584702 in Solid TumorsCOMPLETEDPHASE12010-112011-112011-11
NCT01173601A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive DisorderCOMPLETEDPHASE32010-112013-102013-10
NCT01247350A Study of LY3009104(Baricitinib) for Healthy SubjectsCOMPLETEDPHASE12010-112011-042011-04
NCT01191268A Study in Participants With Type 2 Diabetes Mellitus (AWARD-4)COMPLETEDPHASE32010-112012-092012-02
NCT01253304A Single Dose Study of LY2189265 in Subjects With Varying Degrees of Hepatic (Liver) ImpairmentCOMPLETEDPHASE12010-112011-112011-11
NCT01253525Study of Weekly Paclitaxel With Ramucirumab in Participants With Advanced Gastric AdenocarcinomasCOMPLETEDPHASE12010-112011-102011-10
NCT01134107Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump UseCOMPLETEDPHASE32010-112011-122011-12
NCT01250145A Multiple-Dose Study to Evaluate Skin Irritation and Sensitization of Teriparatide Administered Transdermally in Healthy Postmenopausal WomenCOMPLETEDPHASE12010-112011-052011-05
NCT01248052A First Human Dose Study to Investigate Safety and Tolerability of LY2979165 in Healthy VolunteersCOMPLETEDPHASE12010-112011-052011-05
NCT01257178A Study to Evaluate the Pharmacokinetics of LY2624803 in Subjects With Hepatic ImpairmentTERMINATEDPHASE12010-112010-112010-11
NCT01204710A Study of Olaratumab (IMC-3G3) in Prostate CancerCOMPLETEDPHASE22010-102013-102012-09
NCT01160289A Study of LY900010 in Erectile DysfunctionCOMPLETEDPHASE22010-102011-112011-11
NCT01237899Multiple Dose Study of the Safety, Tolerability, Pharmacokinetics and Effect on Renal Potassium ClearanceCOMPLETEDPHASE12010-102011-012011-01
NCT01243957A Study to Measure if There is Any Difference in How the Body Breaks Down or Inactivates Either Fluoxetine or LY2216684 When Both of These Medicines Are Given Together.COMPLETEDPHASE12010-102011-012011-01
NCT01155661A Safety Study in Participants With Major Depressive DisorderCOMPLETEDPHASE32010-102012-122012-12
NCT01241435A Study of LY2216684 in Participants With Impaired Hepatic FunctionCOMPLETEDPHASE12010-102011-042011-04
NCT01185353A Study in Participants With Rheumatoid Arthritis on Background Methotrexate TherapyCOMPLETEDPHASE22010-102014-032011-12
NCT01185964A Study of Olaratumab in Soft Tissue SarcomaCOMPLETEDPHASE1, PHASE22010-102016-042014-08
NCT01140347A Study of Ramucirumab (IMC-1121B) Drug Product (DP) and Best Supportive Care (BSC) Versus Placebo and BSC as 2nd-Line Treatment in Participants With Hepatocellular Carcinoma After 1st-Line Therapy With SorafenibCOMPLETEDPHASE32010-102015-032014-03
NCT01159938A Study of Postprandial Hyperglycemia in Participants With Type 2 DiabetesCOMPLETEDPHASE42010-102013-022013-02
NCT01118780A Study of Duloxetine in Elderly Generalized Anxiety DisorderCOMPLETEDPHASE42010-102012-072012-07
NCT01236105Effect of Activated Charcoal and Time of Dose on the Pharmacokinetics of LY2624803 in Healthy SubjectCOMPLETEDPHASE12010-102010-122010-12
NCT01226485A Study in Advanced CancerCOMPLETEDPHASE12010-092017-102015-01
NCT01160744A Study of Pemetrexed and Carboplatin/Cisplatin or Gemcitabine and Carboplatin/Cisplatin With or Without IMC-1121B in Participants Previously Untreated With Recurrent or Advanced Non-Small Cell Lung Cancer (NSCLC)COMPLETEDPHASE22010-092018-042014-01
NCT01209832A Tasisulam and Midazolam Drug Interaction Study in Cancer PatientsTERMINATEDPHASE12010-092011-012011-01
NCT01199822Study of the Safety and Pharmacokinetics of Olaratumab (IMC-3G3) in Japanese Participants With Solid TumorsCOMPLETEDPHASE12010-092012-012012-01
NCT01215968A Study to Evaluate the Effect of LY2189265 on the Speed at Which Food and Drink Leaves the Stomach in Patients With Type 2 Diabetes MellitusCOMPLETEDPHASE12010-092011-072011-07
NCT01152190A Study in Benign Prostatic HyperplasiaCOMPLETEDPHASE32010-092012-072012-07
NCT01139762A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary SymptomsCOMPLETEDPHASE32010-092012-052012-02
NCT01144377A Study of LY2541546 in Women With Low Bone Mineral DensityCOMPLETEDPHASE22010-082013-022012-05
NCT01111604A Study of Ramucirumab or Icrucumab in Colorectal CancerCOMPLETEDPHASE22010-082013-122013-12
NCT01087970A Study for Participants With Recurrent or Metastatic Squamous Cell Head and Neck CancerCOMPLETEDPHASE22010-082013-082013-08
NCT01130532A Study in Erectile DysfunctionCOMPLETEDPHASE42010-082012-012012-01
NCT01148498A Biomarker Study of Solanezumab in Patients With and Without Alzheimer'sCOMPLETEDPHASE22010-082012-082012-08
NCT01177943A Bioequivalence (BE) Study in Healthy SubjectsCOMPLETEDPHASE12010-082010-102010-10
NCT01113801A Study in Participants With Diabetic Kidney DiseaseTERMINATEDPHASE22010-072014-072014-05
NCT01158404Notch Inhibitor in Advanced CancerCOMPLETEDPHASE12010-072012-082012-08
NCT01185548A Drug Interaction Study of Tasisulam in Patients With Advanced Cancer or LymphomaTERMINATEDPHASE12010-072010-122010-12
NCT01109524Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung CancerCOMPLETEDPHASE22010-072012-092012-09
NCT01167023Prasugrel Versus Placebo in Adult Sickle Cell DiseaseCOMPLETEDPHASE22010-072011-062011-06
NCT01183650A Study of Tadalafil in Benign Prostatic HyperplasiaCOMPLETEDPHASE12010-072011-042011-04
NCT01178099An Assessment of Prasugrel on Healthy Adults and Sickle Cell AdultsCOMPLETEDPHASE12010-072011-012011-01
NCT01063075A Study in Advanced Solid TumorsCOMPLETEDPHASE22010-062015-102015-05
NCT01081041A Study in Head and Neck CancerCOMPLETEDPHASE22010-062015-092013-08
NCT01133405A Safety Study of LY2886721 Single Doses in Healthy SubjectsCOMPLETEDPHASE12010-062010-102010-10
NCT01137006An Open-Label, Dose-Escalation Study of IMC-20D7S In Participants With Malignant MelanomaCOMPLETEDPHASE12010-062012-082012-08
NCT01149421A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 DiabetesCOMPLETEDPHASE22010-062012-012011-09
NCT01129674A Long-Term, Open-Label, Study on SchizophreniaTERMINATEDPHASE2, PHASE32010-062012-102012-10
NCT01127646A Study in Attention Deficit Hyperactivity Disorder in Children and AdolescentsTERMINATEDPHASE42010-062011-052011-05
NCT01139788A Study of LY2624587 in Patients With Advanced CancerCOMPLETEDPHASE12010-062011-112011-11
NCT01107444Study of LY2181308 in Combination With Docetaxel Versus Docetaxel in Patients With Non-Small Cell Lung CancerCOMPLETEDPHASE22010-052012-062011-12
NCT01253291A Study of Japanese Rheumatoid Arthritis ParticipantsCOMPLETEDPHASE12010-052014-032013-09
NCT01119456A Study of IMC-RON8 in Advanced Solid TumorsCOMPLETEDPHASE12010-052013-112013-11
NCT01253265A Study in Rheumatoid ArthritisCOMPLETEDPHASE12010-052011-122011-12
NCT01126580A Study in Participants With Type 2 Diabetes Mellitus (AWARD-3)COMPLETEDPHASE32010-052012-062011-11
NCT01133392Bioequivalence of Two Lispro FormulationsCOMPLETEDPHASE12010-052010-082010-08
NCT01115738Clopidogrel to Prasugrel in Acute Coronary Syndrome (ACS) PatientsCOMPLETEDPHASE22010-052011-112011-11
NCT01122264A Study in Patients With Erectile DysfunctionCOMPLETEDPHASE42010-052011-062011-06
NCT01287546A Study of LY2875358 in Participants With Advanced CancerCOMPLETEDPHASE12010-04-132016-10-262015-01-08
NCT01107457A Study in Participants With Moderate to Severe PsoriasisCOMPLETEDPHASE22010-042016-072011-01
NCT01099358Study in Advanced Solid TumorsCOMPLETEDPHASE22010-042016-052015-10
NCT01109316Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump UseCOMPLETEDPHASE32010-042011-082011-08
NCT01097707A Study in Men With Benign Prostatic HyperplasiaTERMINATEDPHASE22010-042011-102011-10
NCT01134120A Study in Myeloproliferative DisordersCOMPLETEDPHASE12010-042018-02-222014-04
NCT01105975A Study of LY2484595 in Patients With High LDL-C or Low HDL-CCOMPLETEDPHASE22010-042011-062011-06
NCT01089621A Study for Adolescents With Fibromyalgia SyndromeWITHDRAWNPHASE42010-032010-082010-08
NCT01115803A Study of LY2584702 With Erlotinib or Everolimus in Participants With Solid TumorsTERMINATEDPHASE12010-032011-062011-06
NCT01089556A Study in Painful Diabetic NeuropathyCOMPLETEDPHASE32010-032011-112011-11
NCT01107912Comparison of Prasugrel and Clopidogrel in Very Elderly and Non-Elderly Patients With Stable Coronary Artery DiseaseCOMPLETEDPHASE12010-032011-102011-10
NCT01107925Comparison of Prasugrel and Clopidogrel in Low Body Weight Versus Higher Body Weight With Coronary Artery DiseaseCOMPLETEDPHASE12010-032011-082011-08
NCT01115751A Study in Patients With Advanced or Metastatic CancerCOMPLETEDPHASE12010-032012-072012-07
NCT01086748A Study in Schizophrenia PatientsCOMPLETEDPHASE22010-032012-052012-05
NCT01070329A Study in Depression and Associated Painful Physical SymptomsCOMPLETEDPHASE42010-032011-032011-03
NCT01253278A Multiple-Ascending Dose Study in Type 2 Diabetes Mellitus PatientsCOMPLETEDPHASE12010-032011-052011-05
NCT01115790A Phase 1 Study in Participants With Advanced CancerCOMPLETEDPHASE12010-022016-012016-01
NCT01075282A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2)COMPLETEDPHASE32010-022012-112012-05
NCT01064687A Study in Participants With Type 2 Diabetes MellitusCOMPLETEDPHASE32010-022012-052011-11
NCT01057589A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck CancerCOMPLETEDPHASE22010-022012-102012-02
NCT01029795A Study of LY2599506 (Oral Agent Medication: Glucokinase Activator 1) in Type 2 Diabetes MellitusTERMINATEDPHASE22010-022010-062010-06
NCT00981058First-line Treatment of Participants With Stage IV Squamous Non-Small Cell Lung Cancer With Necitumumab and Gemcitabine-CisplatinCOMPLETEDPHASE32010-01-072024-05-302013-06-17
NCT00918203A Study of Paclitaxel/Carboplatin With or Without Olaratumab (IMC-3G3) in Previously Untreated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)COMPLETEDPHASE22010-012017-11-172013-08
NCT01027871A Study for Patients With Type 2 DiabetesCOMPLETEDPHASE22010-012011-012010-12
NCT01049412A Study for Patients With Type 1 DiabetesCOMPLETEDPHASE22010-012011-012010-12
NCT01340976A Phase 1 Study of LY2787106 in Cancer and AnemiaCOMPLETEDPHASE12010-012014-122014-12
NCT01088464Study of IMC-11F8 in Participants With Advanced Solid TumorsCOMPLETEDPHASE12010-012012-022012-02
NCT01051466A Study of the Neurobiology of DepressionCOMPLETEDPHASE42010-012013-032013-03
NCT01394016A Phase 1 Study of LY2835219 In Participants With Advanced CancerCOMPLETEDPHASE12009-12-072022-04-122014-05-29
NCT01025284A Study for Participants With Small-Cell Lung CancerCOMPLETEDPHASE22009-122012-072012-07
NCT01006252A Study of Tasisulam-sodium Versus Paclitaxel as Treatment for Metastatic MelanomaTERMINATEDPHASE32009-122011-032011-03
NCT01035138A Study of Semagacestat for Alzheimer's PatientsCOMPLETEDPHASE32009-122011-042011-04
NCT01015287A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST Elevation Myocardial InfarctionCOMPLETEDPHASE32009-122013-022013-01
NCT01024244A Study of LY2599506 in Patients With Type 2 DiabetesTERMINATEDPHASE22009-122010-072010-07
NCT01018810A Study for Adults With Plaque PsoriasisTERMINATEDPHASE22009-122010-082010-05
NCT00982111First-line Treatment of Patients With Stage IV Nonsquamous Non-Small Cell Lung Cancer With Necitumumab (IMC-11F8) and Pemetrexed-CisplatinCOMPLETEDPHASE32009-11-022020-12-232012-11-14
NCT00988858A Study of Advanced or Metastatic Non-small Cell Lung CancerCOMPLETEDPHASE22009-112014-112012-07
NCT01007032A Study of IMC-A12 in Advanced Solid TumorsCOMPLETEDPHASE12009-112015-042012-12
NCT01017874A Study of Alimta/Cisplatin/Gefitinib for Asian Non-smoking Participants With Non Small Cell Lung CancerCOMPLETEDPHASE32009-112014-102013-04
NCT01017731Study of Ramucirumab (IMC-1121B) Therapy and Corrected QT (QTc) Interval ChangesCOMPLETEDPHASE22009-112014-052010-04
NCT01026818A Study of Tadalafil After Radical ProstatectomyCOMPLETEDPHASE42009-112012-102012-10
NCT01005680A Study Comparing Two Different Chemotherapy Types in Chinese Patients With Advanced Non Small Cell Lung CancerCOMPLETEDPHASE32009-112012-112012-11
NCT01020786A Study in Non-squamous Non Small Cell Lung Cancer in Asian PatientsCOMPLETEDPHASE42009-112012-062011-03
NCT00969618A Long Term Follow-Up Study for Asian Adult Patients With Attention Deficit Hyperactivity DisorderCOMPLETEDPHASE32009-112012-012012-01
NCT01011556A Study for the Transdermal Application of TeriparatideCOMPLETEDPHASE22009-112011-092011-09
NCT01018680A Study Comparing Duloxetine Versus Placebo in Patients Taking a Nonsteroidal Anti-inflammatory Drug (NSAID) for Knee Pain Due to OsteoarthritisCOMPLETEDPHASE32009-112011-042011-04
NCT01000805A Study of Duloxetine in Major Depressive Disorder (MDD) and Associated Painful SymptomsCOMPLETEDPHASE42009-112010-102010-10
NCT01001104A Study of LY2189265 in Japanese Patients With Type 2 DiabetesCOMPLETEDPHASE22009-102010-122010-12
NCT01004250A Study of Pemetrexed and Bevacizumab for Participants With Advanced Non-Small Cell CancerCOMPLETEDPHASE22009-102013-122012-11
NCT01000480A Study of Pemetrexed and Cisplatin, in Non Small Cell Lung CancerCOMPLETEDPHASE22009-102013-072013-01
NCT00985712A Study on the Effect of 2 Pen Devices on HbA1cCOMPLETEDPHASE42009-102011-072011-07
NCT01107899Study to Learn When Platelets Return to Normal After One Loading Dose of Anti-platelet Drugs in Patients With Symptoms of Acute Coronary SyndromesTERMINATEDPHASE12009-102010-122010-12
NCT00970632A Study of Tadalafil in Men With Benign Prostatic HyperplasiaCOMPLETEDPHASE32009-102011-012011-01
NCT00993421A Weight Loss Study in Overweight Men and WomenTERMINATEDPHASE22009-102010-062010-06
NCT01285037A Study of LY2801653 in Advanced CancerCOMPLETEDPHASE12009-09-092017-09-112017-07-21
NCT00948675Study of Participants With Advanced Non-Small Cell Lung CancerCOMPLETEDPHASE32009-09-012020-11-062013-01-31
NCT00965419A Study of Pediatric Participants With Attention Deficit/Hyperactivity DisorderTERMINATEDPHASE2, PHASE32009-092015-072015-07
NCT01253226A Study for Japanese Participants With Rheumatoid Arthritis (RA)COMPLETEDPHASE12009-092011-082011-08
NCT00992225A Study of LY573636-sodium in Patients With Metastatic Breast CancerCOMPLETEDPHASE22009-092011-042011-04
NCT01742091A Multiple Dose Study of LY2541546 in Healthy Postmenopausal WomenCOMPLETEDPHASE12009-092010-032010-03
NCT01784614A Study of LY2624803 in Japanese Participants With Transient InsomniaCOMPLETEDPHASE12009-092010-032010-03
NCT00982020Study in Adolescents With Schizophrenia or Bipolar DisorderCOMPLETEDPHASE42009-092013-052013-05
NCT01005355Study of IMC-1121B in Patients With Advanced Solid TumorsCOMPLETEDPHASE12009-092011-022011-02
NCT00971997A Study of Insulin Lispro Mix in Type 2 Diabetic Asian PatientsCOMPLETEDPHASE42009-092011-042011-04
NCT00970281A Study of Olanzapine in Patients With SchizophreniaCOMPLETEDPHASE32009-092011-042011-04
NCT00965081A Study for Adult Patients With FibromyalgiaCOMPLETEDPHASE42009-092010-112010-11
NCT00985504A Study of Patients With Major Depressive Disorder and Residual ApathyCOMPLETEDPHASE42009-092010-122010-12
NCT00917384Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and AdenocarcinomaCOMPLETEDPHASE32009-082015-122012-07
NCT00966875A Study in Patients With Rheumatoid ArthritisCOMPLETEDPHASE22009-082012-062011-03
NCT00960986A Duloxetine Dosing Strategy Study in Korean Patients With Major Depressive DisorderCOMPLETEDPHASE42009-082011-042011-02
NCT00958568A Study in Relapse Prevention of Treatment-Resistant DepressionCOMPLETEDPHASE32009-082012-032012-03
NCT00962104Atomoxetine to Treat Asian Adult Patients With Attention-Deficit/Hyperactivity DisorderCOMPLETEDPHASE32009-082011-022011-02
NCT00883051Dose-ranging Study of Oral COL-144 in Acute Migraine TreatmentCOMPLETEDPHASE22009-072010-022010-02
NCT00927186Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic WomenCOMPLETEDPHASE42009-072012-042010-10
NCT00910299Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel (TRIGGER-PCI)TERMINATEDPHASE22009-072011-042011-04
NCT00945945A Study of Duloxetine in Patients With Osteoarthritis Knee PainCOMPLETEDPHASE32009-072010-052010-05
NCT00887926Study of IMC-EB10 in Participant With LeukemiaTERMINATEDPHASE12009-062010-082010-08
NCT00913835A Study of Liposomal Doxorubicin With or Without Olaratumab (IMC-3G3) in Platinum-Refractory or Resistant Advanced Ovarian CancerCOMPLETEDPHASE22009-062014-022011-10
NCT00942188A Study of LY2189102 in Patients With Type 2 DiabetesCOMPLETEDPHASE22009-062010-112010-11
NCT00922636A Study of Pediatric Patients With Attention Deficit/Hyperactivity DisorderCOMPLETEDPHASE2, PHASE32009-062010-122010-12
NCT00845039A Study of Irinotecan and Cetuximab With or Without IMC-A12 for Treatment of Participants With Colon or Rectum Cancer Who Got Worse After Their First Treatment With Oxaliplatin and BevacizumabTERMINATEDPHASE22009-052011-022011-02
NCT00906373A Study of IMC-A12 in Combination With Sorafenib in Participants With Advanced Cancer of the LiverCOMPLETEDPHASE22009-052014-052012-10
NCT00904683Effect of LY2062430 on the Progression of Alzheimer's DiseaseCOMPLETEDPHASE32009-052012-062012-06
NCT00905372Effect of LY2062430 on the Progression of Alzheimer's DiseaseCOMPLETEDPHASE32009-052012-042012-04
NCT00887354A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip FractureCOMPLETEDPHASE42009-042015-082015-08
NCT00882999A Study of Participants With Relapsing-Remitting Multiple Sclerosis (RRMS)COMPLETEDPHASE22009-042012-062011-02
NCT01869959A Study of LY2405319 in Participants With Type 2 DiabetesCOMPLETEDPHASE12009-042009-122009-06
NCT00867009A Study of Induction and Maintenance Treatment of Advanced or Metastatic Non Squamous Non-Small Cell Lung CancerCOMPLETEDPHASE22009-042014-092011-05
NCT00862784A Study of IMC-1121B (Ramucirumab) in Colorectal CancerCOMPLETEDPHASE22009-042011-082011-04
NCT00844857A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar DepressionCOMPLETEDPHASE42009-042012-022012-02
NCT00887549A Study of Thymidylate Synthase Expression in Patients With Non-Small Cell Lung CancerCOMPLETEDPHASE22009-042011-062010-07
NCT00870870A Study of IMC-A12 (Cixutumumab) With and Without Other Standard Chemotherapies in Participants With Lung Cancer Who Have Not Received Chemotherapy BeforeCOMPLETEDPHASE22009-032012-052012-04
NCT00871572A Study for Participants With Type 2 Diabetes MellitusCOMPLETEDPHASE22009-032010-022010-02
NCT00849901A Study in the Treatment of Children and Adolescents With Major Depressive DisorderCOMPLETEDPHASE32009-032011-102011-03
NCT01591317Study of Prasugrel in Korean Healthy Male VolunteersCOMPLETEDPHASE12009-032009-052009-05
NCT00849693A Study in the Treatment of Children and Adolescents With Major Depressive DisorderCOMPLETEDPHASE32009-032011-092011-02
NCT00855582A Study in the Treatment of Erectile Dysfunction and Benign Prostate HyperplasiaCOMPLETEDPHASE32009-032010-072010-07
NCT00861757Multinational Study to Evaluate Tadalafil in Asian Men With Signs and Symptoms of Benign Prostatic HyperplasiaCOMPLETEDPHASE32009-032010-062010-06
NCT00848081A Study of Tadalafil in Men With Benign Prostatic Hyperplasia Symptoms Who Are Being Treated With Alpha BlockersCOMPLETEDPHASE32009-032009-122009-12
NCT00781911A Study of Cixutumumab (IMC-A12) in Islet Cell CancerCOMPLETEDPHASE22009-022016-052011-07
NCT00839332A Study for Participants With Pancreatic CancerCOMPLETEDPHASE1, PHASE22009-022013-122013-02
NCT00840034A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive DisorderCOMPLETEDPHASE22009-022010-012010-01
NCT00837811An Open Label Extension Study in Participants With Rheumatoid ArthritisCOMPLETEDPHASE22009-022012-012011-01
NCT00843518Treatment for Aggression and Agitation in Patients With Alzheimer's DiseaseCOMPLETEDPHASE22009-022011-062011-06
NCT00698841Study to Evaluate the Effect of Cetuximab on Corrected QT (QTc) Interval Changes in Patients With Advanced Malignancies From Solid TumorsCOMPLETEDPHASE22009-022010-022010-02
NCT00853151A Study to Test the Combination of Two Different Kinds of Medications for the Treatment of DiabetesCOMPLETEDPHASE12009-022010-052010-05
NCT00830960A Comparison of Antiplatelet Therapies in Asian Subjects With Acute Coronary SyndromeCOMPLETEDPHASE32009-022010-062010-06
NCT00833638A Study in Erectile DysfunctionCOMPLETEDPHASE42009-022009-062009-06
NCT01214668Dose-Escalation Study of LY573636-sodium and Liposomal Doxorubicin in Patients With Advanced Solid TumorsCOMPLETEDPHASE12009-012012-022012-02
NCT00735696A Study of Ramucirumab (IMC-1121B) With Paclitaxel and Carboplatin in Non-small Cell Lung CancerCOMPLETEDPHASE22009-012012-012011-10
NCT00836693Effect of Tadalafil Once a Day in Men With Erectile DysfunctionCOMPLETEDPHASE32009-012010-012010-01
NCT00827242Study to Treat Patients Who Have Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) With Tadalafil DailyCOMPLETEDPHASE32009-012009-112009-11
NCT00805441A Study in the Treatment of Alcohol Dependence.COMPLETEDPHASE22008-122009-072009-07
NCT00795821A Study in Adult Patients With Major Depressive DisorderCOMPLETEDPHASE2, PHASE32008-122011-032010-02
NCT00762034A Study of Pemetrexed, Carboplatin and Bevacizumab in Participants With Nonsquamous Non-Small Cell Lung CancerCOMPLETEDPHASE32008-122014-122012-04
NCT00767299A Study of Arzoxifene to Treat Korean Women With OsteoporosisCOMPLETEDPHASE22008-122009-102009-10
NCT00791479Effects of LY2189265 on Glycemic Control in Participants With Type 2 DiabetesCOMPLETEDPHASE22008-122010-012010-01
NCT00804986A Study for Patients With Type 2 Diabetes MellitusCOMPLETEDPHASE22008-122010-012010-01
NCT00803361Duloxetine for the Treatment of Generalized Anxiety DisorderCOMPLETEDPHASE32008-122010-012010-01
NCT00838084A Safety Study of LY2811376 Single Doses in Healthy SubjectsCOMPLETEDPHASE12008-122009-062009-06
NCT00804973Study in Participants With Acute Migraines HeadachesTERMINATEDPHASE22008-112009-052009-05
NCT00804570A Study for the Treatment of Alcohol DependenceCOMPLETEDPHASE22008-112010-022010-02
NCT01394003A Study of LY2584702 in Participants With Advanced CancerTERMINATEDPHASE12008-112011-042011-04
NCT00789373A Study of Induction and Maintenance Treatment of Advanced Non-squamous Non-Small Cell Lung CancerCOMPLETEDPHASE32008-112017-112010-06
NCT00785577A Study for Treatment of Pain in Patients With Diabetic Neuropathy.COMPLETEDPHASE22008-112010-062010-05
NCT00790790A Study in the Treatment of Osteoarthritis Knee PainCOMPLETEDPHASE22008-112010-012010-01
NCT00810069Early Versus Delayed Switch in Medication in Patients With Major Depressive DisorderCOMPLETEDPHASE42008-112010-032010-02
NCT00783094Study of Tadalafil Once-a-Day for 12 Weeks in Japanese Men With Benign Prostatic Hyperplasia Followed by an Open-Label ExtensionCOMPLETEDPHASE22008-112010-042009-06
NCT00785928A Study for Patients With Active Rheumatoid Arthritis Despite Ongoing Methotrexate TherapyCOMPLETEDPHASE22008-102010-122010-01
NCT00768131A Study to Determine Whether EGFR Status by FISH Can Predict Results in Non Small Cell Lung Cancer (NSCLC) Patients Treated With Cetuximab, Carboplatin and PaclitaxelWITHDRAWNPHASE22008-102008-102008-10
NCT00784875An Efficacy Study of Compound LY2624803 in the Treatment of Patients With Chronic InsomniaCOMPLETEDPHASE22008-102010-022010-02
NCT00755807Duloxetine for Multiple Sclerosis PainCOMPLETEDPHASE32008-102010-112010-08
NCT00857454A Trial to Evaluate the Ongoing Skin Safety of Testosterone MD-Lotion FormulationsCOMPLETEDPHASE32008-102009-082009-08
NCT01393990A Study of LY2228820 in Participants With Advanced CancerCOMPLETEDPHASE12008-09-042013-12-142013-02
NCT00716274Effects of Atomoxetine on Brain Activation During Attention & Reading Tasks in Participants With ADHD & Comorbid DyslexiaCOMPLETEDPHASE42008-092016-072016-07
NCT00744991A Study for Participants With Relapsed Cutaneous T-Cell LymphomaCOMPLETEDPHASE22008-092010-022010-01
NCT01648764A Study of LY2334737 in Participants With Cancer That is Advanced and/or Has SpreadCOMPLETEDPHASE12008-092012-112012-11
NCT00686959Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung CancerCOMPLETEDPHASE32008-092014-112014-10
NCT00762411Effects of LY450139, on the Progression of Alzheimer's Disease as Compared With PlaceboCOMPLETEDPHASE32008-092011-042011-04
NCT00760747Comparison of Slow and Fast Transition From Stimulants to Atomoxetine in Children and Adolescents With Attention Deficit/Hyperactivity Disorder(ADHD)COMPLETEDPHASE42008-092010-092010-08
NCT00767806A Study for Patient With Chronic Low Back PainCOMPLETEDPHASE32008-092009-072009-07
NCT00687609Pilot Evaluation of Atomoxetine on Attention Deficit Hyperactivity Disorder (ADHD) Symptoms in Adolescents With Cannabis abusETERMINATEDPHASE42008-092009-062009-06
NCT00749216Solanezumab Safety Study in Japanese Patients With Alzheimer's DiseaseCOMPLETEDPHASE22008-092009-072009-07
NCT00703326Phase III Study of Docetaxel + Ramucirumab or Placebo in Breast CancerCOMPLETEDPHASE32008-08-062020-11-192013-03-31
NCT00721162Study of Ramucirumab in Ovarian CancerCOMPLETEDPHASE22008-082015-082012-05
NCT00718159Study of LY573636-sodium in Essential Thrombocythemia and Acute Myeloid LeukemiaCOMPLETEDPHASE12008-082011-122011-12
NCT00728949A Study for Safety and Effectiveness of IMC-A12 by Itself or Combined With Antiestrogens to Treat Breast CancerCOMPLETEDPHASE22008-082015-022012-03
NCT00734474A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on MetforminCOMPLETEDPHASE2, PHASE32008-082012-072011-06
NCT00683475A Study of IMC-A12 or Ramucirumab Plus Mitoxantrone and Prednisone in Prostate CancerCOMPLETEDPHASE22008-082011-092011-09
NCT00734604A Study for Patients With Erectile Dysfunction to Test Whether Tadalafil Taken Once a Day Can Better Improve Psychological Outcomes.COMPLETEDPHASE32008-082009-092009-09
NCT00481117Safety, Tolerability, and Effect of LY2405319 After Multiple Injections in Subjects With Type 2 DiabetesCOMPLETEDPHASE12008-082008-12
NCT00415155A Study of LY2181308 in Patients With Advanced Hepatocellular CarcinomaWITHDRAWNPHASE1, PHASE22008-082011-012011-01
NCT00718419A Study for Patients That Have Been Previously Been Treated in Waldenstrom's Macroglobulinemia or Multiple MyelomaCOMPLETEDPHASE22008-072012-082010-09
NCT01258348A Phase 1b Trial in Patients With Renal Cell CancerCOMPLETEDPHASE12008-072012-022012-02
NCT01284335A Safety Study in Participants With Advanced Solid TumorsTERMINATEDPHASE12008-072016-052012-10
NCT00668148A Five-Tier, Open-Label Study of IMC-A12 in Advanced SarcomaCOMPLETEDPHASE22008-072012-022010-10
NCT00709995A Study for Participants With Metastatic Renal Cell CarcinomaCOMPLETEDPHASE22008-06-302018-09-052010-02-15
NCT00689728A Study for Patients With Rheumatoid Arthritis on Methotrexate (MTX) With an Inadequate Response to TNFα Inhibitor TherapyCOMPLETEDPHASE22008-062010-052010-02
NCT01742078A Study of LY2541546 in Healthy Postmenopausal WomenCOMPLETEDPHASE12008-062010-062010-06
NCT01214655A Study for Patients With Acute LeukemiaTERMINATEDPHASE12008-062011-022011-02
NCT00700427A Long Term Study of a Medication for Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)COMPLETEDPHASE32008-062013-102011-08
NCT00699998A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome SubjectsCOMPLETEDPHASE32008-062012-042012-04
NCT00702650A Titration Trial to Determine the Effectiveness of Testosterone MD-Lotion (Cutaneous Solution) FormulationsCOMPLETEDPHASE32008-062009-072009-07
NCT00696774Switching to Duloxetine in Patients With DepressionCOMPLETEDPHASE42008-062009-072009-07
NCT00673452A Study Comparing Duloxetine and Placebo in the Treatment of FibromyalgiaCOMPLETEDPHASE42008-062009-072009-04
NCT01214642A Dose-Escalation Study for Patients With Advanced CancerCOMPLETEDPHASE12008-052012-062011-12
NCT01779830A Study of LY2624803 in Participants With Transient InsomniaCOMPLETEDPHASE12008-052008-112008-11
NCT00666757A Study Comparing Duloxetine to Other Antidepressants in the Treatment of Severe DepressionCOMPLETEDPHASE42008-052009-032009-02
NCT00630825A Study of Dose Titration of LY2189265 in Overweight Participants With Type 2 Diabetes MellitusCOMPLETEDPHASE22008-042009-012009-01
NCT00664534Pre-Mix Insulin Lispro Treatment for Type 2 Diabetes Patients Who Consume a Light BreakfastCOMPLETEDPHASE42008-042010-112010-11
NCT00666718A Comparison Study of Basal Bolus Therapies Together With Lispro Insulin in Type 2 Diabetes PatientsCOMPLETEDPHASE32008-042010-022010-02
NCT00642174Third Optimizing Anti-Platelet Therapy in Diabetes MellitUS (OPTIMUS-3)COMPLETEDPHASE22008-042009-012009-01
NCT00620321A Study of LY2181308 Sodium in Patients With Relapsed or Refractory Acute Myeloid LeukemiaCOMPLETEDPHASE22008-032010-012010-01
NCT00642018A Study of an Experimental Chemotherapy Combination to Treat Hormone Refractory Prostate CancerCOMPLETEDPHASE22008-032012-042011-08
NCT00617734Study of IMC-A12, Alone or in Combination With Cetuximab, in Participants With Recurrent or Metastatic Squamous Cell Carcinoma (MSCC) of the Head and NeckCOMPLETEDPHASE22008-032012-072012-02
NCT00594568Effect of LY450139 on the Long Term Progression of Alzheimer's DiseaseCOMPLETEDPHASE32008-032011-052011-05
NCT00604214Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients With Septic ShockCOMPLETEDPHASE32008-032012-022011-09
NCT01606397A Study of Multiple Increasing Doses of LY2409021 in Participants With Type 2 DiabetesCOMPLETEDPHASE12008-032008-112008-11
NCT00623233Gemcitabine Plus Bevacizumab in Locally Recurrent or Metastatic Breast CancerCOMPLETEDPHASE22008-032011-012011-01
NCT00607919Treatment of ADHD With Atomoxetine in Children & Adolescents With ADHD & Comorbid DyslexiaCOMPLETEDPHASE42008-032011-022010-11
NCT00641719A Long-term Study for the Treatment of Painful Diabetic NeuropathyCOMPLETEDPHASE32008-032010-032010-03
NCT00636818Atomoxetine Asian Study in Adult Subjects With Attention-Deficit/Hyperactivity Disorder (ADHD)COMPLETEDPHASE22008-032008-102008-09
NCT00640510A Study Comparing Rapid Acting Intramuscular Olanzapine and Placebo in Agitated Patients With SchizophreniaCOMPLETEDPHASE32008-032008-072008-07
NCT00612586Study of Enzastaurin With 5-Fluorouracil/Leucovorin (5-FU/LV) Plus Bevacizumab as Maintenance Regimen Following First Line Therapy for Metastatic Colon CancerCOMPLETEDPHASE22008-022011-112010-01
NCT01215916A Phase 1 Study in Patients With Solid TumorsCOMPLETEDPHASE12008-022011-122011-12
NCT00627042Study of IMC-1121B (Ramucirumab) in Participants With Liver Cancer Who Have Not Previously Been Treated With ChemotherapyCOMPLETEDPHASE22008-022011-052011-05
NCT00618748Safety and Efficacy of Olanzapine in the Long-term Treatment for Bipolar I Disorder, DepressedCOMPLETEDPHASE32008-022010-092010-09
NCT00609518A Study for Patients With Non-Squamous Non-Small Cell Lung CancerCOMPLETEDPHASE22008-022010-062009-10
NCT01524224A Dose-Escalation Study in Participants With Advanced CancerCOMPLETEDPHASE12008-012016-012012-11
NCT00606021A Study Comparing of Two Different Chemotherapy Regimens, in Patients With Advanced Non-Squamous Non-Small Cell Lung CancerCOMPLETEDPHASE22008-012010-122010-12
NCT00577863Study of the Experience of Patients With Osteoporosis Using the Forteo B Pen to Self Administer Once Daily Teriparatide TherapyCOMPLETEDPHASE32008-012008-122008-05
NCT00414960A Trial of Placebo Versus Enzastaurin for Lung Cancer Prevention in Former SmokersCOMPLETEDPHASE22007-122010-092010-09
NCT00536939Trial of Paclitaxel, Bevacizumab, and Enzastaurin Versus Paclitaxel, Bevacizumab and Placebo for Breast CancerTERMINATEDPHASE22007-112008-032008-03
NCT00586508Trial of Enzastaurin and Bevacizumab in Participants With Recurrent Malignant GliomasCOMPLETEDPHASE22007-112013-102013-10
NCT00542919A Study for Patients With Non-Hodgkin's LymphomasCOMPLETEDPHASE22007-112018-02-272010-03
NCT01287520A Study of LY2090314 in Patients With Advanced or Metastatic CancerCOMPLETEDPHASE12007-112011-042011-04
NCT00533702A Study of IMC-1121B (Ramucirumab) With or Without Dacarbazine in Metastatic Malignant MelanomaCOMPLETEDPHASE22007-112011-052011-05
NCT00515697A Study of Ramucirumab in Participants With Metastatic Renal Cell CarcinomaCOMPLETEDPHASE22007-112011-052011-05
NCT00550173A Study for Non-Smoker Patients With Nonsquamous Non-Small Cell Lung CancerCOMPLETEDPHASE22007-112012-012012-01
NCT01606423The Effect of LY2409021 on Blood Sugar Levels When Glucagon Levels Are Increased in Healthy Male ParticipantsCOMPLETEDPHASE12007-112008-032008-03
NCT00557310A Study Using Imaging Technology to Measure Changes in Bone Structure After Treatment With TeriparatideCOMPLETEDPHASE42007-112011-052010-10
NCT00560417Comparison of Two Basal Insulins for Patients With Type 2 Diabetes Taking Oral Diabetes Medicines and ExenatideCOMPLETEDPHASE32007-112009-122009-12
NCT00548808A Study for Type 2 Diabetic PatientsCOMPLETEDPHASE42007-112009-082009-08
NCT00552175A Study for the Treatment of Diabetic Peripheral Neuropathic PainCOMPLETEDPHASE32007-112009-032009-03
NCT00568685Atomoxetine to Treat Korean Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)COMPLETEDPHASE32007-112008-112008-11
NCT00533429Study of Pemetrexed + Carboplatin + Bevacizumab + Enzastaurin Versus Pemetrexed + Carboplatin + Bevacizumab + Placebo in Participants With Non-Small Cell Lung Cancer Who Have Not Been Previously Treated With ChemotherapyCOMPLETEDPHASE22007-102009-022009-02
NCT00509821Enzastaurin Before and Concomitant With Radiation, Followed by Enzastaurin in Participants With Newly Diagnosed GlioblastomaCOMPLETEDPHASE22007-102016-032010-02
NCT00520676Chemotherapy in Treating Patients With Non-Small Cell Lung CancerCOMPLETEDPHASE32007-102010-072010-07
NCT00857961A Study of the Pharmacokinetics of Testosterone Metered Dose (MD)-Lotion FormulationsCOMPLETEDPHASE22007-102008-012008-01
NCT00540124Pilot Study Investigating Safety and Efficacy of Tadalafil as Treatment for Benign Prostatic Hyperplasia (BPH) in Asian MenCOMPLETEDPHASE22007-102008-062008-06
NCT00546910Comparison of Atomoxetine Versus Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)COMPLETEDPHASE42007-102009-052009-05
NCT00475657Pemetrexed and Cisplatin as Treatment in Small Cell Lung CancerTERMINATEDPHASE22007-102008-042008-04
NCT00538681Study for Participants With Advanced, Not Amenable to Surgery, or Metastatic Lung Cancer Comparing Treatment With Pemetrexed + Cisplatin + Enzastaurin Versus Pemetrexed + Cisplatin + PlaceboTERMINATEDPHASE22007-092008-112008-11
NCT00530621Study of Enzastaurin Versus Placebo With Pemetrexed for Participants With Advanced or Metastatic Lung CancerCOMPLETEDPHASE22007-092008-102008-10
NCT00530335Atomoxetine Phase 2 Study in Japanese Adult Patients With Attention Deficit/Hyperactivity Disorder (ADHD)COMPLETEDPHASE22007-092008-042008-04
NCT00523419Chemotherapy for Patients With OsteosarcomaCOMPLETEDPHASE22007-092010-062009-06
NCT00520936A Study of Pemetrexed in Children With Recurrent CancerCOMPLETEDPHASE22007-092010-022010-02
NCT00536471A Study Comparing Duloxetine and Placebo in Assessing Energy and Vitality in Major Depressive Disorder (MDD) PatientsCOMPLETEDPHASE42007-092008-122008-05
NCT00494026Chemotherapy and Radiotherapy to Treat Patients With Limited Stage of Small Cell Lung Cancer (SCLC)TERMINATEDPHASE22007-092008-102008-10
NCT00520923A Study for Patients With SchizophreniaCOMPLETEDPHASE22007-092008-102008-10
NCT00490451A Study of LY573636-Sodium in the Treatment of Patients With Metastatic Soft Tissue SarcomaCOMPLETEDPHASE22007-082010-022010-02
NCT00520481Study With IMC-A12 (Cixutumumab) in Patients Who Have Not Previously Been Treated With Chemotherapy With Metastatic Prostate CancerCOMPLETEDPHASE22007-082013-082012-01
NCT00835185Study of IMC-11F8 in Participants With Colorectal CancerCOMPLETEDPHASE22007-082010-102010-01
NCT00529789Open-Label Study of Duloxetine in the Treatment of Children and Adolescents With Major Depressive DisorderCOMPLETEDPHASE22007-082008-092008-09
NCT00510146Olanzapine Treatment of Patients With Bipolar I DisorderCOMPLETEDPHASE32007-082010-072010-03
NCT00510952Comparison of Two Basal Insulins for Patients With Type 2 Diabetes on Anti-Hyperglycemic Medications (IOPE)COMPLETEDPHASE32007-082008-102008-10
NCT00510276Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) With Atomoxetine in Young Adults and Its Effects on Functional OutcomesCOMPLETEDPHASE42007-082009-022009-02
NCT00494013Comparison of Two Basal Insulins for Patients With Type 2 Diabetes (IOOY)COMPLETEDPHASE32007-082008-092008-09
NCT01214629A Study for Participants With Advanced CancerCOMPLETEDPHASE12007-072012-052012-05
NCT00503399Comparison of the Effects of 2 Drugs on Lumbar Spine Volumetric BMD in Men With Glucocorticoid-Induced OsteoporosisCOMPLETEDPHASE32007-072010-102010-10
NCT00533026Duloxetine - Warfarin Pharmacodynamic StudyCOMPLETEDPHASE12007-072007-102007-10
NCT00490854A Study for Patients With Type 2 Diabetes MellitusCOMPLETEDPHASE2, PHASE32007-072008-052008-05
NCT00466440A Phase 2 Study With Enzastaurin Plus Chemotherapy or Placebo Plus Chemotherapy for Prostate Cancer PatientsCOMPLETEDPHASE22007-062010-062009-08
NCT00503685Study Using IMC-A12 (Cixutumumab) With or Without Cetuximab in Participants With Metastatic Colorectal Cancer Who Have Failed a Treatment Regimen That Consisted of a Prior Anti-EGFR TherapyCOMPLETEDPHASE22007-062009-032009-03
NCT00487240Comparison of Two Basal Insulin Therapies for Patients With Type 1 DiabetesCOMPLETEDPHASE32007-062008-082008-08
NCT00452413A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung CancerCOMPLETEDPHASE1, PHASE22007-052013-112009-07
NCT00451178A Study of Participants With Lymphoma Who Take R-CHOP and Enzastaurin Compared to Participants Who Take R-CHOP OnlyCOMPLETEDPHASE22007-052013-012012-02
NCT00475644A Study of Enzastaurin in Participants With Follicular LymphomaCOMPLETEDPHASE22007-052014-122012-04
NCT00482014A Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin With Radiation Therapy Followed by Pemetrexed in Patients With Inoperable Non-Small-Cell Lung CancerCOMPLETEDPHASE1, PHASE22007-052011-102011-10
NCT01606371A First-in-Human Study of LY2409021 in Healthy Participants and Participants With Type 2 DiabetesCOMPLETEDPHASE12007-052007-102007-10
NCT00452257A Study of Enzastaurin in Patients With LeukemiaCOMPLETEDPHASE12007-052008-092008-09
NCT00451555Enzastaurin Plus Fulvestrant vs. Placebo Plus Fulvestrant in Breast CancerCOMPLETEDPHASE22007-04-112018-10-182010-12-28
NCT00447213A Study for Patients With Type 1 Diabetes MellitusCOMPLETEDPHASE2, PHASE32007-042008-052008-05
NCT00471354A Study for Patients With Attention-Deficit/Hyperactivity Disorder Treated With AtomoxetineCOMPLETEDPHASE42007-042008-112008-11
NCT00437268A Study of Irinotecan Plus Cetuximab With or Without Enzastaurin in Participants With Colorectal CancerCOMPLETEDPHASE22007-032009-052009-05
NCT00437294Enzastaurin in Combination of Capecitabine to Treat Breast CancerTERMINATEDPHASE22007-032009-032009-03
NCT00447057Study of Pemetrexed Versus Pemetrexed Plus Erlotinib as Treatment of Nonsquamous Non-Small Cell Lung Cancer (NSCLC)COMPLETEDPHASE22007-032011-062010-07
NCT00437125Study on the Tolerability of Duloxetine in Depressed Patients With Parkinson's DiseaseCOMPLETEDPHASE42007-032009-072009-07
NCT00385944The Effect on Blood Cells, Known as Platelets, Using Prasugrel vs Clopidogrel in Patients With the Heart Problem Acute Coronary Syndrome (ACS)COMPLETEDPHASE22007-032007-102007-10
NCT00447278A Study Comparing the Effect of Atomoxetine Versus Other Standard Care Therapy on the Long Term Functioning in Attention-Deficit/Hyperactivity Disorder (ADHD) Children and AdolescentsCOMPLETEDPHASE32007-032009-072009-03
NCT00436280Chemotherapy for Participants With LymphomaCOMPLETEDPHASE22007-022012-112009-11
NCT00437112Evaluate the Efficacy and Safety of Insulin Compared to Glargine in Patients With Type 2 DiabetesCOMPLETEDPHASE32007-022008-052008-05
NCT00428610A Study of Chemotherapy Treatment for Patients With Ovarian CancerCOMPLETEDPHASE22007-022012-012011-02
NCT00422162A Study Evaluating Duloxetine in Patients Hospitalized for Severe DepressionCOMPLETEDPHASE42007-022008-082008-08
NCT00870155A Study for Patients With Multiple SclerosisTERMINATEDPHASE2, PHASE32007-022009-092009-09
NCT00409006Chemotherapy for Patients With Non-Small Cell Lung Cancer Who Are Non-SmokersCOMPLETEDPHASE22007-022010-052009-08
NCT00447421A Study to Treat Small Cell Lung Cancer With a Combination of Cisplatin, Pemetrexed, and RadiotherapyTERMINATEDPHASE1, PHASE22007-022008-052008-05
NCT00433290Duloxetine vs. Placebo in the Treatment of Osteoarthritis Knee PainCOMPLETEDPHASE32007-022008-052008-05
NCT00383331Pemetrexed and Gemcitabine Every 14 Days Versus Every 21 Days in Advanced Non Small Cell Lung CancerTERMINATEDPHASE22007-022008-012008-01
NCT00420381Evaluation of Enzastaurin in the Treatment of Persistent or Recurrent Ovarian or Primary Peritoneal CancerCOMPLETEDPHASE22007-012014-122008-05
NCT00428714Phase 2 Trial of Enzastaurin in Prostate Cancer in Participants Who Have Had Hormonal and ChemotherapyCOMPLETEDPHASE22007-012011-012009-06
NCT00415636Safety and Tolerability of IC83/LY2603618 Administered After Pemetrexed 500 mg/m2 Every 21 Days in Patients With CancerCOMPLETEDPHASE12007-012010-072010-03
NCT01445119A Phase I Trial of Enzastaurin (LY317615) in Combination With Carboplatin in Adults With Recurrent GliomasCOMPLETEDPHASE12007-012013-072013-07
NCT00433160Phase 3 Clinical Trial of Teriparatide in JapanCOMPLETEDPHASE32007-012009-092008-09
NCT00424593Duloxetine Versus Placebo in Chronic Low Back PainCOMPLETEDPHASE32007-012008-102007-12
NCT00420095A Study for Patients With Diabetes Mellitus (IOPA)COMPLETEDPHASE42007-012008-012008-01
NCT00415363Study of Enzastaurin Versus Placebo in the Treatment of Patients With Brain Metastases of Lung Cancer, After Whole Brain Radiation TherapyCOMPLETEDPHASE22006-122011-012011-01
NCT00420004A Study for Participants With Major DepressionCOMPLETEDPHASE22006-122008-032008-03
NCT00408993Duloxetine Versus Placebo in the Treatment of Patients With Diabetic Peripheral Neuropathic Pain in ChinaCOMPLETEDPHASE32006-122008-022008-02
NCT00768391Study of IMC-3G3 in Patients With Tumors That Are Not Responding to Standard Therapies or No Therapy is AvailableCOMPLETEDPHASE12006-122010-012009-03
NCT00415194A Study for Patients With Head and Neck CancerCOMPLETEDPHASE32006-122010-032010-03
NCT00343291A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLCCOMPLETEDPHASE22006-122010-122010-05
NCT00415168Pemetrexed Plus Cisplatin as First-Line Treatment in Stage IV or Recurrence of Gastric CancerCOMPLETEDPHASE22006-122009-072009-07
NCT00316225Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or AbdomenCOMPLETEDPHASE22006-122009-032009-03
NCT00408876Duloxetine Versus Placebo in Chronic Low Back PainCOMPLETEDPHASE32006-122007-112007-11
NCT00414973A Study for Patients With OsteoporosisCOMPLETEDPHASE32006-122008-072008-07
NCT00402324A Comparison of Olanzapine in Combination With a Mood Stabilizer vs Mood Stabilizer Alone, in Mixed Bipolar PatientsCOMPLETEDPHASE42006-122008-022008-02
NCT00391118Comparing Two Treatments for Ovarian Cancer: Standard Chemotherapy Plus Enzastaurin, or Placebo ("Sugar Pill")COMPLETEDPHASE22006-112012-072010-04
NCT00383292A Study of Tasisulam in Treating Participants With Malignant MelanomaCOMPLETEDPHASE22006-112015-072011-09
NCT00384774A Placebo-Controlled Adaptive Treatment Assignment Study of Intravenous COL-144 in the Acute Treatment of MigraineCOMPLETEDPHASE22006-112007-062007-06
NCT00550927Enzastaurin and Bevacizumab in Treating Patients With Locally Advanced or Metastatic CancerCOMPLETEDPHASE12006-112012-092010-03
NCT00386425Evaluate Protein C Levels in Severe Sepsis Patients on Drotrecogin Alfa (Activated)COMPLETEDPHASE22006-112009-082009-08
NCT00380718Chemotherapy for Patients With Non-Small Cell Lung CancerCOMPLETEDPHASE42006-112009-112008-09
NCT00869986A Study for Patients With Relapsing Remitting Multiple SclerosisCOMPLETEDPHASE2, PHASE32006-112009-092009-09
NCT00406848A Study Comparing the Efficacy and Safety of Duloxetine and Placebo for the Treatment of Depression in Elderly PatientsCOMPLETEDPHASE42006-112009-112009-07
NCT00406354Comparison of Atomoxetine Versus Placebo in Children and Adolescents With ADHD and Comorbid ODD in GermanyCOMPLETEDPHASE42006-112009-012009-01
NCT00402051Chemotherapy With Pemetrexed in Combination With Platinum for Advanced Non-Small Cell Lung Cancer (NSCLC)COMPLETEDPHASE22006-112009-052008-12
NCT00401973Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With OlanzapineCOMPLETEDPHASE32006-112008-092008-09
NCT00408421Duloxetine Versus Placebo for Osteoarthritis Knee PainCOMPLETEDPHASE32006-112007-102007-10
NCT00422734Tadalafil Taken Daily Compared to Placebo on Improvement of Getting and Maintaining an Erection and Sexual Quality of LifeCOMPLETEDPHASE32006-112008-012008-01
NCT00386087Enzastaurin For Breast Cancer Patients Who Previously Received an Anthracycline and a Taxane ChemotherapyCOMPLETEDPHASE22006-112007-09
NCT00414323Evaluation of the Effects of Duloxetine on NorepinephrineCOMPLETEDPHASE12006-112007-05
NCT00391209Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes MellitusCOMPLETEDPHASE32006-102008-052008-05
NCT00391274Chemotherapy for Patients With Non-Small Cell Lung Cancer (NSCLC)COMPLETEDPHASE32006-102010-062008-12
NCT00393705Lispro Mid Mixture (MM) Intensive Mixture Therapy With Progressive Dose-Titration of Lispro Low Mixture (LM) or Biphasic Insulin Aspart 30/70 (S019)COMPLETEDPHASE42006-102009-032009-03
NCT00380692Atomoxetine Versus Placebo for Symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents With Autism Spectrum DisorderCOMPLETEDPHASE42006-102008-102008-05
NCT00383422Study Comparing Arzoxifene With Raloxifene in Women After Menopause With OsteoporosisCOMPLETEDPHASE32006-102008-072008-07
NCT00386009Effects of Tadalafil Once a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic HyperplasiaCOMPLETEDPHASE22006-102008-052008-05
NCT00386815Safety Confirmation Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural MesotheliomaCOMPLETEDPHASE22006-102007-02
NCT00402116Phase 1/2 Study of Enzastaurin in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) PatientsCOMPLETEDPHASE1, PHASE22006-092009-122009-12
NCT00363766Study of LY573636-Sodium in Patients With Metastatic Non-Small Cell Lung CancerCOMPLETEDPHASE22006-092008-102008-10
NCT00385671An Open-Label Comparison of Duloxetine to Other Alternatives for the Management of Diabetic Peripheral Neuropathic PainCOMPLETEDPHASE42006-092009-112009-08
NCT00356525Chemotherapy Treatment in Re-occurring Non Small Cell Lung Cancer (NSCLC) After Previous Chemotherapy and Surgical Removal of the NSCLC TumorTERMINATEDPHASE22006-092009-042008-06
NCT00380588Randomized Phase 2 Study With Gemcitabine Alone and Combination Therapy for Patients With Advanced Biliary Tract CancerCOMPLETEDPHASE22006-092008-102008-10
NCT00377520A Trial for Patients With Advanced/Recurrent Endometrial CancerCOMPLETEDPHASE22006-092008-092007-10
NCT00370292Dosage Schedule Study of Pemetrexed Monochemotherapy for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)COMPLETEDPHASE22006-092008-092008-09
NCT00374855A Study in People With Mild HypertensionCOMPLETEDPHASE22006-092006-11
NCT00355849Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 DiabetesCOMPLETEDPHASE32006-082008-062008-06
NCT00356109Evaluate the Efficacy of Insulin Patients With Type 1 DiabetesCOMPLETEDPHASE32006-082008-052008-05
NCT00374868Pemetrexed Plus Cisplatin Bi-Weekly, in Patients With Urothelial Cancer (Metastatic, Locally Advanced or Non-Resectable)COMPLETEDPHASE1, PHASE22006-082008-042008-04
NCT00350792Pemetrexed/Carboplatin Non-Small Cell Lung Cancer (NSCLC) Elderly PatientsCOMPLETEDPHASE22006-082009-112008-11
NCT00357968Trial in Subjects Undergoing Cardiac Catheterization With Planned Percutaneous Coronary Intervention With StentingCOMPLETEDPHASE22006-082007-062007-06
NCT00377858Comparison of Two Approaches to Insulin Therapy in Patients With Type 2 Diabetes (IOOX)COMPLETEDPHASE42006-082008-092008-09
NCT00363415Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung CancerCOMPLETEDPHASE32006-082008-062008-06
NCT00384930Study of Tadalafil Once-a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic HyperplasiaCOMPLETEDPHASE2, PHASE32006-082008-102007-10
NCT00356135Effect of Prasugrel on Platelets After One Week in Patients Already Taking Clopidogrel After a Cardiac EventCOMPLETEDPHASE22006-072008-122008-12
NCT00782002Safety Study of IMC-18F1,to Treat Advanced Solid Tumors in Subjects That no Longer Respond to Standard TherapyCOMPLETEDPHASE12006-072009-112009-03
NCT00765115A Study of Healthy Subjects to Assess the Effect of LY450139 on Amyloid Beta Peptide Production Rate and or Dose Response.COMPLETEDPHASE12006-072007-092007-09
NCT00190918A Trial for Patients With Gestational Trophoblastic DiseaseCOMPLETEDPHASE22006-072007-07
NCT00355030Somatropin + Leuprorelin vs Somatropin Alone in Pubertal Children With Idiopathic Short StatureCOMPLETEDPHASE32006-062015-072015-07
NCT00330473A Concordance Study Comparing Insulin Treatments in Patients With Type 2 DiabetesCOMPLETEDPHASE32006-062008-052008-05
NCT00332202PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily EnzastaurinCOMPLETEDPHASE32006-062013-072013-04
NCT00343252Effect of Teriparatide Compared to Risedronate on Back Pain in Women With a Spine Fracture Caused by OsteoporosisCOMPLETEDPHASE32006-062010-062009-06
NCT00325234Pemetrexed-Carboplatin and Gemcitabine-Vinorelbine in Advanced Breast CancerCOMPLETEDPHASE22006-062010-082010-04
NCT00334802Combination Chemotherapy of Gemcitabine and Paclitaxel for Metastatic Breast CancerCOMPLETEDPHASE22006-062010-032008-02
NCT00330915A Study of Pemetrexed and Folic Acid Given Before Surgery (Neoadjuvant Treatment) to Patients With Rectal Cancer.COMPLETEDPHASE22006-062008-062008-06
NCT00324051Patient's Preference Between Conventional Oral Olanzapine Tablet vs Olanzapine Orodispersible TabletCOMPLETEDPHASE42006-052007-092007-09
NCT00320541A Trial of Paclitaxel and Bevacizumab vs. Gemcitabine, Paclitaxel, and Bevacizumab in Advanced Breast CancerCOMPLETEDPHASE22006-052012-082009-04
NCT00326911Cetuximab and Bevacizumab With or Without Gemcitabine to Treat Metastatic Pancreatic CancerTERMINATEDPHASE22006-052008-122008-10
NCT00337662Efficacy Study of Early Onset of Antipsychotic Drug Action in SchizophreniaCOMPLETEDPHASE42006-052007-122007-12
NCT00329082Effects of LY2062430 in Subjects With Mild-to-Moderate Alzheimer's Disease and in Healthy VolunteersCOMPLETEDPHASE22006-052008-052008-05
NCT00325364Study of Human Insulin Inhalation Powder in Patients With Type 2 DiabetesCOMPLETEDPHASE32006-042008-052008-05
NCT00320489Olanzapine Pamoate Depot Versus Oral Olanzapine on Treatment Outcomes in Outpatients With SchizophreniaCOMPLETEDPHASE32006-042009-092009-09
NCT00785941A Study of IMC-A12 Every 2 Weeks in Patients With Tumors Who No Longer Respond to Treatment or No Treatment is AvailableCOMPLETEDPHASE12006-042007-112007-10
NCT00322621Maintenance of Effect of Duloxetine in Patients With Diabetic Peripheral Neuropathic Pain (DPNP)COMPLETEDPHASE42006-042007-102007-10
NCT00320528Efficacy of Atomoxetine on Psychosocial Function of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)COMPLETEDPHASE32006-042008-102008-10
NCT00316199Efficacy Study of Gemcitabine-Paclitaxel to Treat Metastatic Breast CancerCOMPLETEDPHASE22006-042008-042008-04
NCT00316238A Study Using Rapid Acting Intramuscular Olanzapine in Agitated Patients With SchizophreniaCOMPLETEDPHASE22006-042007-05
NCT00308282A Multi-Site Study to Evaluate the Safety and Effect of Study Drug on Participants With Rheumatoid ArthritisCOMPLETEDPHASE22006-03-282007-10-182007-06-18
NCT00308750First Line Chemotherapy Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)COMPLETEDPHASE22006-032009-072009-07
NCT00309140An Open Label Study of Oral Enzastaurin in Participants With CancerCOMPLETEDPHASE22006-032009-072009-07
NCT00303602Comparing the Effect of Under the Tongue Olanzapine Versus Swallowed Olanzapine on Body Mass Index (A Ratio of Weight to Height)COMPLETEDPHASE42006-032007-122007-12
NCT00786383Study of IMC-1121B in Patients With Advanced Solid Tumors Not Responding To Standard TherapyCOMPLETEDPHASE12006-022009-012009-01
NCT00295815Enzastaurin Versus Lomustine in GlioblastomaCOMPLETEDPHASE32006-012014-052007-08
NCT01682187A Dose-Escalation Study in Participants With Recurrent Malignant GliomaCOMPLETEDPHASE12005-12-152024-09-302012-05-22
NCT00267020Phase 2 Study of Gemcitabine or Gemcitabine + Enzastaurin in Participants With Advanced or Metastatic Pancreatic CancerCOMPLETEDPHASE22005-122008-052008-05
NCT00266656Long-Term Growth and Skeletal Effects of Early Growth Hormone Treatment in Turner SyndromeCOMPLETEDPHASE42005-122015-092015-09
NCT00269152Feasibility Study of Pemetrexed in Combination With Cisplatin or Carboplatin as Adjuvant Treatment of Non-Small Cell Lung CancerCOMPLETEDPHASE22005-122013-072007-11
NCT00529100Concurrent Pemetrexed, Cisplatin and Radiation Therapy in Patients With Stage IIIA/B Non Small Cell Lung CancerCOMPLETEDPHASE1, PHASE22005-122012-092010-08
NCT00549302Study the Safety and Effectiveness of Tadalafil on High Blood Pressure in the Blood Vessel Going From the Heart to the LungsCOMPLETEDPHASE32005-122012-022012-02
NCT00279201The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes (IOOV)COMPLETEDPHASE42005-122009-112009-11
NCT00266643Tolerability of Switching to Duloxetine for the Management of Diabetic Nerve PainCOMPLETEDPHASE42005-122007-04
NCT00380744A Safety and Pharmacokinetics Study in Participants With Rheumatoid ArthritisCOMPLETEDPHASE1, PHASE22005-112007-112007-11
NCT00266630Efficacy and Safety of Olanzapine in the Extended Treatment for Manic or Mixed Episode of Bipolar I DisorderCOMPLETEDPHASE32005-112009-052009-05
NCT00259298Evaluation of the Effects of Teriparatide on Skeleton Images in Postmenopausal Women With OsteoporosisCOMPLETEDPHASE42005-112009-072009-07
NCT00279214Hemodynamic and Perfusion Response to Drotrecogin Alfa (Activated) in Patients With Septic ShockCOMPLETEDPHASE42005-112007-11
NCT00259285Pemetrexed and Cisplatin Treatment Before Surgery in Non Small Cell Lung CancerTERMINATEDPHASE22005-112007-122007-12
NCT00259272Validation of Multidimensional Assessment of THYmic States (MATHYS): A Study in a Population of Bipolar Patients Treated With OlanzapineCOMPLETEDPHASE32005-112008-052008-05
NCT00259311Efficacy Study of LY2422347 to Treat InsomniaCOMPLETEDPHASE22005-112006-11
NCT00785538A Study of IMC-A12 in Participants With Tumors Who No Longer Respond to Treatment or For Whom No Treatment is AvailableCOMPLETEDPHASE12005-102011-012011-01
NCT00362102A Phase II Study of Cetuximab Plus Irinotecan in Patients With EGFR-detectable Metastatic Colorectal CarcinomaCOMPLETEDPHASE22005-102006-072006-07
NCT00251550Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural MesotheliomaCOMPLETEDPHASE1, PHASE22005-102006-08
NCT00244322Effects of LY450139 Dihydrate on Subjects With Mild to Moderate Alzheimer's DiseaseCOMPLETEDPHASE22005-102006-12
NCT00244296To Determine How Effective Duloxetine is in Treating Women 65 Years and Older With Symptoms of Stress Urinary Incontinence, or With a Combination of Stress Urinary Incontinence and Urge Urinary Incontinence SymptomsCOMPLETEDPHASE42005-102007-01
NCT00207116An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastatic Non Small Cell Lung CarcinomaCOMPLETEDPHASE12005-092006-032006-03
NCT00149214Preoperative Treatment of Breast Cancer With Two Different Sequential Treatment RegimensCOMPLETEDPHASE22005-092011-032008-02
NCT00236899Phase III Study of Two Different Schedules (Weekly and Tri-weekly) of Combination of Gemcitabine and Two Taxanes in MBCCOMPLETEDPHASE32005-092010-082010-08
NCT00157326Tadalafil in Subjects With Mild to Moderate HypertensionCOMPLETEDPHASE22005-092006-06
NCT00233025Duloxetine Versus Placebo in the Treatment of FMSCOMPLETEDPHASE32005-092007-06
NCT00231725Complaints Associated With Use of Pre-Filled Pen B With Type 2 Diabetics on Twice-Daily InsulinCOMPLETEDPHASE32005-092006-04
NCT00239629Teriparatide and Strontium Ranelate Head-To-Head Comparison TrialCOMPLETEDPHASE42005-092007-01
NCT00216918Neuropsychological Functioning in Children With Attention-Deficit/Hyperactivity Disorder.COMPLETEDPHASE42005-092006-06
NCT00192114Enzastaurin for Patients With Metastatic Colorectal CancerCOMPLETEDPHASE22005-082008-032008-03
NCT00157339Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPDCOMPLETEDPHASE32005-082008-052008-05
NCT00110357Study of Erbitux™ (Cetuximab) in Pediatric Patients With Refractory Solid TumorsCOMPLETEDPHASE12005-082008-032008-03
NCT00207077Study of Cetuximab in Combination With Tarceva in Patients With Solid TumorsCOMPLETEDPHASE12005-082007-052007-05
NCT00125918PHIRST-1: Tadalafil in the Treatment of Pulmonary Arterial HypertensionCOMPLETEDPHASE32005-082007-082007-08
NCT00127634Study of Human Insulin Inhalation Powder in Patients With Type 1 DiabetesCOMPLETEDPHASE32005-072008-052008-05
NCT00489359Trial of Pemetrexed and Carboplatin in Patients With Recurrent Ovarian or Primary Peritoneal CancerCOMPLETEDPHASE1, PHASE22005-072010-022010-02
NCT00129220Trial of Olanzapine in Patients With Manic or Mixed Episode of Bipolar I DisorderCOMPLETEDPHASE32005-072009-012009-01
NCT00125892A Study of Duloxetine in the Treatment of FibromyalgiaCOMPLETEDPHASE32005-072007-03
NCT00133380A Study in People With High CholesterolCOMPLETEDPHASE22005-072006-09
NCT00116519A Study in People With Abnormal Fat Levels in the BloodCOMPLETEDPHASE22005-072006-10
NCT00191269Gemcitabine Monotherapy for Metastatic Breast Cancer After Anthracycline and Taxane RegimenCOMPLETEDPHASE22005-062010-032008-03
NCT00190671A Study of Pemetrexed and Cyclophosphamide Given Every 21 Days in Advanced Breast Cancer PatientsCOMPLETEDPHASE1, PHASE22005-062008-032008-03
NCT00190866Study of Duloxetine Versus Placebo in the Treatment of Fibromyalgia SyndromeCOMPLETEDPHASE32005-062007-06
NCT00113594Olanzapine Treated Adolescents With Schizophrenia or Bipolar I DisorderCOMPLETEDPHASE32005-062006-03
NCT00333281A Study of Visual Effects of Erectile Dysfunction Medications Dosed Daily for Six MonthsCOMPLETEDPHASE42005-062006-08
NCT00190879Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adults With ADHD and Comorbid Social Anxiety DisorderCOMPLETEDPHASE42005-062007-05
NCT00109096Study of Pemetrexed in the Treatment of Patients With Ovarian Cancer Who Have Failed Prior Platinum-Based ChemotherapyCOMPLETEDPHASE22005-062007-03
NCT00191308Molecular Profiling in Lung Cancer PatientsCOMPLETEDPHASE22005-052010-122008-07
NCT00191386Long-Term Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder (AD/HD)COMPLETEDPHASE32005-052009-082009-08
NCT00191945Efficacy and Safety of Atomoxetine in Children With Recent Diagnosis of Attention-Deficit/Hyperactivity Disorder (ADHD)COMPLETEDPHASE32005-052008-022008-02
NCT00191919A Randomized Double Blind Study Evaluating Duloxetine in Outpatients With MDD and PainCOMPLETEDPHASE32005-052006-05
NCT00191906Comparison of Atomoxetine and Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and/or Reading Disorder (RD)COMPLETEDPHASE42005-042007-122007-12
NCT00106002Pemetrexed as the First Treatment in Advanced or Metastatic Breast CancerCOMPLETEDPHASE22005-042007-122007-12
NCT00122837A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety DisorderCOMPLETEDPHASE32005-042007-01
NCT00191633Study of Atomoxetine in Children With ADHD to Assess Symptomatic and Functional OutcomesCOMPLETEDPHASE42005-042006-06
NCT00162318A Phase I Study of Cetuximab in Combination With Gefitinib in Patients With Advanced/Metastatic Non-Small Cell Lung CancerCOMPLETEDPHASE12005-032006-042006-04
NCT00102804Pemetrexed and Best Supportive Care Versus Placebo and Best Supportive Care in Non-Small Cell Lung Cancer (NSCLC)COMPLETEDPHASE32005-032013-122007-08
NCT00191854Gemcitabine Combinations in Metastatic Breast Cancer (MBC), 1st LineCOMPLETEDPHASE22005-032009-112008-08
NCT00105989Duloxetine Versus Placebo in the Prevention of Recurrence of Major Depressive DisorderCOMPLETEDPHASE32005-032008-012008-01
NCT00105092Enzastaurin as Second and Third-Line Treatment for Non-Small Cell Lung Cancer.COMPLETEDPHASE22005-032007-02
NCT00191594Open-Label Duloxetine Extension Phase in Patients Who Have Completed Previous Duloxetine TrialsCOMPLETEDPHASE32005-032006-08
NCT00191542Atomoxetine vs Placebo in the Treatment of ADHD in Swedish Children and AdolescentsCOMPLETEDPHASE32005-032006-08
NCT00191581Local Registration Trial in China Humalog Mix 50COMPLETEDPHASE32005-032006-04
NCT00190983A Trial for Patients With Advanced/Recurrent Cervical CancerCOMPLETEDPHASE22005-022007-102007-10
NCT00191295Atomoxetine Versus Placebo in Children With Attention Deficit/Hyperactivity Disorder (ADHD)COMPLETEDPHASE2, PHASE32005-022006-09
NCT00191867Clinical Trial of Teriparatide in JapanCOMPLETEDPHASE22005-022006-03
NCT00112346Study of Gemcitabine/Platinum +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung CancerCOMPLETEDPHASE22005-012006-122006-12
NCT00793975Study of IMC-1121B in Patients With Tumors That Have Not Responded to TherapyCOMPLETEDPHASE12005-012009-062009-06
NCT00095199Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung CancerCOMPLETEDPHASE32005-012011-072011-07
NCT00191412A Study of Pemetrexed in the Treatment of Patients With Advanced Metastatic Cancer of the LiverCOMPLETEDPHASE22005-012006-03
NCT00122863Duloxetine Compared With Placebo in the Prevention of Relapse in Generalized Anxiety DisorderCOMPLETEDPHASE32005-012007-03
NCT00191503Gemcitabine and Pemetrexed in Primary Unknown AdenocarcinomaCOMPLETEDPHASE22005-012005-11
NCT00190853Biomechanical and Electrophysiological Effects of Duloxetine in the Treatment of Women With Urinary Stress IncontinenceCOMPLETEDPHASE32005-012006-09
NCT00112294Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung CancerCOMPLETEDPHASE32004-122008-082007-04
NCT00869726A Study for Patients With Secondary Progressive Multiple SclerosisCOMPLETEDPHASE2, PHASE32004-122009-052009-05
NCT00191334Gemcitabine in Ovarian CancerCOMPLETEDPHASE22004-122007-122007-12
NCT00190944Effects of Teriparatide on Distal Radius Fracture HealingCOMPLETEDPHASE22004-122007-06
NCT00191022Comparison of LY686017 With a Marketed Drug in the Treatment of Social Anxiety DisorderCOMPLETEDPHASE22004-122007-01
NCT00101842Gemcitabine and Platinol Followed by Pemetrexed and Gemcitabine in Patients With Advanced or Metastatic Bladder CancerCOMPLETEDPHASE1, PHASE22004-122006-07
NCT00162110A Trial of Erbitux for Recurrent and Metastatic Mucinous Gastrointestinal Adenocarcinoma Involving the Peritoneal SurfacesCOMPLETEDPHASE22004-112007-012007-01
NCT00801177Study of IMC-11F8 in Patients With Tumors Who Have Not Responded to Standard TherapyCOMPLETEDPHASE12004-112007-022007-02
NCT00097591A Comparison of Prasugrel (CS-747) and Clopidogrel in Acute Coronary Syndrome Subjects Who Are to Undergo Percutaneous Coronary InterventionCOMPLETEDPHASE32004-112007-072007-07
NCT00082212A Study in Patients With Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal CarcinomaTERMINATEDPHASE22004-112007-062007-06
NCT00097214Carboplatin Plus Cetuximab for Treatment of Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)COMPLETEDPHASE22004-112007-042007-04
NCT00097227Trial of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)COMPLETEDPHASE22004-112007-042007-04
NCT00099515Comparing Intensive and Standard Training for Human Insulin Inhalation Powder (HIIP)COMPLETEDPHASE22004-112005-09
NCT00079924Effects of Teriparatide in Postmenopausal Women With OsteoporosisCOMPLETEDPHASE42004-112007-05
NCT00083720Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to ChemotherapyCOMPLETEDPHASE22004-102008-042008-04
NCT00191191To Investigate Efficacy and Safety of Pemetrexed as Second or Third Line Therapy in Patients With Non-small Cell Lung Cancer (NSCLC)COMPLETEDPHASE22004-102008-102008-10
NCT00192023An Italian Study of the Efficacy of Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) and Comorbid Oppositional Defiant Disorder (ODD).COMPLETEDPHASE32004-102008-052006-08
NCT00767715A Study in the Treatment of Acute ManiaTERMINATEDPHASE42004-102005-042005-04
NCT00102219A Study of Pemetrexed Plus Doxorubicin Given to Patients With Advanced Breast CancerCOMPLETEDPHASE22004-102007-10
NCT00122850A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety DisorderCOMPLETEDPHASE32004-102005-11
NCT00192101Gemcitabine Plus Cisplatin Single Dose Versus Split Dose in the Treatment of Patients With Locally Advanced or Metastatic Breast Cancer After Failure of Anthracyclines and/or TaxanesCOMPLETEDPHASE22004-102005-07
NCT00547625Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Sex Organ/Urinary Tract ProblemsCOMPLETEDPHASE22004-102005-07
NCT00547183Study the Safety and Effectiveness of Tadalafil in Men With Diabetes Who Have Problems Getting and Keeping an ErectionCOMPLETEDPHASE32004-102005-05
NCT00422578Effect of Tadalafil on the Quality of Life and Sexual Life in Erectile DysfunctionCOMPLETEDPHASE42004-102005-09
NCT00191737An Open-Label Study of Atomoxetine in Adolescents With Attention-Deficit/Hyperactivity DisorderCOMPLETEDPHASE32004-102006-02
NCT00094549Olanzapine vs. Comparator and Placebo in the Treatment of Patients With Bipolar I DisorderCOMPLETEDPHASE42004-102006-12
NCT00191516An Open-Label Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity DisorderCOMPLETEDPHASE32004-102006-02
NCT00191347A Study of Biweekly Pemetrexed and Gemcitabine in Patients With Metastatic Breast CancerCOMPLETEDPHASE22004-102005-11
NCT00191061A Comparison of Tolerability and Efficacy of Different Doses of Duloxetine for the Treatment of Major Depressive DisorderCOMPLETEDPHASE42004-102006-01
NCT00191997Optimal Length of Treatment Continuation With Olanzapine After Remission of Manic or Mixed EpisodeCOMPLETEDPHASE42004-102006-03
NCT00190775A Randomized, Double-Blind Comparison of Placebo and Atomoxetine Hydrochloride Given Once a Day in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)COMPLETEDPHASE42004-092009-102009-07
NCT00461786A Study of Single Agent Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal CancerCOMPLETEDPHASE22004-092008-052007-10
NCT00191724Adjuvant Treatment of Pulmonary Embolism With Drotrecogin Alfa (Activated): Phase II Exploratory StudyCOMPLETEDPHASE22004-092008-012008-01
NCT00190736Efficacy and Safety of Once-Daily Atomoxetine Hydrochloride in Adults With ADHD Over an Extended Period of Time (6 Months)COMPLETEDPHASE42004-092006-09
NCT00421083Efficacy and Safety of Tadalafil in Subjects With Erectile Dysfunction Caused by Spinal Cord InjuryCOMPLETEDPHASE32004-092005-06
NCT00190892Olanzapine Plus Carbamazepine in the Treatment of Bipolar I ManiaCOMPLETEDPHASE42004-092006-06
NCT00088465Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective DisorderCOMPLETEDPHASE32004-082010-122010-12
NCT00192036Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung CancerCOMPLETEDPHASE22004-082009-112008-01
NCT00190957Atomoxetine Treatment of Adults With ADHD and Comorbid Alcohol AbuseCOMPLETEDPHASE42004-082006-01
NCT00479726Lilly's Emotional and Physical Symptoms of Depression Study (LEAPS)COMPLETEDPHASE42004-082005-01
NCT00475969Duloxetine vs Placebo in the Treatment of General AnxietyCOMPLETEDPHASE32004-082005-06
NCT00191932Switching to Duloxetine From Other AntidepressantsCOMPLETEDPHASE42004-082006-03
NCT00087711A Randomized Phase 3 Trial of Pemetrexed and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Locally Advanced or Metastatic Non Small Cell Lung CancerCOMPLETEDPHASE32004-072008-032007-01
NCT00090012Comparison of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia and Schizoaffective DisorderCOMPLETEDPHASE42004-072006-03
NCT00103571Olanzapine Versus Aripiprazole in the Treatment of Acutely Ill Patients With SchizophreniaCOMPLETEDPHASE42004-072006-08
NCT00192062A Trial of Gemcitabine Combined With Vinorelbine as First Line Chemotherapy for Metastatic Breast CancerCOMPLETEDPHASE22004-072007-06
NCT00485901Comparison of Intramuscular Olanzapine and Intramuscular Haloperidol in Patients With SchizophreniaCOMPLETEDPHASE32004-072005-01
NCT00386581Efficacy, Tolerability, and Safety of Once-Daily Atomoxetine Hydrochloride Versus Placebo in Russian Children and Adolescents With Attention-Deficit/Hyperactivity DisorderCOMPLETEDPHASE32004-072005-02
NCT00191321Teriparatide Use in Hip Replaced SubjectsCOMPLETEDPHASE32004-072005-12
NCT00191750A Study of Pemetrexed in Small Cell Lung Cancer, Which Has ReturnedCOMPLETEDPHASE22004-072006-09
NCT00191984A Study of the Combination of Pemetrexed and Irinotecan Every Two Weeks in Metastatic Colorectal CancerCOMPLETEDPHASE22004-062008-052007-02
NCT00088010Effects of Arzoxifene on Bone Fractures and Incidence of Breast CancerCOMPLETEDPHASE32004-062009-112009-06
NCT00122824Duloxetine Compared With Placebo in Patients With Generalized Anxiety DisorderCOMPLETEDPHASE32004-062005-09
NCT00190788Extended Therapy of Drotrecogin Alfa (Activated) 4 vs 7 Days InfusionCOMPLETEDPHASE32004-062007-05
NCT00547352Study to Determine a Preference Between Sildenafil or Tadalafil Treatment for Problems Getting an ErectionCOMPLETEDPHASE42004-062005-06
NCT00088491Comparison of Intramuscular Olanzapine Depot to Oral Olanzapine and Low-Dose Depot in Patients With SchizophreniaCOMPLETEDPHASE32004-062006-10
NCT00088478Comparison of Intramuscular Olanzapine Depot With Placebo in the Treatment of Patients With SchizophreniaCOMPLETEDPHASE32004-062005-04
NCT00485810Examining Rapid Acting Intra-Muscular Olanzapine in Japanese Patients With SchizophreniaCOMPLETEDPHASE1, PHASE22004-062004-11
NCT00485875Safety and Efficacy of Switching From a Stimulant Medication to Atomoxetine in Children and Adolescents With ADHDCOMPLETEDPHASE42004-062005-01
NCT00191659Study of Broader Efficacy of Atomoxetine in the Treatment of ADHD in Children/AdolescentsCOMPLETEDPHASE32004-062006-04
NCT00192088A Study of Pemetrexed Plus Oxaliplatin as First Line Therapy in Advanced Gastric CarcinomaCOMPLETEDPHASE22004-052006-05
NCT00191399Bipolar Depression Study: Bipolar Depression Assessment Study on Treatment ResponseCOMPLETEDPHASE42004-052006-03
NCT00191880Open-Label Trial of Atomoxetine to Evaluate Academic Outcome in Children Ages 8-11 Years With Attention Deficit/Hyperactivity DisorderCOMPLETEDPHASE32004-052006-06
NCT00191685Duloxetine in the Treatment of Melancholic DepressionCOMPLETEDPHASE32004-052005-09
NCT00191451A Study of Gemcitabine and Carboplatin (Plus Herceptin in Human Epidermal Growth Factor Receptor 2 Positive [HER2+] Patients) With Metastatic Breast CancerCOMPLETEDPHASE22004-042008-102008-10
NCT00110370Comparing Pre-Mixed Insulin With Insulin Glargine Combined With Rapid-Acting Insulin in Patients With Type 2 DiabetesCOMPLETEDPHASE42004-042006-04
NCT00085956Effects of Arzoxifene on Bone Mass and the UterusCOMPLETEDPHASE32004-042007-02
NCT00088205Oral Enzastaurin in Participants With Relapsed Mantle Cell LymphomaCOMPLETEDPHASE22004-032008-052008-05
NCT00320515Study of Pemetrexed Plus Cisplatin in Advanced Gastric CancerCOMPLETEDPHASE1, PHASE22004-032008-072008-07
NCT00191165Efficacy and Safety of a High Dosage Compared to the Label Dosage of Somatropin in Early Pubertal Stage Children With Growth Hormone DeficiencyCOMPLETEDPHASE32004-032008-042008-04
NCT00190710A Trial of Carboplatin and Gemcitabine Versus Gemcitabine Alone in Patients With Non-Small-Cell Lung CancerCOMPLETEDPHASE32004-032007-08
NCT00547495Study the Safety and Effectiveness of Tadalafil in Men With Problems Getting or Maintaining an Erection When Taken Prior to Desiring an ErectionCOMPLETEDPHASE32004-032004-11
NCT00191620Study Comparing Short Infusion Vs. Fixed Dose of Cisplatin + Gemcitabine in Non Small Cell Lung Cancer.COMPLETEDPHASE22004-032006-05
NCT00191035Maintenance of Benefit With Atomoxetine Hydrochloride in Adolescents With ADHDCOMPLETEDPHASE42004-032006-11
NCT00091650Olanzapine in Patients With Borderline Personality DisorderCOMPLETEDPHASE32004-032005-11
NCT00079872Pemetrexed Plus a Comparator Versus a Combination of 2 Comparators in First-Line Treatment of Colorectal CancerCOMPLETEDPHASE22004-022006-05
NCT00485459Atomoxetine Hydrochloride Versus Placebo in Taiwanese Children and Adolescents With ADHDCOMPLETEDPHASE32004-022004-11
NCT00494377Duloxetine Versus Duloxetine Plus Non-Drug Therapy for DepressionCOMPLETEDPHASE42004-022005-06
NCT00485849A Study of Atomoxetine for Attention Deficit and Hyperactive/Impulsive Behaviour Problems in Children With ASDCOMPLETEDPHASE42004-022004-10
NCT00191711Intravesical Gemcitabine Instillation Followed by Transurethral Resection for the Treatment of Patients With Superficial Bladder Cancer at Low Risk.COMPLETEDPHASE22004-022005-10
NCT00190905Safety and Effectiveness Study of Duloxetine HCl in Women of Different Backgrounds With Stress Urinary Incontinence Who May Also Have Other Various Medical Conditions.COMPLETEDPHASE42004-022005-07
NCT00088036Efficacy and Safety of Olanzapine in Patients With Borderline Personality DisorderCOMPLETEDPHASE32004-022006-01
NCT00191477Instillation of Gemcitabine in Patients With Superficial Bladder CancerTERMINATEDPHASE32004-012008-062008-03
NCT001919712nd Line Gemcitabine Monotherapy for Transitional Cell Carcinoma of Urothelium (TCC) After CDDP RegimenCOMPLETEDPHASE22004-012006-09
NCT00485550Comparison of Atomoxetine Plus Either Comparator or Placebo in Children With ADHD Who Haven't Responded to Stimulant TherapyCOMPLETEDPHASE32004-012005-03
NCT00489775Duloxetine Versus Paroxetine for Major DepressionCOMPLETEDPHASE32004-012005-06
NCT00078260A Comparison of Two Doses of Pemetrexed in Patients Who Have Lung CancerCOMPLETEDPHASE32003-122008-042006-10
NCT00207155An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal CancerCOMPLETEDPHASE12003-122006-022006-02
NCT00191464Long-Term Effects of Insulin Plus Metformin Regimens on the Overall and Postprandial Glycemic Control of Patients With Type 2 DiabetesCOMPLETEDPHASE42003-122005-09
NCT00191698Comparison of Atomoxetine and Placebo in Children and Adolescents With ADHD and ODDCOMPLETEDPHASE32003-122007-112005-06
NCT00074828New Oral Anticoagulant Therapy for the Prevention of Blood Clots Following Hip or Knee Replacement SurgeryCOMPLETEDPHASE22003-122005-05
NCT00486083Comparison Atomoxetine Hydrochloride and Comparator in Pediatric Outpatients With ADHDCOMPLETEDPHASE32003-122004-10
NCT00485680Olanzapine Versus Comparator in the Treatment of Bipolar DisorderCOMPLETEDPHASE32003-122005-06
NCT00475397Duloxetine Stress Urinary Incontinence Efficacy and Safety StudyCOMPLETEDPHASE32003-122004-10
NCT00192049A Randomized Study Comparing Single Agent Gemcitabine Intravesical Therapy Versus Mitomycin C in Patients With Intermediate Risk Superficial Bladder CancerCOMPLETEDPHASE22003-122007-04
NCT00191672A Trial Of Gemcitabine Plus Paclitaxel And Gemcitabine Plus Docetaxel In Metastatic Breast CancerCOMPLETEDPHASE22003-122006-11
NCT00071136Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)COMPLETEDPHASE1, PHASE22003-122006-08
NCT00382135A Study of Semen Characteristics After 9 Months of Daily Tadalafil 20 mgCOMPLETEDPHASE42003-112005-12
NCT00532207Study of Teriparatide in the Treatment of Postmenopausal Women With OsteoporosisCOMPLETEDPHASE32003-112004-12
NCT00073411Duloxetine Compared to Escitalopram and Placebo in the Treatment of Patients With DepressionCOMPLETEDPHASE32003-112005-05
NCT00485771Olanzapine/Fluoxetine Combination Versus Comparator in the Treatment of Bipolar I DepressionCOMPLETEDPHASE42003-112005-01
NCT00490880Neoadjuvant Chemo (Gemcitabine and Cisplatin) With Radical Cystectomy or Radiotherapy in Patients With Bladder CancerCOMPLETEDPHASE22003-112004-08
NCT00190931A Functional Outcomes Study With Atomoxetine-Hydrochloride and Placebo in Adults With Attention-Deficit/Hyperactivity DisorderCOMPLETEDPHASE42003-112005-07
NCT00190749Safety Study of Olanzapine and a Comparator in Patients With Schizophrenia and Schizoaffective DisorderCOMPLETEDPHASE42003-102008-062008-06
NCT00381732A Study to Evaluate the Efficacy and Safety of 2.5mg and 5mg Tadalafil Given Once a Day to Men With Erectile DysfunctionCOMPLETEDPHASE32003-102006-06
NCT00191009Adding Atomoxetine To Standard Medication Treatment In Patients With Alzheimer's DiseaseCOMPLETEDPHASE2, PHASE32003-102006-01
NCT00547092Study For Which Treatment, Tadalafil or Sildenafil, is Preferred For Problems Getting or Maintaining an ErectionCOMPLETEDPHASE42003-102004-11
NCT00088049Study of Olanzapine vs. Aripiprazole in the Treatment of SchizophreniaCOMPLETEDPHASE42003-102007-07
NCT00490373Trial of Pemetrexed for Patients With Pancreatic Cancer Which Cannot be Treated With Surgery or is MetastaticCOMPLETEDPHASE22003-102005-04
NCT00191048Treatment With Atomoxetine Hydrochloride in Children and Adolescents With ADHDCOMPLETEDPHASE42003-102006-03
NCT00063401Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube CancerCOMPLETEDPHASE22003-092006-062006-06
NCT00087698Phase II Trial of Neo-Adjuvant Pemetrexed Plus Cisplatin Followed by Surgery and Radiation for Pleural MesotheliomaCOMPLETEDPHASE22003-092008-022008-02
NCT00069875A Study With Gemcitabine, Cisplatin, and LY293111 in Non-Small Cell Lung CancerCOMPLETEDPHASE22003-092005-12
NCT00486122Evaluation of Continuous Symptom Treatment of ADHDCOMPLETEDPHASE42003-092004-06
NCT00490659Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose Gemcitabine) in Patients With Lung Cancer With Positive NodesCOMPLETEDPHASE22003-092004-12
NCT00191893Bone Effects of Teriparatide Following AlendronateCOMPLETEDPHASE32003-092006-11
NCT00190801Phase 2 Study on Use of a Combination of Pemetrexed in Patients With Advanced Gastric CarcinomaCOMPLETEDPHASE22003-092005-09
NCT00190840A Single Arm Phase 2 Study of Pemetrexed as 2nd-Line Treatment of Advanced Non-Small Cell Lung CancerCOMPLETEDPHASE22003-092005-10
NCT00100776Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective DisorderCOMPLETEDPHASE42003-092005-11
NCT00190827Effectiveness of Duloxetine in the Treatment of Stress Urinary Incontinence(Uncontrolled Leakage of Urine)COMPLETEDPHASE32003-092006-05
NCT00190814Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Due to Physical Stress and Urge.COMPLETEDPHASE32003-092006-05
NCT00191802Compliance and Acceptance of Teriparatide Injection in Severely Osteoporotic PatientsCOMPLETEDPHASE32003-092005-10
NCT00191178Effects of Insulin in Perceived Mood Symptoms in Patients With Type 2 DiabetesCOMPLETEDPHASE42003-082005-07
NCT00542984Comparison Medications in the Treatment of Postmenopausal Women With OsteoporosisCOMPLETEDPHASE32003-082004-11
NCT00191555Efficacy Study of Switching Stabilized Schizophrenic Patients From Conventional to Atypical Antipsychotic TreatmentCOMPLETEDPHASE42003-082006-05
NCT00063570Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane TherapyCOMPLETEDPHASE22003-072008-012008-01
NCT00547417To Determine Effect and Safety of Tadalafil Taken by Men of Different Races and With Different Diseases When Needed for ErectionsCOMPLETEDPHASE32003-072004-03
NCT00489983Trial of Pemetrexed or Pemetrexed With Gemcitabine for Patients With Advanced Lung Cancer Who Are Not Eligible for Platinum-Based Chemotherapy and Have Not Previously Been Treated With ChemotherapyCOMPLETEDPHASE22003-072005-03
NCT00491114Intravesical Chemotherapy Treatment of Superficial Bladder CancerCOMPLETEDPHASE22003-072004-08
NCT00485407Guiding Dose Increases in Patients Incompletely Responsive to Usual Doses of AtomoxetineCOMPLETEDPHASE32003-072005-06
NCT00490711Treatment of Paclitaxel Plus Carboplatin Followed by Gemcitabine Plus Carboplatin for Patients With Epithelial Ovarian CancerCOMPLETEDPHASE22003-072005-04
NCT00071695Duloxetine vs. Active Comparator in the Treatment of Patients With DepressionCOMPLETEDPHASE42003-072004-05
NCT00192075A Randomized Trial of Avastin + Gemcitabine + 5-Fluorouracil (5FU)/Folinic Acid Versus Avastin + Oxaliplatin + 5FU/Folinic Acid in Metastatic Colorectal CancerCOMPLETEDPHASE22003-062007-11
NCT00543023A Study of the Treatment of Postmenopausal Women With OsteoporosisCOMPLETEDPHASE32003-062004-08
NCT00485862Combination Therapy in Patients With DepressionCOMPLETEDPHASE42003-062005-01
NCT00072865Pemetrexed and Carboplatin in Locally Advanced or Metastatic Breast CancerCOMPLETEDPHASE22003-062005-09
NCT0055153824 Hour Plasma Glucose Profiles Comparing Lispro Mix 75/25 vs. GlargineCOMPLETEDPHASE42003-052004-12
NCT00063388Phase II Study in Patients With Recurrent Non-Small-Cell Lung CancerCOMPLETEDPHASE22003-052005-062005-06
NCT00065533Pemetrexed as First Line Chemotherapy for Advanced Breast CancerCOMPLETEDPHASE22003-052005-06
NCT00059215A Trial of CS-747 (Prasugrel) Compared With Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention (PCI)COMPLETEDPHASE22003-042004-012004-01
NCT00063141Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal CancerCOMPLETEDPHASE32003-042007-102006-06
NCT00063128Safety and Efficacy of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus.COMPLETEDPHASE22003-042004-04
NCT00547599Determine If the Stress That Comes With Not Developing an Erection Affects Tadalafil EffectsCOMPLETEDPHASE42003-042004-01
NCT00547573Determine Safety and Effectiveness of Tadalafil in Asian Men When Taken as Needed for Getting and Keeping an ErectionCOMPLETEDPHASE32003-042003-12
NCT00532545Bone Marker Changes With Teriparatide/Postmenopausal OsteoporosisCOMPLETEDPHASE42003-042004-04
NCT00532428Long Term Effects of Raloxifene Treatment on Bone QualityCOMPLETEDPHASE42003-042003-09
NCT00491127Cisplatin With Gemcitabine With Dexamethasone in Patients With Aggressive Non-Hodgkin's LymphomaCOMPLETEDPHASE22003-042004-06
NCT00485628Safety Study in Outpatient Japanese Children With ADHDCOMPLETEDPHASE22003-042003-10
NCT00485498Managing Acute Schizophrenia, a Comparison Between Two Atypical AntipsychoticsCOMPLETEDPHASE42003-042003-12
NCT00475358Efficacy and Safety Stress Urinary Incontinence StudyCOMPLETEDPHASE32003-042005-02
NCT00067912Duloxetine vs. Active Comparator for the Treatment of DepressionCOMPLETEDPHASE42003-042004-03
NCT00061815Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal CancerCOMPLETEDPHASE32003-032005-112004-12
NCT00191139Gemcitabine or Gemcitabine Plus Docetaxel After Cisplatin, Etoposide and Radiation in Non Small Cell Lung Cancer (NSCLC)COMPLETEDPHASE22003-032009-022008-11
NCT00067730A Safety Evaluation of Drotrecogin Alfa (Activated) in Patients With Blood Cancer, Severe Infection Related to Bone Marrow TransplantationCOMPLETEDPHASE42003-032003-10
NCT00532246Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene or PlaceboCOMPLETEDPHASE42003-032003-08
NCT00490399Trial of Gemcitabine and Cisplatin in Patients With Inoperable Biliary Tract CarcinomasCOMPLETEDPHASE22003-032004-09
NCT00062673Study of Duloxetine in Elderly Patients With Major Depressive DisorderCOMPLETEDPHASE32003-032004-07
NCT00191828A Study on Induced Weight Gain During Atypical Antipsychotic Treatment and Its Management With Psychoeducational ProgrammeCOMPLETEDPHASE42003-032005-08
NCT00191789Neoadjuvant Sequential Administration of Two Gemcitabine Combinations in Operable Breast CancerCOMPLETEDPHASE22003-022009-042009-04
NCT00055419A Study of Cetuximab in Patients Who Have Stage IV Colorectal CancerCOMPLETEDPHASE22003-022004-082004-07
NCT00050609Study of Tadalafil for the Treatment of Diabetic Patients With Symptoms of Upset Stomach and Delayed Stomach EmptyingCOMPLETEDPHASE22003-022003-09
NCT00486005Weight Gain Management in Patients With SchizophreniaCOMPLETEDPHASE42003-022003-10
NCT00061464Pemetrexed Plus Gemcitabine for Patients With Locally Advanced or Metastatic NSCLC Who Have Not Had Previous Chemotherapy.COMPLETEDPHASE22003-022006-02
NCT00568893An Open Label Study of Severe Sepsis in AdultsCOMPLETEDPHASE42003-012003-10
NCT00191360Extension Study on Safety of Long-Term Growth Hormone Replacement in Adult Patients With Growth Hormone DeficiencyCOMPLETEDPHASE32003-012006-05
NCT00489996Trial Comparing 3 and 4 Week Regimen of Gemcitabine and Cisplatin in Patients With Lung CancerCOMPLETEDPHASE22003-012005-06
NCT00055250A Study With LY293111, Gemcitabine and Placebo in Patients With Pancreatic CancerCOMPLETEDPHASE22003-012005-10
NCT00190996Evaluate Safety and Efficacy of Duloxetine in Predominant Stress Urinary IncontinenceCOMPLETEDPHASE32003-012006-06
NCT00061451Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Clinical TrialCOMPLETEDPHASE22002-122006-09
NCT00543218PTH Comparison in Post Menopausal WomenCOMPLETEDPHASE32002-122004-06
NCT00191529Growth Hormone Treatment in Short Children Born Small for Gestational AgeCOMPLETEDPHASE32002-122007-06
NCT00485823Assessment of a Weight Management Program for Weight Gain in Patients With SchizophreniaCOMPLETEDPHASE42002-122003-09
NCT00049777A Trial of Heparin in Patients With Severe Sepsis Who Are Undergoing Treatment With Drotrecogin Alfa (Activated)COMPLETEDPHASE42002-122005-08
NCT00061477Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal MesotheliomaCOMPLETEDPHASE22002-122006-09
NCT00191841Gemcitabine in Combination With Cisplatin as Neoadjuvant NSCLC ChemotherapyCOMPLETEDPHASE22002-122006-02
NCT00042562Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major DepressionCOMPLETEDPHASE32002-122003-12
NCT00051558Comparison of Teriparatide With Alendronate for Treating Glucocorticoid-Induced OsteoporosisCOMPLETEDPHASE32002-112008-012006-07
NCT00568737The Study of Drotrecogin Alfa (Activated) in Adult Patients With Severe Sepsis at a Low Risk of DeathCOMPLETEDPHASE32002-112005-02
NCT00049764Investigation of the Efficacy and Safety of Drotrecogin Alfa (Activated) in Pediatric Severe SepsisCOMPLETEDPHASE32002-112005-04
NCT00191763Neo-Adjuvant Gemcitabine and Cisplatin in Treating Patients With Early Stage of Non Small Cell Lung CancerCOMPLETEDPHASE22002-112005-12
NCT00547287Studying the Preference of Tadalafil to Sildenafil in Men With Problems Getting an Erection Across NationsCOMPLETEDPHASE32002-112004-05
NCT00551356Lispro Mix 25 vs. Glargine in Type 2 DiabeticsCOMPLETEDPHASE32002-112003-07
NCT00489073Duloxetine Versus Placebo for FibromyalgiaCOMPLETEDPHASE32002-112003-12
NCT00051298Olanzapine Versus Placebo in the Treatment of Adolescents With SchizophreniaCOMPLETEDPHASE32002-112005-04
NCT00050206Olanzapine Versus Placebo in the Treatment of Mania in Adolescents With Bipolar I DisorderCOMPLETEDPHASE42002-112005-05
NCT00475696Urge Incontinence Bladder Overactivity StudyCOMPLETEDPHASE22002-112005-03
NCT00051909Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's DiseaseCOMPLETEDPHASE22002-112003-06
NCT00191646An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior ChemotherapyCOMPLETEDPHASE32002-102009-082009-08
NCT00191282Hyperglycemia and Cardiovascular Outcomes With Type 2 DiabetesCOMPLETEDPHASE42002-102007-102007-10
NCT00191815Combination Chemotherapy for Metastatic Breast CancerCOMPLETEDPHASE22002-102007-10
NCT00191568Gemcitabine, Oxaliplatin and Radiotherapy in Treating Patients With Completely Resected Pancreatic CancerCOMPLETEDPHASE22002-102007-05
NCT00547508To Determine How Different Doses of Tadalafil Work on Getting and Keeping an Erection 26 or 36 Hours After TakingCOMPLETEDPHASE32002-102003-09
NCT00191438Phase III Study of Gemcitabine Plus a Cytotoxic Agent Versus Two Cytotoxic AgentsCOMPLETEDPHASE32002-102007-03
NCT00058968A Study for the Treatment of Painful Diabetic NeuropathyCOMPLETEDPHASE32002-102005-03
NCT00190723A Study of LY317615 in Patients With Brain TumorsCOMPLETEDPHASE22002-102006-12
NCT00045760The Study of Drotrecogin Alfa (Activated) in a Subpopulation of Adult Patients With Severe SepsisCOMPLETEDPHASE42002-09
NCT00044863Study of Erbitux (Cetuximab) in Patients With Metastatic Colorectal CarcinomaCOMPLETEDPHASE22002-082005-122005-12
NCT001914252-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxifene or Calcium/Vit D in Severe Postmenopausal OsteoporosisCOMPLETEDPHASE42002-082005-11
NCT00044395Treatment for Symptomatic Peripheral Neuropathy in Patients With DiabetesCOMPLETEDPHASE32002-072005-10
NCT00044421Treatment of Peripheral Neuropathy in Patients With DiabetesCOMPLETEDPHASE32002-072006-10
NCT00191607A Randomized Trial for Patients With Platinum Resistant Ovarian, Fallopian or Primary Peritoneal Cancer.COMPLETEDPHASE32002-072005-11
NCT00191490A Randomized Study Evaluating the Feasibility and Activity of Three Different Combination With Gemcitabine as First Line Therapy for Non Small Cell Lung CancerCOMPLETEDPHASE22002-072005-05
NCT00042666A Study of Oral LY317615 in Relapsed or Refractory Diffuse Large B-Cell Lymphomas.COMPLETEDPHASE22002-062008-092008-09
NCT00042679A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer.COMPLETEDPHASE22002-06
NCT00042575Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major DepressionCOMPLETEDPHASE32002-062002-08
NCT00191100Comparative Study of Gemcitabine,Cisplatin and Radiation Versus Cisplatin and Radiation in Cancer of the CervixCOMPLETEDPHASE32002-052008-042008-04
NCT00036309Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive DisorderCOMPLETEDPHASE32002-052003-07
NCT00051493ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial.COMPLETEDPHASE22002-042002-12
NCT00035321The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant DepressionCOMPLETEDPHASE32002-042005-07
NCT00191243Docetaxel vs. Docetaxel-Gemcitabine in Breast CancerCOMPLETEDPHASE22002-032009-042007-08
NCT00034554Study of gp75 Vaccine in Patients With Stage III and IV MelanomaCOMPLETEDPHASE12002-032004-092004-09
NCT00191373A Trial for HER2 Positive Breast Cancer Patients With Metastatic DiseaseCOMPLETEDPHASE22002-032007-07
NCT00034268A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung CancerCOMPLETEDPHASE32002-03
NCT00036335Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and PainCOMPLETEDPHASE32002-032003-01
NCT00191152A Phase III Trial For Patients With Metastatic Breast CancerCOMPLETEDPHASE32002-022008-112008-11
NCT00332553Study of Hot Flashes and Night Sweats in Postmenopausal Women Receiving Combination Raloxifene and Oral EstrogenCOMPLETEDPHASE22002-022004-05
NCT00190606Efficacy and Safety of Duloxetine, Placebo and Pelvic Floor Muscle Training in Subjects With Stress Urinary IncontinenceCOMPLETEDPHASE22002-012006-04
NCT00035256Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenopausal Women With OsteoporosisCOMPLETEDPHASE42001-102005-07
NCT00190567Biomechanical Effects of Duloxetine on Bladder and Sphincter Muscle Function in Women in Pure Genuine Stress IncontinenceCOMPLETEDPHASE22001-102006-04
NCT00190762A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Alone in the Treatment of MesotheliomaCOMPLETEDPHASE32001-102005-11
NCT00034476A Phase IIb Study to Determine the Efficacy and Safety of the Study Drug in Patients With Severe SepsisCOMPLETEDPHASE1, PHASE22001-102002-10
NCT00191230Gemcitabine/Platinum Containing Regimens as Preoperative Chemotherapy for Patients With Non Small Cell Lung CancerCOMPLETEDPHASE22001-092006-07
NCT00191204Open Label Phase III Duloxetine Study for Stress Urinary IncontinenceCOMPLETEDPHASE32001-092006-05
NCT00034801Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With SchizophreniaCOMPLETEDPHASE42001-092003-03
NCT00036504Efficacy and Safety of Twice-Daily Insulin Lispro Low Mixture Compared to a Once-Daily Long Acting Insulin Comparator in Patients Who Have Been Using One or More Oral Antihyperglycemic Agents Without InsulinCOMPLETEDPHASE42001-082002-08
NCT00036062A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects With Acute Lung InjuryCOMPLETEDPHASE1, PHASE22001-082002-12
NCT00034580Olanzapine Versus Active Comparator in the Treatment of Bipolar I DisorderCOMPLETEDPHASE42001-082002-08
NCT00036088Olanzapine Versus An Active Comparator in the Treatment of SchizophreniaCOMPLETEDPHASE42001-082002-07
NCT00191256Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy in Non Small Cell Lung CancerCOMPLETEDPHASE22001-062006-07
NCT00190619Efficacy and Safety of DuloxetineCOMPLETEDPHASE32001-052006-05
NCT02416271The Forteo Alendronate Comparator TrialCOMPLETEDPHASE42001-042003-052003-05
NCT00191087Duloxetine in the Treatment of Stress Urinary Incontinence.COMPLETEDPHASE32001-042006-05
NCT00044187The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I DisorderCOMPLETEDPHASE42001-042003-09
NCT00190632To Evaluate the Safety in Patients Taking Duloxetine for Stress Urinary IncontinenceCOMPLETEDPHASE32001-032006-04
NCT00191074Amendment (g) Unblinded Extension Phase of Somatropin in Patients With Idiopathic Short StatureCOMPLETEDPHASE32001-022006-01
NCT00190645To Evaluate the Safety of Duloxetine in Patients With Stress Urinary IncontinenceCOMPLETEDPHASE32001-022006-05
NCT00190697A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue TreatmentCOMPLETEDPHASE42001-012007-04
NCT00034541Study of Cetuximab in Combination With Carboplatin-Paclitaxel in Non-Small Cell Lung CancerCOMPLETEDPHASE1, PHASE22000-122003-052003-05
NCT00191126Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Early Stages NSCLCCOMPLETEDPHASE32000-092007-092007-09
NCT00190684Long-Term, Open Label Atomoxetine StudyCOMPLETEDPHASE32000-082009-102009-10
NCT00006459Paclitaxel With or Without Gemcitabine in Treating Women With Advanced Breast CancerCOMPLETEDPHASE32000-072005-10
NCT00190658Somatropin Treatment in Patients With SHOX Deficiency and Turner SyndromeCOMPLETEDPHASE32000-022010-092004-07
NCT00406926The Effect of Growth Hormone in Very Young Girls With Turner SyndromeCOMPLETEDPHASE31999-082003-08
NCT00490191Comparison of Two Growth Hormone Dosing Methods in Adults With Growth Hormone DeficiencyCOMPLETEDPHASE41999-012001-07
NCT00003669Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Recurrent, Advanced, or Metastatic Endometrial CancerCOMPLETEDPHASE21998-112001-04
NCT00003670Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Metastatic Refractory Ovarian Cancer or Primary Peritoneal CancerCOMPLETEDPHASE21998-102001-01
NCT00037713Survival in a Randomized Phase III Trial in Patients With Limited Disease (LD) Small Cell Lung Cancer Vaccinated With Adjuvant BEC2 and BCGCOMPLETEDPHASE31998-092002-102002-10
NCT00190593Raloxifene Use for The HeartCOMPLETEDPHASE31998-062005-11
NCT00570011Low and Conventional Dose of Somatropin in Growth Hormone Deficient Adult PatientsCOMPLETEDPHASE31997-061998-12
NCT00670501Effects of Teriparatide in the Treatment of Postmenopausal Women With OsteoporosisCOMPLETEDPHASE31996-081999-041999-04
NCT00670319Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmenopausal Women With OsteoporosisCOMPLETEDPHASE31994-111999-091999-09
NCT00191113Somatropin Treatment to Final Height in Turner SyndromeCOMPLETEDPHASE31989-022007-122007-12
NCT00055432Gemzar (Gemcitabine) and Alimta (Pemetrexed) in the Treatment of Patients With Recurrent Platinum-Sensitive and Platinum-Resistant Ovarian or Peritoneal CancerTERMINATEDPHASE2
NCT00051506ALIMTA(Pemetrexed)/Cisplatin and ALIMTA(Pemetrexed)/Carboplatin in Extensive Stage Small Cell Lung Cancer.COMPLETEDPHASE2
NCT00034463ALIMTA (Pemetrexed) in Patients With Locally Advanced or Metastatic CancerCOMPLETEDPHASE1
NCT00035971EVA: Evista Alendronate ComparisonCOMPLETEDPHASE4
NCT00065312An Evaluation of an Oral Antidiabetic Agent for the Treatment of Type 2 DiabetesCOMPLETEDPHASE2
NCT00035061A Phase 2 Trial of ALIMTA (Pemetrexed) in Locally Advanced or Metastatic Recurrent Transitional Cell Carcinoma of the UrotheliumCOMPLETEDPHASE2
NCT00089869A Combination of Two Currently Approved Drugs to Enhance the Treatment of SchizophreniaCOMPLETEDPHASE1, PHASE2
NCT00046137Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With OsteoporosisCOMPLETEDPHASE3
NCT00034619A Phase 2 Trial of ALIMTA (LY231514, Pemetrexed) Plus Oxaliplatin Administered Every 21 Days for First-Line Treatment of Patients With Advanced Colorectal Cancer.COMPLETEDPHASE2
NCT00035035A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas.COMPLETEDPHASE3
NCT00034125Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer.COMPLETEDPHASE3
NCT00034593A Phase 2 Trial of ALIMTA (Pemetrexed) Plus Gemcitabine in Locally Advanced or Metastatic Transitional Cell Carcinoma of the UrotheliumCOMPLETEDPHASE2
NCT00094640Pharmacokinetic Characterization of Intramuscular Olanzapine DepotCOMPLETEDPHASE1
NCT00097383Study of Alimta and Epirubicin Administered in Patients With Locally Advanced or Metastatic Breast CancerCOMPLETEDPHASE1, PHASE2
NCT00034606Comparing 3 Schedules of Alimta Plus GemzarCOMPLETEDPHASE2
NCT00034502A Trial of ALIMTA (Pemetrexed) Plus Irinotecan in Patients Who Have Been Previously Treated For Metastatic Colorectal Cancer.COMPLETEDPHASE1, PHASE2
NCT00034489A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer.COMPLETEDPHASE2